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Congenital heart disease (CHD) is defined as anatomical defects of the heart or intrathoracic great 
vessels that are actually or potentially of functional significance (1). It comprises a wide spectrum of 
simple, moderate, and complex heart lesions. This condition has an estimated birth incidence of 9 
per 1,000 newborns and continues to affect most patients throughout their lives. Thanks to advances 
in diagnostic capacities, therapies, and critical care, the life expectancy of these children increased 
substantially. Nowadays, about 90% of children born with a heart lesion reach adult age (2). Despite 
these improved prospects and irrespective of the initial treatment, most patients with CHD cannot be 
considered as cured. These patients remain at risk for developing complications such as heart failure, 
endocarditis, and arrhythmias throughout their entire life spectrum. In order to prevent these 
complications, life-long follow-up and care is required. Indeed, as CHD became a life-cycle disease, 
patients move from pediatric cardiology, over adolescent clinics, to adult-focused settings and even 
geriatric care (3). At each life stage an age-appropriate care program is required to address the 
specific medical and non-medical needs of this population.  
During childhood, patients should receive care at specialized pediatric cardiology programs. 
When reaching adulthood, care should be provided at different levels according to the heart defect 
and related care needs. According to expert-based international consensus statements, care can be 
provided at three different levels; more specifically in adult congenital heart disease (ACHD) 
programs located in tertiary care centers; non-specialist care settings (e.g., general cardiology care); 
or in shared care programs (4;5). International guidelines state that during the developmental 
transition of young people with CHD towards adulthood, provision of continuous, uninterrupted care 
is mandatory. Therefore, in most cases, a timely transfer from pediatric to adult-centered care is 
essential. However, in some healthcare settings specific care programmes are provided to patients 
with CHD ‘from birth until death’. In these latter programs, an actual transfer of care from pediatric 
to adult-centered care is not mandatory, since patients are provided continuous care at each age or 
life stage. (5-7). Over the past decade, the issues of transfer and transition have received increasing 
attention (5-10).  
Definitions  
Although numerous definitions of transfer and transition can be found in the literature, to 
date, there is unfortunately no standard definition of these concepts available. Neither is there a 
clear distinction with or between other related constructs, such as transition process, transition 
planning, transition readiness, etc. (11). Both in literature and clinical practice, these concepts are 
frequently, although incorrectly, used interchangeably.  
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 Transfer has been defined as “an event or series of events through which adolescents and 
young adults with chronic physical and medical conditions move their care from a pediatric to an 
adult healthcare environment” (12). The goal of transfer of care is to maximize patient's functioning 
through the provision of high-quality, developmentally appropriate, continuous healthcare services 
(13). In late adolescence, a pediatric setting may be less suitable to provide (age-)appropriate care. 
Therefore, it is recommended to transfer the care for patients from a pediatric to an adult-focused 
setting when patients reach adult age where one is available (14). More specifically, patients with 
CHD ought to be transferred from pediatric cardiology to an Adult Congenital Heart Disease (ACHD) 
program, understanding that this may not be feasible in areas not having such an ACHD center. 
 
 Transitions, in general, are passages from one life phase, physical condition, or social role to 
another (15). Four types of transition have been previously described (16). First, ‘health/illness 
transitions’ refer to changes in health status of patients and range from adapting to a chronic illness, 
returning home from hospitalization, or recovering from surgery. Second, ‘developmental transitions’ 
occur with standard changes in the developmental stages of life such as adolescence, parenthood or 
aging. Third, ‘situational transitions’ pertain to environmental, contextual, and social changes, such 
as changing educational or professional roles or altered family situations. Fourth, ‘organizational 
transitions’ reflect changes in leadership, policies or organizational structures, affecting both 
personnel and clients of an organization (16). 
 
With respect to the provision of adolescent health care, developmental transitions are the 
most relevant type of transition. From this perspective, transition can be viewed as the evolution of 
an individual with a chronic condition from a dependent child to an independent adult. It 
corresponds with “the process by which adolescents and young adults with chronic childhood 
illnesses are prepared to take charge of their lives and their health in adulthood” (12). Transition as a 
healthcare intervention is frequently defined as “a purposeful, multi-faceted, planned process that 
addresses the medical, psychosocial, and educational/vocational needs of adolescents and young 
adults with chronic physical and medical conditions” (17). All too often, it is added that this process is 
undertaken “as patients move from child-centered to adult-oriented healthcare systems”. However, 
this additional statement may confuse the distinction from the concept of transfer. Furthermore, it is 
frequently argued that the transition process is needed to prepare patients for the transfer from 
pediatric to adult care (10;12). However, transition should not end at the time of transfer, because 
the individual continues to evolve towards adulthood (12). Indeed, transitional care remains 
important to further coach and guide individuals with CHD towards adulthood, even beyond the 
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event of transfer to adult care. Among young adults who remain with a pediatric cardiologist into 
adulthood (i.e., do not undergo transfer of care), transition remains an important and necessary 
process. Indeed, transition is normal and something that every adolescent or young adult with CHD 
needs to go through. 
 
Transfer 
Transfer of care from a pediatric to an ACHD program allows patients with CHD to be cared for 
in an environment suiting their medical and psychosocial needs. For example, adult survivors of CHD 
may develop comorbidities with which pediatricians are not familiar. Healthcare transfer overlaps, 
however, also with other significant life events, such as independent living, employment, 
relationships, and family planning, which adult providers are better suited to address. From a 
practical perspective, pediatric hospitals in many areas have an upper age limit (typically 16-18 years) 
for inpatient care. For these reasons, the involvement of adult specialists, where available, is 
mandatory for the overall well-being of young adults with CHD, as is true for young adults living with 
other types of chronic health conditions. 
 
Not only is a transfer of care important from the perspective of providing high-quality care, it 
is also important to many young people. Although data are mixed, with many young adults being 
reluctant to leave the comfort of the familiar pediatric setting (18), others indicate a lack of 
enthusiasm for continuing to share a waiting room with infants and toddlers (19), feeling that the 
experience of attending the pediatric cardiology clinic is something that they have “outgrown”.  
 
The organization of transfer of care 
Numerous expert-based recommendations emphasize the need to develop structured and 
flexible plans for the transfer of care from pediatric cardiology to an adult-focused care setting (8-
10;20). These recommendations indicate that transfer of care, or the actual handing-off of the 
responsibility of care to the patient and a team of ACHD providers, should be part of a 
comprehensive transition program (8;10).  
 
The transfer of care should be made towards the recommended level of ACHD care based on 
an established algorithm for the initial evaluation and ongoing follow-up of adults with CHD (20). It is 
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recommended that every patient, irrespective of the level of disease complexity, should be seen by 
an ACHD specialist at least once after the transfer from pediatric cardiology. During this initial post-
transfer evaluation, a thorough clinical assessment of the patient’s overall status is performed in 
order to perform a risk stratification and decide on the advised setting, level, and frequency of future 
follow-up visits (20). Hence, this initial visit to a regional ACHD center provides a good opportunity 
for the care team to review patient’s understanding about the heart lesion(s), anticipated prognosis 
including the possible need for (redo-)interventions in the future, the risk of developing 
complications, and strategies to access adult healthcare, especially in urgent situations (9;20).  
 
Based on international expert opinion, the recommended levels of follow-up are: 
Level 1 – Specialist care: Care exclusively performed by specialized CHD cardiologists in regional 
tertiary ACHD clinics (9;20) or at satellite centers. Satellite centers are regional hospitals in 
which a CHD cardiologist performs outpatient visits (21). This level of care is indispensable for 
patients with complex cardiac conditions (9).  
 
Level 2 – Shared care: Shared care is defined as care performed by a general cardiologist in 
collaboration with and/or by sending reports to specialist centers (9;21). Patients with mild to 
moderate complexity lesions can be seen in shared care facilities (9). 
 
Level 3 – Non-specialist care: Non-specialist cardiac care refers to follow-up provided by a 
general adult cardiologist but without a formal collaboration with an ACHD program; or care 
provided by a general practitioner or family physician (9;20;21). This level of care is appropriate 
for patients who are at low risk for developing comorbidities or long-term complications (9;20). 
These are typically mild heart defects. Access to specialized ACHD care must, however, be 
possible at any time if needed. 
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Table 1.1: Overview of primary heart defects with corresponding level of anatomical complexity 
 
Congenital Heart Lesions:  
Primary diagnosis 
Level of anatomical complexity based on Task Force 1  
  
Hypoplastic left heart syndrome complex 
Univentricular physiology complex 
Tricuspid atresia complex 
Tetralogy of Fallot moderate 
Pulmonary atresia with VSD complex 
Pulmonary atresia without VSD complex 
Double Outlet Right Ventricle complex 
Double Inlet Left Ventricle complex 
Truncus arteriosus complex 
Transposition of the Great Arteries (TGA) complex 
Congenitally Corrected-TGA complex 
Coarctation of the aorta moderate 
Atrioventricular Septal Defect moderate 
Atrial Septal Defect type 1 moderate 
Ebstein malformation moderate 
Pulmonary Valve abnormality moderate to complex 
Aortic valve abnormality simple if isolated, moderate if associated 
Aortic abnormality moderate 
Left ventricle outflow tract obstruction moderate 
Atrial Septal Defect type 2 simple if repaired without residua, moderate if associated 
Ventricular Septal Defect (VSD) simple if repaired without residua, moderate if associated 
Mitral valve abnormality simple if isolated, moderate if associated 
Pulmonary vein abnormality moderate 
 
 Despite the well-established rationale for transferring patients to adult care, only three-
quarters of pediatric cardiology programs in Europe and North America appeared to transfer their 
patients to adult-focused care, and only one in two transfer patients to formalized ACHD programs 
(22). These data were published in 2009 and the situation may have improved in the interim. 
Nonetheless, it is clear that ACHD guidelines and review articles published before this study had not 
led all pediatric cardiology programs to adopt transfer of care (12;23;24).  
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A prerequisite of transferring adolescents to ACHD programs is that they have not yet left the 
healthcare system (i.e., become lost to follow-up) before reaching the age of transfer. Likewise, the 
process of transfer needs to be seamless from the patient’s perspective in order to not discourage 
young adults from attending their first ACHD appointment. Unfortunately, loss to follow-up is a 
common problem in CHD and occurs both within the pediatric age range, as during and after the 
transfer process. Reid and colleagues were the first to report on the scope of the problem of loss to 
follow-up (25). Among 360 young adults (19-21 year) with moderate or complex CHD, only 47% had 
attended an ACHD clinic after the transfer of care (25). This occurred in the context of a universal 
healthcare system free of financial barriers to care. Mackie and colleagues demonstrated how 
increasing age is associated with a steady decline in attendance at pediatric cardiology clinics, with 
>20% of youth with complex lesions lost to follow-up before reaching adult age (26). Loss to follow-
up was even more prevalent among subjects having less severe lesions but requiring periodic 
cardiology reassessments (26). As a result, less than half of the adults in Canada who require ACHD 
care are actually followed in such centers (27). Yeung and colleagues reported on 158 adults with 
moderate or complex CHD referred to an ACHD program in Colorado (USA), of whom 99 (63%) had a 
lapse in care of more than two years since being seen in a pediatric cardiology clinic (28). One third 
had been told there was no need for follow-up (28), despite guidelines to the contrary (29). 
 
To date, only a limited set of risk factors for loss to follow-up has been identified, including 
male sex (26), lower socio-economic status, absence of chart documentation regarding the need for 
follow-up (25;30), and fewer surgical interventions (25). Interview data has identified additional 
factors contributing to loss to follow-up, including a lack of awareness of the importance of follow-up 
and lack of an organized approach within some families to remembering appointments (30). The 
presence of comorbid conditions, avoidance of risk-taking behaviors, and a history of attending 
pediatric cardiology appointments without a parent or sibling were factors found to be associated 
with a successful transfer (31).  
 
In order to bring about a change in practice, outcome data among young adults who 
experienced care gaps is needed. Among 52 Danish adults with CHD who sought and obtained 
cardiology care in response to an article in the lay press about loss to follow-up, 62% had significant 
residual lesions and over one third had symptoms at presentation in the adult clinic (32). A study 
performed by Yeung and colleagues reported that care gaps were associated with an increased risk 
of cardiac symptoms at presentation and with a three-fold greater likelihood of needing a catheter or 
surgical intervention within six months of being seen at the adult care facility (28). As important as 
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these experiences are, more outcome data are highly needed with respect to transfer from pediatric 
to adult care, and in particular to identify which clinical practices best promote successful transfer of 
care. 
 
 Transition 
 
When working with ’adolescents with CHD,’ it is likely more natural for healthcare providers to focus 
on the ’with CHD’ qualifier and pay less attention to the ’adolescent’ role. From developmental and 
psychological perspectives, however, adolescents are quite different from children and adults and 
represent a distinct group that warrants one’s attention and respect. Regardless of the presence of a 
chronic medical condition, a number of changes occur in adolescence, including those related to 
cognition, emotions, sexuality, and identity (33;34). As individuals progress through adolescence, 
they move from concrete thinking to more complex abstract thinking and toward social autonomy 
(34).  
 
Healthcare transition does not occur in isolation and should be considered within the 
broader context of other developmental transitions common to adolescence and young adulthood, 
including education, employment, and social relationships. There are distinct developmental tasks 
that occur during adolescence and others that take place during young adulthood (8). For example, 
adolescent tasks include setting educational and vocational goals whereas typical tasks during 
adulthood include obtaining and maintaining employment. With regard to social and family 
relationships, peers play a prominent role for adolescents, while the selection of life partners and 
reproductive issues become more prominent in adulthood. These patterns are present for most 
individuals, irrespective of the presence of CHD. Adolescents and young adults with CHD, however, 
might benefit from additional support because individuals with pediatric-onset chronic medical 
conditions are known to achieve fewer developmental milestones (e.g., autonomy, psychosexual 
development, social development) or achieve these milestones at a later age than healthy peers 
(35;36).  
Furthermore, adolescence is the developmental stage in which people typically challenge 
authority and take risks (34;37). Risk-taking increases between childhood and adolescence and 
subsequently decreases between adolescence and adulthood (37). Adolescents take risks partially to 
establish peer acceptance and autonomy and to experiment with choices (38). Egocentric thinking 
and the sense of invincibility (‘it won’t happen to me’) are strongest during adolescence (39). Risky 
health behaviours are certainly not uncommon among adolescents with CHD, with over one-quarter 
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reporting cigarette smoking, binge drinking, or illicit drug use in a 30 day recall period (40). 
Furthermore, many young people with CHD have overly optimistic expectations regarding their life 
expectancy (25). Although risk-taking during adolescence is understandable from a developmental 
perspective, parents and healthcare providers can support adolescents with CHD to mature and 
develop effective long-term health behaviours. Positive relationships and having personal goals 
might also serve as protective factors to lessen involvement in risky behaviours (39).  
 
Despite the well-established importance of developing, implementing, and testing of 
comprehensive transition programs (10;12;41;42), currently there are minimal empirical data 
regarding transitional care of young people with CHD. As indicated before, three-quarters of 
American and European pediatric cardiology programs reported that they transfer patients from 
pediatric to adult care at an average age of 18 years (22). Of those that transfer patients to adult care 
providers, less than one-third reported that they provide structured preparation within the form of 
transition for patients and family (22). Therefore, there is clear discordance between 
recommendations for a structured approach to transition and what is currently being provided to 
patients with CHD. 
 
The organization of transition 
 
The general objective of a transition program is to provide adolescents diagnosed with a 
chronic condition the time, support, and possibility to develop a set of skills, attitudes, and behaviors 
needed to prepare for adult life. Furthermore, a transition program aims more specifically, to 
prepare young patients for the transfer of care to an adult-focused program(10;14). A transition 
program aims to support patients in accomplishing skills related to decision-making, self-advocacy, 
and self-efficacy (43). Furthermore, transitional care aims to result in uninterrupted, patient-
centered, age and developmentally appropriate, comprehensive care. Ultimately, the 
implementation of a transition program should result in the optimization of the everyday functioning 
of the adolescent, satisfaction with life, and future productivity in adult life (10;17).  
 
In 2011, recommendations about managing the transition to adulthood of adolescents with 
CHD were published by the American Heart Association (AHA) (10). This comprehensive document 
recommends a formal transition process to prepare young people with CHD to become responsible 
for their health care in order to achieve optimal quantity and quality of life.  
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Based on these recommendations, transitional care should start at an early age (e.g., 10-12 
years) with a pre-transition phase (7). This preparatory phase, generally established in pediatric 
cardiology, aims to introduce and explain the objectives and key elements of transition and transfer 
early in childhood. At a young age, it is appropriate to raise the awareness of the patient and parents 
about the implications of the heart lesion(s), the need for life-long specialized follow-up, and the 
importance of maintaining a heart-healthy lifestyle. Furthermore, such a pre-transition phase 
provides parents the opportunity to gradually adapt to the growing independence of their adolescent 
child (10).  
 
When an adolescent is provided care as part of a transition program, three components are 
generally included: education and skills development, counseling, and assessment of transition 
readiness (44;45).  
 
An important component of a transition program is a comprehensive educational curriculum 
for patients and parents regarding the condition, treatment, preventive measures, and lifestyle 
matters (10). Several educational topics should be included in this curriculum (5-7;46) such as: the 
name, description and anatomy of the heart defect; medication regimen; importance of medication 
adherence; prevention of complications; signs of deterioration needing medical assessment; 
preventive strategies of endocarditis; need for life-long follow-up; healthy lifestyle choices; heart-
healthy sexual behaviors; maternal and fetal risk of pregnancy; and recurrence rates of heart 
defect(s). Although previous research revealed that significant gaps remain in the knowledge of 
patients regarding their heart defect (47-56), limited evidence is available supporting the 
effectiveness of educational interventions in young people with CHD (57-59). Furthermore, it remains 
currently unknown if the provision of education will result in improvement of the health behaviors of 
young people with CHD.  
 
Furthermore, a second component of transitional care is supporting patients in developing 
self-management skills needed to gradually assume responsibility for their health and health care. 
Self-management skills to be included in the transition curriculum are: scheduling follow-up 
appointments independently from parents, coordinating prescription renewals, be actively engaged 
in open communication with healthcare professionals during outpatient visits, being able to discuss 
topics of concern with providers, and knowing how to obtain and maintain healthcare and health 
insurance (8-10;12). Finally, issues requiring counseling include education and employment; 
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disclosing the heart defect to any future employers and colleagues; sexuality, pregnancy and family 
planning (10).  
 
Finally, at the end of the transition phase, patients’ readiness to function as an autonomous 
adult should be assessed. This includes evaluating whether an adolescent can meet the expectations 
of society and the adult healthcare system before formally being transferred to an ACHD program 
(10). It is generally assumed that patients should be capable of planning their own check-ups; be 
responsible for adhering to the prescribed medication regimen and health behaviors; be able to 
recognize signs and symptoms of complications; and understand the nature, prognosis, and 
implications of their condition (10). Assessing the level of self-management and self-efficacy of 
adolescents with regard to their care is mandatory in order to evaluate the patient’s readiness to 
transfer care (14;43;60-62). 
 
Research objectives 
 
Irrespective the current insights, there remain blind spots in the body of knowledge regarding 
transfer and transition of adolescents and young adults with CHD. Therefore, this PhD dissertation 
aimed to address three main objectives (see Figure 1.1).  
 
The first objective was to determine the relevance of investigating the concepts of transfer and 
transition in a population of young people with CHD, and the magnitude of the problem. This 
objective was addressed in several research questions investigated as part of this PhD:  
 
1. What is the importance of studies investigating transfer and transition on the ACHD nursing 
research agenda? (Chapter 2) 
2. What are the destinations of transfer in adolescents and young adults with CHD leaving 
pediatric cardiology? (Chapter 3) 
3. How are the guidelines for the management of ACHD follow-up care implemented in 
practice? (Chapter 4) 
 
The second objective was to identify multilevel predictors of care gaps within a broad 
population of young patients diagnosed with a complex chronic condition from existing literature. 
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This objective was addressed in a systematic literature review focusing on the following research 
question:  
 
4. What is the current evidence base on multilevel factors that have an impact on the 
occurrence of care gaps in adolescents and young adults with complex chronic conditions? 
(Chapter 5) 
 
Finally the third objective was to assess intermediate outcomes (i.e., disease-related 
knowledge and health behaviors) of transitional care provision in a sample of adolescents with CHD. 
A set of subsequent research questions was investigated to address this last aim:  
 
5. What is the adolescents’ understanding and knowledge of their heart defect after their 
transfer to ACHD care? (Chapter 6) 
6. What are the psychometric properties of the Health Behavior Scale-Congenital Heart 
Disease? (Chapter 7) 
7. What is the impact of a structured education program on the disease-related knowledge 
level of young people with CHD? (Chapter 8) 
8. What is the effectiveness of transitional care on the disease-related knowledge and health 
behaviors of young people with CHD? (Chapter 9) 
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Figure 1.1: Overview of research objectives addressed in this PhD dissertation 
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people with complex chronic conditions 
1. Transfer and transition as research priorities in ACHD nursing 
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Abstract 
Background: Since the population of adults with congenital heart disease (CHD) is growing, the 
role of nurse specialists is expanding. In order to advance ACHD nursing, the establishment of an 
international nursing research agenda is recommended. We aimed to investigate research priorities as 
perceived by nurse specialists and researchers in ACHD. 
 
Methods: We applied a sequential quan-qual design. In the quantitative phase, a two-round 
Delphi study was conducted, in which 37 nurse specialists and nurse researchers in ACHD care 
participated. Respondents assessed the level of priority of 21 research topics using a 9-point rating scale 
(1=no priority at all; 9=very high priority). In the qualitative phase, semi-structured interviews were 
performed with six selected Delphi panelists, to scrutinize pending research questions.  
 
Results: This study revealed that priority should be given to studies investigating knowledge and 
education of patients, outcomes of Advanced Practice Nursing, quality of life, transfer and transition, 
and illness experiences and psychosocial issues in adults with CHD. A low priority was given to post-
operative pain, sexual functioning, transplantation in ACHD, and health care costs and utilization. 
Agreement about the level of priority was obtained for 14 out of 21 research topics. 
 
Conclusion: Based on this study, we could develop an international research agenda for ACHD. 
Researchers ought to focus on these areas of highest priority, in order to expand and strengthen the 
body of knowledge in ACHD nursing. 
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Introduction 
The number of adults with congenital heart disease (CHD) in society is continuously increasing (1). 
Based on a population study in Québec, Canada, it is estimated that the prevalence of CHD is 4.09 per 
1000 adults (2). Extrapolating these figures to the approximated population of adult individuals (≥ 18 
years), there are about 1 million and 2.4 million adult patients with CHD in the USA and in Europe, 
respectively.  
 
 Irrespective of the treatment received in early childhood, patients with CHD remain susceptible 
to develop medical complications, such as arrhythmias, ventricular dysfunction, endocarditis, and 
secondary pulmonary hypertension (1,3). They are also prone to experience psychosocial and behavioral 
problems (4,5) such as anxiety (5), depression (5), compromising health behavior (6) and declined social 
integration due to problems with employability and insurability (7-10). Specific issues such as 
reproduction and pregnancy, requires an increasing attention (11,12). Hence, life-long specialized care is 
recommended for most patients, to prevent and treat possible medical and non-medical problems 
(13,14). Furthermore, a significant proportion of patients is at risk for re-operation and thus need to be 
seen regularly in ACHD regional centers and followed for life (15,16). As a result, a series of task forces, 
consensus statements, and guidelines have been convened to better define the appropriate delivery of 
care, the practice and providers of care for this growing population of adult patients (15-21). Nursing has 
played a pivotal role in patient care, teaching and research since adult congenital heart disease (ACHD) 
programs were first described (22). 
 
 According to consensus documents produced by American, Canadian and European societies,  
nurses who are trained and educated in adult congenital heart disease (ACHD) care, play an integral role 
of the interdisciplinary ACHD teams (18,20,23-27). Nurse specialists play a key role in assessing patients’ 
needs, counseling patients and their families, and facilitating the transition and transfer of adolescents 
with CHD to adult care (4,13,22,27,28). Despite the acknowledged role ACHD nurses have made, the 
nursing aspects of care provided by ACHD nurse specialists is, however, not based on scientific evidence. 
Therefore, the need to develop a nursing research agenda in ACHD is pivotal to expand the current body 
of knowledge and furthermore to provide evidence-based ACHD nursing care (4,29). The primary focus 
of research conducted by nurses includes issues such as quality of life (30-38), illness experiences (39-
47), knowledge and education (48-54), and transition and transfer to adult services (55-58).  
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  To further advance the practice of ACHD nursing based on scientific merit, the development of 
an international nursing research agenda has been recommended (59). The purpose, of this study was to 
identify research priorities as perceived by nurse specialists and researchers in ACHD nursing.  
 
Materials and methods 
Study design 
We used a sequential quan-qual design. This is a form of mixed methods research design, 
comprised of a quantitative (quan) phase, followed by a qualitative (qual) phase (60). In the quantitative 
phase, a Delphi study was conducted. A Delphi study is a structured consensus method that uses a group 
facilitation technique, consisting of multiple survey rounds. This technique is used when the goal is to 
transform the opinions of individual experts into a single group consensus (61-63). A panel of informed 
individuals, knowledgeable and experienced with the subject under investigation, is identified and 
compiled (61). These experts are sent a series of multiple structured questionnaires. Hence, the process 
of a Delphi study is multistaged. Results from each round are reported descriptively to the participants 
in subsequent rounds. Presentation of the collective opinion provides the participant with additional 
information, through which the panelist can confirm or adjust the scores given in the preceding survey 
rounds. Data collection is completed when a predetermined level of consensus is reached within the 
participating panel (61). In the present study, we used the Delphi method to quantitatively assess the 
level of priority that ACHD nurse experts give to a set of predefined research topics. For the present 
study, the Delphi study consisted of two rounds in which electronic questionnaires were individually 
filled out by the participants.  
 
 Upon completion of the Delphi study, we initiated the qualitative phase. Semi-structured 
telephone interviews were conducted with panelists who participated in both proceeding rounds of the 
Delphi study.  
 
Sample 
Potential participants for the Delphi survey were sought from the membership list of the 
International Society for Adult Congenital Heart Disease (ISACHD) Nursing Network (64). In addition, 
names of nursing participants at the 2007 ACHD congress in Philadelphia and personal contacts known 
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to the authors were added. Finally, the clinic directory of the Adult Congenital Heart Association 
(www.achaheart.org) was screened to identify hospitals that had nurse specialists in their ACHD 
program. An email was sent to this list of individuals to identify potential participants. Eligibility criteria 
were (i) nurses whose clinical practice primarily focused on ACHD care; (ii) held a position as a nurse 
specialist, nurse practitioner or nurse researcher in ACHD; (iii) expressed their willingness to participate 
in this Delphi study; and (iv) availability of valid contact information. A total of 47 nurses met the 
inclusion criteria. During the first Delphi round, 37 of the 47 eligible participants completed the survey 
form (response rate=78.7%). In the second round, 33 of the 37 nurses who participated in the first 
round, completed the form (response rate=89.2%). The characteristics of the participants (n=37) are 
described in Table 2.1. 
 
 Potential participants for the qualitative phase were selected based on the priority scores they 
individually gave to predetermined research topics during the Delphi study. Individual ratings of the 
level of priority were compared to the overall group rating. Potential interviewees were selected if their 
individual ratings were either divergent or convergent with the overall group rating. Furthermore, 
potential interviewees were included when they were actively involved in nursing research. A total of six 
out of eight potential interviewees (75%) agreed to participate.  
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Table 2.1: Professional characteristics of panelists of the Delphi study (n=37) 
 
Variables n (%) 
Gender  
Female 
Male 
 
35 (94.6%) 
2 (5.4%) 
 
Age in years (median;Q1-Q3) 44;39-50 
 
Highest level of education 
Certificate in nursing/ Associate degree 
Bachelor in nursing/ Polytechnic 
Master of Science in Nursing 
PhD-student 
PhD/Doctorate 
 
5 (13.5%) 
4 (10.8%) 
23 (62.2%) 
2 (5.4%) 
3 (8.1%) 
 
Type of hospital 
Local hospital 
Regional hospital 
University hospital 
Other 
 
3 (8.1%) 
1 (2.7%) 
32 (86.5%) 
1 (2.7%) 
 
Work setting (>1 setting possible) 
Outpatient clinic 
Cardiac ward/Cardiac surgery 
Research/Academic 
Education 
Other 
CCU/ICU 
Cathlab 
 
31 (83.8%) 
14 (37.8%) 
9 (24.3%) 
8 (21.6%) 
6 (16.2%) 
4 (10.8%) 
3 (8.1%) 
 
Involvement in nursing research 27 (73.0%) 
 
Years of experience in ACHD (median; Q1-Q3) 
 
5; 3-10 
Country 
USA 
UK  
Canada 
Belgium 
The Netherlands 
Singapore 
Denmark 
Sweden 
 
19 (51.4%) 
4 (10.8%) 
4 (10.8%) 
3 (8.1%) 
3 (8.1%) 
2 (5.4%) 
1 (2.7%) 
1 (2.7%) 
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 Delphi survey instrument 
The Delphi survey form was developed in two stages. First, a literature review was performed 
to determine the topics already investigated in nurse-led studies. We conducted a systematic 
literature search in the databases Medline and Cinahl, using the keywords ‘congenital heart’ AND 
adult AND nurs*. This search resulted in 330 hits (Figure 2.1), published between January 1980 and 
July 2010.  
 
 After elimination of duplicates, publications by non-nurses, and articles for which no abstract 
or full text was available, 159 publications were identified for further analysis. Overall, 101 articles 
pertained to ACHD, nine of which were editorials, eight were conference abstracts, and 84 were full 
articles. Forty-six articles were either reviews or reports, leaving 64 empirical studies for systematic 
analysis. The majority of these empirical nursing studies investigated quality of life (n=10) (30-38;62), 
followed by illness experiences and psychosocial issues (n=9) (39-47), knowledge and education (n=7) 
(48-54), transfer and transition (n=4) (55-58), and health behavior (n=4) (66-69) (Figure 2.1). Issues 
that were investigated to a lesser extent were: pregnancy and gynaecological issues (11,12,70); 
organization of care (71,72); sexual functioning (73); implementation of advanced practice nursing 
(29); post-operative pain (74); nursing care in general (75); health care costs and utilization (76); 
physical activity (77); and palliative care (78). Based on the results of this systematic literature 
review, a preliminary list of 13 research topics in ACHD nursing was composed.  
 
This preliminary list was then presented to the executive board of the ISACHD Nursing 
Network. The members of this board were asked to propose additional topics for nursing research. 
Eight additional topics were proposed, resulting in a total of 21 ACHD-related research topics. These 
21 topics were included in the final survey form for round one of the Delphi study. Respondents were 
asked to indicate the level of priority for each of the 21 predefined research topics, using a 9 point-
rating scale (1=no priority at all; 9=very high priority). Free text space was provided, giving 
participants the opportunity to generate ideas and suggest additional research topics based on their 
professional experiences. The survey form was accompanied by a short self-report questionnaire on 
professional characteristics. 
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Figure 2.1: Flowchart systematic literature review 
 
Chapter 2: Transfer and transition as research priorities in ACHD nursing 
 
 
28 
 
Data collection 
Eligible experts received an electronic invitation explaining the aims of the study and 
describing the methodological principles of a Delphi survey. A questionnaire was attached to this 
letter with instructions to be completed within two weeks. Non-responders received up to three 
reminders.  
 
 After data collection was completed in round 1, data were analyzed descriptively (median, 
Q1-Q3 and range).The panelists were then invited to partake in round two. In this second round, all 
panelists were given their personal responses from round one, the overall group rating of all 21 
predefined research topics. Furthermore, panelists were given the opportunity to reconsider their 
initial scores in light of the results of the preceding round. Again, in the second Delphi round, experts 
indicated the level of priority of each research topic using a 9-point rating scale. Data collection in 
round two was completed when there was agreement for more than two-thirds of the 21 research 
topics. 
 
 Next, to further scrutinize the pending research questions in depth, qualitative data 
collection commenced. Using an interview guide, semi-structured telephone interviews, were 
conducted. Individual interview guides were developed using the individual ratings given to the 
research topics in the quantitative phase. Interviewees were asked to clarify the priority levels they 
assigned to certain research topics. Furthermore, interviewees were asked to formulate research 
questions they would suggest for future studies regarding each of the research topics in the top five. 
Six interviews, each lasting 30-60 minutes, were conducted audio taped and transcribed verbatim.  
 
Data analysis 
Descriptive statistics of the quantitative data from the two sequential Delphi rounds were 
obtained using Statistical Package for the Social Sciences 17.0 (SPSS Inc., Chicago, IL). Frequency 
tables of attributed priority scores were composed and median scores, range of scores and quartiles 
(Q1-Q3) were calculated. Furthermore, priority scores collected in round two of the Delphi study 
were analyzed using RIDIT analysis in order to classify the research topics according to an increasing 
level of priority. RIDIT analysis is a statistically valid method to analyze ordinal data (79,80). In this 
analysis technique, the distribution of item scores is compared with a reference distribution. We 
used the distribution of priority scores over all research topics in our sample of panelists as the 
reference distribution. The RIDIT obtained for each item reflects the probability that this particular 
research topic received a higher priority score than another randomly selected topic of the list (81). 
Chapter 2: Transfer and transition as research priorities in ACHD nursing 
 
 
29 
 
RIDIT’s value ranges from 0 to 1, and higher RIDIT-scores indicate a greater chance that a specific 
research topic received a higher priority than another randomly selected topic.  
 
 Additionally, a Disagreement Index (DI) was calculated for each research topic, to evaluate 
whether consensus was reached about the assigned level of priority. The DI expresses the diffusion 
of ratings. To calculate the DI, the Interpercentile Range (IPR) is divided by the Interpercentile Range 
Adjusted for Symmetry (IPRAS). A DI-value greater than 1 indicates significant disagreement (82).  
 
 Finally, qualitative data obtained from the semi-structured interviews were analyzed using a 
descriptive content analysis, in which verbatim transcripts were labeled. 
 
Results 
Quantitative analysis of research priorities in ACHD nursing 
Analysis of the priority scores revealed that 17 out of 21 ACHD-related research topics received 
a median score ≥ 7 on a scale from 1 to 9 (Figure 2.2). The four remaining research topics received a 
median priority score of five or six. Analysis of the range of scores for each research topic, revealed a 
great variability in the lowest score, whereas the highest score was always nine, with the exception 
of one topic that received a maximum score of eight.  
 
 Based on RIDIT-analysis, we were able to determine a rank order of research priorities 
(Figure 2.2). The research topics that were given top priority in ACHD nursing were knowledge and 
education of patients, followed by outcomes of advanced practice nursing (APN), quality of life, 
transfer and transition to ACHD care, illness experiences and psychosocial issues, pregnancy and 
gynecological issues, health behavior, exercise capacity, role development of APN, organization of 
care, and palliative care and end-of-life issues. A low priority was given to post-operative pain, sexual 
functioning, transplantation in ACHD, and health care costs and utilization.  
 
Analysis of the Disagreement Index (DI) demonstrated that there was agreement on the 
priority scores given to 14 out of 21 (66.7%) suggested topics. There was agreement on the 13 
highest ranked research topics, as well as on the lowest ranked topic. There was disagreement 
among the panel of experts on the priority that should be assigned to the topics regarding 
long-term survival, survival outcomes of specific interventions, cognition issues, nursing care in 
general, health care costs and utilization, transplantation in ACHD and sexual functioning. 
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Qualitative analysis of research priorities in ACHD nursing 
 
In semi-structured interviews, participants were asked to reflect on specific themes and 
research questions for the five topics that received the highest priority in the Delphi study. The 
themes and research questions suggested are listed in Table 2.2. For knowledge and education of 
patients, specific research questions were formulated with respect to (i) patients’ knowledge of the 
impact of the disease; (ii) development of an educational plan for life; and (iii) learning difficulties or 
neuro-cognitive impairment in patients with CHD. Research on outcomes of the APN role should 
specifically target the implementation of different APN roles in ACHD care. For quality-of-life 
research, it is suggested to undertake studies in specific subgroups of patients with CHD. 
Furthermore, studies on the development of a transition program for adolescents with CHD, and 
evaluation of the effectiveness of different models of transitional care are advocated (Table 2.2).  
 
Discussion 
ACHD is a growing area of practice, one in which a growing number of nurses are directly 
involved. Numerous ACHD programs have nurse specialists on staff (71) and are assumed to provide 
evidence-based care. In addition, an increasing number of nurses are undertaking empirical studies in 
adults with CHD. As providers are preparing for the next decade of ACHD care, it is important to 
know the priority of topics to be examined in future studies. Therefore, in this study we examined 
the research priorities as perceived by nurse specialists and nurse researchers in ACHD and, 
subsequently, developed an international nursing research agenda. The five most important areas for 
ACHD nursing research were: patient’s knowledge and education, APN outcomes, quality of life, 
transfer and transition to adult CHD care, and illness experiences and psychosocial issues. 
 
Indeed, highest priority was given to studies investigating the knowledge and education of 
adults with CHD. As pediatric patients move into adult setting, it is assumed they are prepared to 
become responsible for their life and health care. In order to take up this responsibility, however, 
adults with CHD need to have sufficient knowledge about their disease, treatment and preventive 
measures. To date, seven studies were conducted by nurses concerning knowledge and education 
(48-54). These studies have reported that important gaps in the knowledge of these patients exist 
concerning their heart defect, treatment and preventive measures; and pointed out that there is a 
need to develop, implement and evaluate structured educational activities (52,54).  
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Figure 2.2: Priority scores of 21 predefined research topics in ACHD  
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Table 2.2: Suggested research questions on top 5 research priorities in ACHD (n=6) 
 1. KNOWLEDGE AND EDUCATION OF PATIENTS WITH CHD 
 (i) Knowledge on the impact of the disease: 
 
 What is the knowledge of patients on continuity of care (e.g., knowledge on health care 
insurance, reasoning for follow-up, recommended frequency of follow-up visits, how to 
navigate through the healthcare system)?  
 What is the knowledge of patients regarding pharmacological treatment (e.g., prescribed 
frequency and doses of medication, possible side-effects, consequences of non-
adherence)? 
 What is the knowledge of patients, both sexes, on pregnancy counseling (e.g., knowledge 
on potential risks and complications during pregnancy)? 
 What is the knowledge of patients concerning recommended and/or allowed physical 
activities with regard to their heart condition?  
 
(ii) Development of an educational plan for life: 
 
 What do patients want to know at different stage of their life and their disease? 
 Which components from educational models implemented in patients with a chronic 
condition can be implemented in CHD care? 
 Which educational interventions or programs are effective in enhancing the level of 
knowledge in patients with CHD? 
 
(iii) Learning difficulties and neuro-cognitive impairment: 
 
 What is the proportion of patients with CHD who are neuro-cognitively impaired? 
 Which factors could predict the development of learning difficulties in patients with 
CHD?  
 
 2. OUTCOMES OF ADVANCED PRACTICE NURSING 
 (i) Evaluation of the implementation of APN roles: 
 Which outcomes, parameters and/or indicators should be measured in order to evaluate 
the impact of different APN roles?  
 What is the impact of APN roles in ACHD care on the predefined outcomes, parameters 
and/or indicators related? 
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 3. QUALITY OF LIFE 
  What is the quality of life in the overall sample of patients with CHD? 
 What is the quality of life in specific subgroups of patients with CHD (e.g., cyanotic heart 
lesions) based on their clinical characteristics? 
 What is the quality of in children and adolescents with CHD? 
 What is the quality of life in adult patients with CHD? 
 What is the quality of life in patients with CHD across different levels of care and settings 
for cardiac follow-up? 
 What are the psychometric properties of the instruments used to investigate quality of 
life? 
 
 4. TRANSFER AND TRANSITION TO ADULT HEALTH SERVICES 
 (i) Development of a transition program: 
 What is the core content or the key elements of a transition program for patients with 
CHD? 
 
(ii) Evaluation of the effectiveness of transition programs: 
 Which outcomes, parameters and/or indicators should be measured in order to evaluate 
the effectiveness of a transition program in patients with CHD? 
 Which factors influence continuity of care in adults with CHD? 
 What benefits could a transition program give to patients, parents, healthcare workers 
and the healthcare system in CHD care? 
 What is the effectiveness of different organizational models of transition and transfer of 
care in patients with CHD? 
 
 5. ILLNESS EXPERIENCES AND PSYCHOSOCIAL ISSUES 
  What is the impact of illness experiences of patients with CHD on their daily living? 
 Which psychosocial and behavioral problems occur in adolescents with CHD (e.g., 
anxiety, depression, etc.)? 
 
Chapter 2: Transfer and transition as research priorities in ACHD nursing 
 
 
34 
 
In the present study, participants indicated that priority should be given to studies assessing 
the level of knowledge of patients regarding the need for follow-up, their treatment, pregnancy 
counseling and physical activities. Further, future research should focus on the development and 
evaluation of an educational plan for the lifespan of patients.    
 
 In our study, the second research priority was research on the outcomes of APN. Indeed, 
when performing our systematic review, there were no publications identified which investigated the 
outcomes of the implementation of the APN role. However, to advance the role of ACHD nursing, it is 
important to measure the impact of APN and to identify targets for improvement. Although during 
our Delphi study, a lower priority score was assigned to studies examining role development of APN, 
interviewees stressed however the importance of conducting research on the development and 
impact of the APN role. Internationally, a number of different roles are defined within the scope of 
APN. To better define the qualifications, tasks, responsibilities and outcomes of ACHD APNs, future 
research on role development is needed.  
 
 The third priority in the research agenda was quality of life in adults with CHD. To date, ten 
nurse led studies were conducted on quality of life in ACHD patients (30-38;65). Hence, quality of life 
is the topic most frequently investigated by nurses involved in ACHD care. Furthermore, a survey 
among European ACHD nurse specialists showed that 90% of the nurse specialists who were involved 
in nursing research, conducted quality-of-life research (29). Therefore, it could be counterintuitive 
that quality-of-life research is still highly needed. The present study, however, revealed that 
additional studies on quality of life are required, particularly studies conducted in specific subgroups 
of patients based on for example their age, type of heart defect or other clinical characteristics. 
Additionally, it is for example, important to identify patients with a high risk for poor quality of life, 
and investigate interventions to improve their quality of life.  
 
 The fourth priority was the transition and transfer of adolescents with CHD to adult-focused 
facilities. Since the majority of patients with CHD need cardiac follow-up throughout their entire life 
span (16,18,20,83-85), a timely transfer of care from pediatric cardiology to different levels of adult-
focused care has been recommended (18-20;85). Several consensus documents have described the 
need for the implementation of transition programs that prepare adolescents with CHD for the 
transfer of care when becoming an adult (18,27,85). To date, only four nurse-led studies in this area 
were found. These studies either investigated the experiences and expectations of patients with CHD 
regarding transfer and transition (56,58), or studied the current practices on transfer and transition 
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in 69 European and North-American centers (55). The need for additional research on the 
development of transition programs, subsequently followed by experimental studies evaluating the 
effectiveness of such programs, was expressed in our study.  
 The fifth research priority was the illness experiences and psychosocial issues of patients with 
CHD. In order to give patients comprehensive care, attention must be given to both medical and non-
medical complications patients might experience (4). Nurses need to comprehend which 
psychosocial obstacles patients face when growing up with CHD. It is suggested that future research 
should focus on the impact of illness experiences of adults with CHD in their daily living.  
 
 This study was the first to establish an international nursing research agenda for ACHD 
nursing. However, there are some limitations to bear in mind when interpreting the results of this 
study. First, only 73% of the panelists who participated in the Delphi study were involved in research. 
This could imply that nurses gave priority to certain research topics without taking the feasibility of 
such studies into account. Second, when using the Delphi technique, consideration must be given to 
the level of consensus to be employed. However, a universally recommended level of agreement 
does not exist. McKenna et al. suggested a minimal agreement of 51% amongst panelists, while 
others would recommend to obtain a consensus level of 65%, 70% or even 80% (63,86). We chose to 
terminate data collection through the subsequent Delphi rounds, when agreement on the priority 
scores was obtained for at least two third of the 21 research topics. We calculated a Disagreement 
Index for each of the 21 predefined research topics in order to evaluate whether agreement was 
obtained. Third, because we used a mixed methods design, we had the opportunity to investigate the 
top five research priorities in depth by conducting semi-structured interviews. These interviews 
revealed that panelists possibly indicated certain research priorities based on their own hospital 
experience and current working setting suggesting possible bias. For example, when a nurse worked 
in a hospital where patients were not transferred from pediatric cardiology to an adult-focused 
facility because the hospital provides one comprehensive program for the entire life-span of the 
patient, nurses gave a low priority score to this research area.  
 
Conclusion 
Based on this mixed methods study, an international nursing research agenda on ACHD has 
been established. Topics that should receive the highest priority are: patient knowledge and 
education, APN outcomes, quality of life, transfer and transition to adult care, and illness experiences 
and psychosocial issues. Hence, current and future nurse researchers should consider these areas in 
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order to expand the evidence basis, strengthen the body of knowledge and prepare ACHD nursing for 
the next decade. 
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Abstract 
Objectives: The transfer of adolescents with congenital heart disease from pediatric to adult 
care was examined. The aims were to investigate where these adolescents received adult-centered 
care, to determine the proportion of patients with no follow-up and with no appropriate follow-up 
after leaving pediatric cardiology, and to explore the determinants of no-follow-up and no 
appropriate follow-up. 
 
Background: Even after successful treatment, many patients require lifelong cardiac 
surveillance by specialized practitioners. Although guidelines describe the most appropriate level of 
follow-up, this is not always implemented in practice. 
 
Methods: A descriptive, observational study was performed, including 794 patients with 
congenital heart disease examined and/or treated at a tertiary care center.  
 
Results: Overall, 58 of the 794 patients included (7.3%) were not in follow-up. Cessation of 
follow-up was found in 2 of 74 patients with complex (2.7%), 31 of 448 patients with moderate 
(6.9%), and 25 of 272 patients with simple (9.2%) heart defects, Moreover, 684 patients (86.1%) 
remained in specialized follow-up. According to international guidelines, 81 patients (10.2%) did not 
receive the minimal level of cardiac care. Multivariable logistic regression revealed that male sex and 
no prior heart surgery were associated with no follow-up. Male sex, no prior heart surgery, and 
greater complexity of congenital heart disease were associated with no appropriate level of cardiac 
follow-up. 
 
Conclusions: The proportion of patients in this study lost to follow-up was substantially lower 
than in other Western countries. Because only patient-related factors were examined with respect to 
loss to follow-up, further examination of patient-related, hospital-related, and healthcare-related 
determinants of lack of follow-up is needed. 
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Introduction 
Congenital heart disease (CHD) is considered to be the most common birth defect, with an 
incidence of 0.8% in newborns (1). A substantial increase in life expectancy has been observed in the 
past decades, with approximately 90% of children born with CHD surviving into adulthood (2). 
Despite this improvement, patients with CHD can experience residua or sequelae of the initial 
treatment they received. Therefore, these defects are considered to be “repaired” rather than 
“cured”. Hence, even after successful primary treatment or surgery, many patients with CHD require 
lifelong cardiac surveillance by specialized practitioners (3-5). 
 
 International guidelines and consensus statements describe the most appropriate setting for 
follow-up of patients with CHD. During childhood, these patients are most appropriately followed up 
in pediatric programs. As they approach adulthood, a timely transfer to an adult congenital heart 
disease (ACHD) program is advocated (6-9). However, different levels of adult-centered care exist. 
For instance, guidelines categorize the level of ACHD care into 3 types: 1) specialist care; (2) shared 
care; and (3) non-specialist care (6). Specialist care is follow-up given by specialized ACHD 
cardiologists and is provided mainly at tertiary care centers. Shared care is follow-up given by a 
general adult cardiologist in close collaboration with a CHD specialist. Nonspecialist care is follow-up 
given by a general or community cardiologist, or a general practitioner, with access to specialized 
care if needed (6). 
 
 Guidelines describe which level of care is most appropriate for each type of heart defect 
(5,6,9). Except for patients with ligated and divided ductus arteriosus, all patients should continue to 
receive cardiac care from a specialized ACHD program, a local healthcare provider, or a collaboration 
between local and specialist providers (9). Patients with complex heart defects, such as cyanotic 
heart disease or transposition of the great arteries, should receive checkups every 6 to 12 months at 
a specialist center (5). Patients with moderate -complexity lesions, such as Tetralogy of Fallot, 
atrioventricular septal defects, or coarctation of the aorta, should have follow-up visits every 1 to 2 
years (5). This is preferably done at specialist centers (5) but can also be undertaken at shared care 
facilities if the CHD course is uncomplicated (6). Patients with simple heart defects, such as small 
atrial septal defects or patent ductus arteriosus, need medical check-ups every 3 to 5 years, either in 
a non-specialized setting or at shared care facilities (5,6). 
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When patients with CHD transition from adolescence to adulthood, they should be 
transferred to the most appropriate adult-focused facility without interruption (10). However, 
studies in Canada (11,12), Germany (4), the United Kingdom (13), and the United States  (14) have 
demonstrated that 21% to 76% of adolescents with CHD are either lost to follow-up or experience 
lapses in care after leaving pediatric cardiology. To the best of our knowledge, no studies have 
comprehensively assessed the settings of care in which adolescents with CHD receive care after 
leaving pediatric cardiology. Therefore, the aims of the present study were: 1) to determine the 
transfer destinations of adolescents with CHD after leaving pediatric cardiology; 2) to determine the 
proportion of patients with no follow-up and no appropriate follow-up after leaving pediatric 
cardiology; and 3) to explore the determinants of no-follow-up and no appropriate follow-up. 
 
Methods 
Setting 
As part of the Switch² (Self-Management and Well-being Improvements by Transitioning 
Adolescents With Chronic Disorders in Hospital and at Home) research program (15), we conducted a 
descriptive, observational study at the University Hospitals Leuven (Leuven, Belgium). Belgium is a 
small country with a high population density. Belgium currently has 7 tertiary care centers for 
pediatric cardiology (16). The pediatric cardiology department of the University Hospitals Leuven 
cares for 27% of Belgian patients with CHD. At this center, it is standard practice to transfer patients 
from pediatric cardiology to adult-focused services when they reach 16 years of age, unless they are 
medically unstable. Because the pediatric CHD and ACHD programs are located in the same building, 
transferring patients and medical information is easy. Furthermore, both programs share one 
database of the clinical follow-up of patients. Although transfer from pediatrics to adult-focused care 
is well established, we do not have a formal transition program that prepares adolescents for the 
transfer and to take responsibility of their own care (17). 
 
Study population 
Eligible patients were adolescents with CHD, which was defined as structural abnormalities of 
the heart or intrathoracic great vessels that are actually or potentially of functional significance (18); 
were born between 1984 and 1988; and had one or more cardiac consults in pediatric cardiology 
between 2000 and 2004. The rationale for selecting these patients is that they had at least 1 
outpatient visit at pediatric cardiology during adolescence, showing that they were not considered to 
be cured in childhood. Because they were 21 years of age or older in 2009, it could be assumed that 
all patients were cared for in adult-focused care facilities. We excluded patients who had died and 
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those who had morphologically normal hearts, Wolff-Parkinson-White syndrome or cardiac 
arrhythmia without structural defects, non-cardiac congenital defects, or pulmonary hypertension 
without structural anomalies. Heart transplant recipients were also excluded. On the basis of the 
center’s database and outpatient appointment lists, we were able to identify all patients who met 
the inclusion and exclusion criteria. We included all 813 patients who were eligible for inclusion in 
this study. Nineteen patients moved abroad and were excluded for statistical analysis because we 
could not obtain information about their current level of care. Hence, the final sample comprised 794 
patients. Socio-demographic and clinical characteristics of this sample are presented in Table 3.1.  
 
Definitions 
To categorize patients according to their primary heart defect, we used a modified version of 
the hierarchy of heart defects developed by the CONCOR (CONgenital COR Vitia) project, an initiative 
to form a national registry of patients with CHD in the Netherlands (18). The modifications are 
detailed elsewhere (16). In Table 3.1, the heart defects are rank ordered according to the CONCOR 
classification scheme. Furthermore, using the criteria of the Task Force 1 of the 32nd Bethesda 
Conference, we categorized patients according to the complexity of their heart defects (simple, 
moderate, and complex) (20). 
 
 Transfer destinations were defined based on the three levels of CHD care described by 
Deanfield et al. (6): specialist care, shared care, and non-specialist care. For the purposes of the 
present study, we subdivided specialist care into pediatric cardiology care, ACHD care, and care at 
satellite centers. The latter type of care refers to local hospitals that have a CHD cardiologist-
operated outpatient clinic. Shared care is defined as care performed by general cardiologists who see 
patients with CHD but who send reports to a specialist centers for passing on information and 
obtaining clinical advice, if needed. Finally, non-specialist care is defined as care by general adult 
cardiologists who do not send follow-up reports to a specialist centers or care provided by general 
practitioners.  
For inferential statistics, patients were noted as having no follow-up if they indicated that 
they were currently not in cardiac follow-up or if they could not be contacted by mail or phone. 
Minimal levels of care were determined according to the type and complexity of heart defects (5,6).  
The guidelines of Task Force 4 of the 32nd Bethesda Conference (5), with a few exceptions, are 
applied by our pediatric and ACHD cardiologists. Their expert opinions were used to determine the 
appropriate minimal level of care for our patients. Patients were noted as being in appropriate 
follow-up if they received follow-up in a setting that was minimally required or more specialized.  
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Table 3.1: Sociodemographic and Clinical Characteristics of 794 Patients with CHD 
Socio-demographic and clinical characteristics                                                                  n (%) 
   
Year of birth 
 
1984 
1985 
1986 
1987 
1988 
147 (18.5) 
126 (15.9) 
175 (22.0) 
158 (19.9) 
188 (23.7) 
 
Sex 
 
Male 
Female 
421 (53.0) 
373 (47.0) 
 
Primary CHD diagnosis 
 
Hypoplastic left-heart syndrome 
Univentricular physiology 
Tetralogy of Fallot 
Pulmonary atresia with VSD 
Pulmonary atresia without VSD
 
DORV 
DILV 
Truncus arteriosus 
TGA 
Congenitally-corrected TGA 
Coarctation of the aorta 
AVSD 
ASD type I 
Ebstein malformation 
Pulmonary valve abnormality 
Aortic valve abnormality 
Aortic abnormality 
    Left ventricle outflow tract obstruction 
ASD type II 
VSD 
Mitral valve abnormality 
Pulmonary vein abnormality 
Other 
 
1 (0.1) 
14 (1.8) 
72 (9.1) 
0 (0) 
2 (0.3) 
18 (2.3) 
1 (0.1) 
3 (0.4) 
31 (3.9) 
4 (0.5) 
90 (11.3) 
48 (6.0) 
10 (1.3) 
3 (0.4) 
94 (11.8) 
106 (13.4) 
14 (1.8) 
22 (2.8) 
60 (7.6) 
118 (14.9) 
51 (6.4) 
10 (1.3) 
22 (2.8) 
Complexity of primary CHD 
diagnosis 
 
Simple 
Moderate 
Complex 
 
272 (34.3) 
448 (56.4) 
74 (9.3) 
Prior interventions No intervention 
Only catheter intervention 
Only surgical intervention 
    Both catheter and surgical 
intervention 
 
301 (37.9) 
60 (7.6) 
379 (47.7) 
54 (6.8) 
Distance from home to 
University Hospitals Leuven 
(km) 
 
0-49 
50-99 
100-149 
150-199 
>200 
235 (29.6) 
407 (51.3) 
125 (15.7) 
26 (3.3) 
1 (0.1) 
Values are n (%);
 
ASD= atrial
 
septal defect; AVSD= atrioventricular septal defect; CHD= congenital heart disease; 
DILV= double-inlet left ventricle; DORV= double-outlet right ventricle; TGA= transposition of the great arteries; 
VSD= ventricular septal defect 
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Procedure 
For 676 patients, data on setting of cardiac follow-up were obtained from our hospital 
information system. The remaining 137 patients received an information letter, including an 
informed consent form, requesting information about their current follow-up settings. We 
telephoned patients as a reminder. Nine patients could not be contacted by mail or telephone; they 
were untraceable. Sex, year of birth, primary CHD diagnosis, CHD complexity, prior cardiac surgery, 
prior catheter interventions, and distance from patients’ home to the University Hospitals Leuven 
was determined on the basis of the patients’ medical records and additional data.  
 
The institutional review board of the University Hospitals Leuven approved the study 
protocol. The study was performed in accordance with ethical standards, as described in the 2002 
Declaration of Helsinki. 
 
Statistical analysis 
Data were analyzed using SPSS version 17.0 (SPSS, Inc., Chicago, Illinois). Nominal and ordinal 
data are presented as absolute numbers and percents. To determine sociodemographic and clinical 
variables associated with no follow-up and no appropriate follow-up, we performed multivariable 
logistic regression analysis using a backward stepwise method. Results are reported as odds ratios 
(ORs) and 95% confidence intervals (CIs). All tests were 2-sided, and a p value of 0.05 was used as a 
cut-off for statistical significance.  
 
Results 
Transfer destinations  
Out of the 794 patients included in the study, a total of 627 adolescents with CHD (79.0%) 
received follow-up at a tertiary care center. Of these, 613 (97.8%) were transferred to ACHD 
programs, and 14 (2.2%) were still in follow-up at pediatric cardiology (Figure 3.1). In addition, 57 
patients (7.2%) received follow-up at a satellite center. Hence, altogether, 86.1% of the patients 
continued to receive specialist care when they reached young adulthood. Fifty-two adolescents 
(6.5%) received cardiac follow-up from a general adult cardiologist. In 29 of the 52 cases (55.8%), 
cardiologists sent exam reports to CHD specialists; this type of follow-up was considered to be shared 
care.  
 
 Forty-nine patients (6.2%) had no cardiac follow-up after leaving pediatric cardiology, and 9 
patients (1.1%) were untraceable. Hence, 58 of the 794 patients included (7.3%) were considered to 
be lost to follow-up. More specifically, 2 of the 74 patients with complex (2.7%), 31 of the 448 
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patients with moderate (6.9%), and 25 of the 272 patients with simple (9.2%) heart defects were no 
longer in cardiac follow-up. 
 
Minimal level of cardiac care 
On the basis of primary diagnosis and complexity of the congenital heart lesions, we 
subdivided patients into 3 groups relating to the minimal level of care they should receive. The first 
group consisted of patients who should receive specialist care exclusively (Table 3.2). This level of 
care can be performed at pediatric cardiology, ACHD programs, or satellite centers. In all, 225 
patients (90%) received specialist care. Ten patients (4%) received shared care, 9 patients (3.6%) 
received non-specialist care, 5 patients (2%) were no longer in follow-up, and 1 (0.4%) patient was 
untraceable. These latter levels of care were suboptimal for these patients.  
 
Among 247 patients who should receive specialist or shared care, 215 patients (87%) 
received specialist care and 7 patients (2.8%) received shared care (Table 3.3). Four patients (1.6%) 
received nonspecialist care, 17 patients (6.9%) were not in follow-up, and 4 patients (1.6%) were 
untraceable.  
 
Of the 297 patients for whom nonspecialist care would be sufficient, 244 patients (82.2%) 
continued specialized follow-up, 12 patients (4%) received shared care, and 10 patients (3.4%) 
received nonspecialist care. Twenty-seven patients (9.1%) were not in cardiac follow-up, and 4 
patients (1.3%) were untraceable (Table 3.4).  
 
Altogether, our data revealed that 81 patients (10.2%) did not receive follow-up at the 
recommended level of care. These patients were considered as receiving no appropriate cardiac 
follow-up.  
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Figure 3.1: Transfer destinations in 794 patients with CHD 
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Table 3.2: Congenital Heart Defects Requiring Specialist Care 
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Table 3.3 Congenital Heart Defects Requiring Specialist or Shared Care 
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Table 3.4: Congenital Heart Defects for Which Non-specialist Care Is Sufficient 
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Factors associated with ‘no follow-up’ and ‘no appropriate follow-up’ 
We investigated the association between five socio-demographic and clinical variables and no 
follow-up and no appropriate follow-up: sex, prior heart surgery, prior catheter intervention, 
complexity of heart defect, and distance from patients’ homes to our hospital. Independent 
correlates of no cardiac follow-up after leaving pediatric cardiology were male sex (OR:1.80; 
95%CI:1.02 to 3.17) and no prior heart surgery (OR: 5.97; CI: 3.04 to11.72). No appropriate level of 
cardiac follow-up after leaving pediatric cardiology was associated with male sex (OR: 1.63; CI: 1 to 
2.63), no prior heart surgery (OR: 3.30; CI: 1.88 to 5.77,); and greater complexity of CHD (OR: 1.61; CI: 
1.04 to 2.49).  
 
Discussion 
Continuing follow-up is important for many patients with CHD. However, studies have shown 
that numerous patients are lost to follow-up or have  lapses in care after leaving pediatric cardiology 
(4,11-14). Furthermore, not all patients receive the optimal level of care. Therefore, we investigated 
the destinations of transfer in adolescents with CHD, determined the proportion of patients with no 
follow-up and no appropriate follow-up after they leave pediatric cardiology, and sought correlates 
of no-follow-up and no appropriate follow-up.  
Comparing our findings with published data, the situation at our center appears to be 
substantially better than in other Western countries. To date, five studies have described the 
proportion of patients lost to follow-up and/or experiencing lapses in care after leaving pediatric 
cardiology (21). Reid et al. (11) investigated medical care in 360 patients aged 19-to 21 years with 
complex CHD.  These patients were followed up in pediatric cardiology at the Hospital for Sick 
Children in Toronto, Ontario, Canada, before the age of 18 years. The investigators defined successful 
transfer as patients attending ≥1 appointment at a Canadian ACHD center. In this study, 53% of the 
patients did not successfully transfer, and >25% had no cardiac appointments after the age of 18 
years.  
At the German Heart Center in Munich, Germany, Wacker et al. (4) evaluated the rate and 
outcomes of adults with CHD lost to follow-up at their institution. Patients were selected from the 
CHD program registry (n>10,500). This population included a broad spectrum of CHD. Loss to follow-
up was defined as patients’ failing to return for follow-up visits to their center for >5 years. The 
investigators found that >76% of patients were lost to follow-up.  
 In another study, de Bono and Freeman (13) assessed 59 patients with coarctation of the 
aorta. This study was performed in the United Kingdom at a local ACHD clinic without on-site 
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cardiothoracic surgery or pediatric cardiology facilities. Patients who were in follow-up at the ACHD 
clinic at the time of the study, but who were not being seen at other cardiac clinics for a period of ≥2 
years, were considered lost to follow-up. Thirty-nine percent of the patients had ≥1 episode of lost to 
follow-up.  
Yeung et al. (14) conducted a study in Denver, Colorado, that determined the proportion of 
patients (with a moderate or complex heart defects) who experienced lapses in medical care after 
leaving pediatric cardiology. A lapse in care was defined as a >2-year interval between leaving 
pediatric cardiology and presentation at the ACHD clinic. In 63% of patients, lapses of care were 
observed, with a median interval duration of 10 years.  
Mackie et al. (12) conducted a population-based investigation in Quebec, Canada, of 643 
patients diagnosed with CHD before 6 years of age and currently 22 years old.  Lack of follow-up, 
defined as the absence of an outpatient assessment by a cardiologist, was retrieved from the 
physician billing database. This study revealed that 61% of the patients failed to receive cardiac 
follow-up after their 18th birthdays. Subgroup analyses showed that 47% of patients with moderate 
or complex heart defects (mild defects were excluded) were lost to follow-up after their 18th 
birthdays, whereas 21% of patients with complex lesions (mild and moderate defects were excluded) 
were lost to follow-up.  
Generally, a wide variation in percents of patients lost to follow-up or those with lapses of 
care has been observed. However, these data are not comparable, because the studies differed 
substantially in terms of definition of loss to follow-up, study population, inclusion criteria, 
recruitment setting (pediatric cardiology, ACHD clinic, or population based), data collection methods 
(database or retrospective evaluation), and follow-up period. This likely resulted in an 
underestimation and overestimation of the proportions of patients lost to follow-up. For example, de 
Bono and Freeman (13) and Yeung et al. (14) recruited patients at ACHD clinics. By doing so, they 
underestimated the problem of loss to follow-up, because patients not under medical surveillance 
were excluded in their studies. In contrast, Wacker et al. (4) included all patients recorded in their 
center’s registry and considered patients to be lost to follow-up if they did not have  checkups in that 
specific center. Consequently, they probably overestimated lost to follow-up, because a substantial 
number of patients with mild defects may not have needed ongoing cardiac follow-up, and some 
patients received cardiac follow-up at other centers.  
Regardless of the limited comparability across these studies, our study demonstrated a 
considerably lower proportion of loss to follow-up. There are several explanations. First, at our 
center, pediatric cardiology and an ACHD program are located in the same building. Hence, patients 
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do not have to go to another hospital when being transferred to adult care. Second, pediatric and 
ACHD cardiologists at our center use the same medical records, hospital information system, and 
database. This facilitates transfer of medical information. Third, to keep patients under medical 
surveillance, our clinic sends outpatient visit reminders to the patients, according to the proposed 
frequency of follow-up visits. Non-responding patients will receive up to 3 reminders. Fourth, 
Belgium has a compulsory health insurance system, covering almost the entire population. 
Therefore, noninsurance or underinsurance is no barrier for patients wanting to obtain the care 
needed. Fifth, there is no mandatory general practitioner gate-keeping system in Belgium, resulting 
in easy access to tertiary care, which increases the accessibility of CHD care. Finally, Belgium is a 
small country with a high population density. Hence, the distances from patients’ homes to 
specialized centers are relatively short. In our sample, 80% of the patients lived <100 km (<62 mi) 
from our hospital.  
To what extent these factors affected our findings is unknown. However, obviously not only 
patient-related factors but also healthcare system- related and hospital-related factors have an 
impact on successful continuation of cardiac follow-up when patients reach adulthood. Indeed, the 
availability and structure of CHD programs will have an impact on how care is provided (22,23). To 
address this issue, we are currently preparing the INTERCHANGE (INTERnational study on the 
Continuation of Heart health checks in young Adults with coNGEnital heart disease) study, an 
international study on healthcare-related, hospital-related, and patient-related determinants of lack 
of cardiac follow-up in adulthood. This will be an observational study using a multilevel approach, 
with data collection at three levels: country, center, and patient levels. Across Europe and North 
America >20 centers will participate, including about 7,500 patients.  
In the present study, we focused on the minimal level of care. We found that 10.2% of our 
patients did not receive follow-up at the minimally recommended level. However, we also observed 
that the level of care exceeded the guidelines in many patients (5). For instance, in the group of 
patients for whom nonspecialist care is sufficient (Table 3.4), 86.3% of patients received specialist or 
shared care. If the ACHD program is saturating, there would be an opportunity to discharge patients 
with mild heart defects to lower levels of care. So far, we have not done so, because our pediatric 
cardiology and ACHD programs are located in a teaching hospital. In terms of training of cardiology 
fellows, it is considered to be appropriate to have exposure to the entire spectrum of CHD.  
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Study limitations 
First, this study was conducted in one tertiary center with a specific structure and located in a 
particular healthcare system. Thus, our results are not generalizable. Second, this study mainly 
applied the Task Force 4 recommendations for cardiac follow-up (5). These recommendations are not 
completely consistent with, for instance, European guidelines (6). Application of European guidelines 
would likely result in different findings. Third, only patient-related correlates of no follow-up and no 
appropriate follow-up were investigated, leaving healthcare system-related and hospital-related 
factors unaddressed. The planned INTERCHANGE study, however, will address these factors.  
 
Conclusion 
Only 7.3% of our patients with CHD were no longer in cardiac follow-up after leaving 
pediatric cardiology. Of the patients with complex, moderate and simple CHD, 2.7%, 6.9%, and 9.2%, 
respectively, were no longer in follow-up. According to international guidelines, 10.2% of our 
patients did not receive follow-up at the minimally recommended level. No follow-up was associated 
with male sex and no prior heart surgery. No appropriate follow-up was correlated with male sex, no 
prior heart surgery, and greater complexity of CHD. Our results are substantially better than those in 
other Western countries. Firm explanations for the observed differences will be determined in our 
future study on healthcare-, hospital- and patient-related determinants.  
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Abstract  
Objective: Although different guidelines on ACHD care advocate for lifetime cardiac follow-up, 
a critical appraisal of the guideline implementation is lacking. We investigated the implementation of 
the ACC/AHA 2008 guidelines for Adult Congenital Heart Disease (ACHD) follow-up by investigating 
the type of healthcare professional; care setting and frequency of outpatient visits in young adults 
with CHD. Furthermore, correlates for care in line with the recommendations or untraceability were 
investigated. 
Methods: A cross-sectional, monocentric, observational study was conducted, including 306 
patients with CHD who had a documented outpatient visit at pediatric cardiology before age 18y. 
Results: Two-hundred ten patients (68.6%) were in cardiac follow-up; 20 (6.5%) withdrew from 
follow-up and 76 (24.9%) were untraceable. Overall, 198 patients were followed-up in tertiary care, 
one quarter (n=52) of which were seen at a formalized ACHD care program, and three quarters 
(n=146) remained at pediatric cardiology. Of those followed in formalized ACHD and pediatric 
cardiology care, the recommended frequency was implemented in 94.2% and 89%, respectively 
(p=.412). No predictors for the implementation of the guidelines were identified. Risk factors for 
becoming untraceable were: none or lower number of heart surgeries; health insurance issues; and 
non-white ethnicity. 
Conclusions: A significant number of adults continue to be cared for by pediatric cardiologists, 
indicating that transfer to adult-oriented care was not standard practice. Frequency of follow-up for 
the majority of patients was in line with the ACC/AHA 2008 guidelines. A considerable proportion of 
young adults were untraceable in the system, which makes them vulnerable for discontinuation of 
care. 
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Introduction 
The number of adults born with congenital heart disease (CHD) is expanding substantially (1). 
Longitudinal studies have demonstrated that although mortality rates have declined spectacularly 
over the past decades, morbidity rates in this population tend to be high. Since most adults with CHD 
face a number of potential complications and reoperations as they age, lifetime cardiac follow-up is 
required in most patients (2). 
In childhood, patients are standardly followed-up in pediatric cardiology programs. As 
patients grow into adulthood, changing healthcare needs advocate a transfer from pediatric to adult 
healthcare services (3). Several professional organizations for both pediatric and adult care propose 
educational programming and ultimately a transfer of care to provide continuous care in accordance 
with the developmental stage of patients diagnosed with CHD (3;4). Furthermore, a recent 
population-based study was the first to demonstrate a beneficial effect of increased referral rates to 
ACHD care centers on mortality in adults with CHD (5).  
The requirements for adult CHD (ACHD) follow-up care have been outlined by several 
cardiovascular task forces. These documents detailed the type of professionals, the preferred setting 
and the frequency at which surveillance should be provided (6). The ACC/AHA 2008 management 
guidelines supported the framework for the organization of ACHD care that was developed at the 
32nd Bethesda conference in 2001 (7;8). A hierarchical algorithm for ACHD care provision is based 
primarily upon the anatomical classification of the diagnosed heart lesion(s). Patients diagnosed with 
a simple defect are generally recommended to receive follow-up care in the general medical 
community every 3 to 5 years. This level of non-specialized care can be provided by a primary care 
physician or a community cardiologist. A more intensive frequency of visits is advised for patients 
with moderately to highly complex defects, as they have an increased vulnerability to develop 
comorbidities. In case of moderately complex defects, collaborative care is preferably provided in 
specialist centers, even though shared care between community providers and ACHD specialists can 
be recommended if the course of the condition is uncomplicated. Care exclusively provided by 
cardiologists who are specialized in ACHD is proposed every 6-12 months for patients with highly 
complex CHD (8). Hence, these recommendations are in line with the stratified model of ACHD care 
delivery, as proposed by the European Society of Cardiology (6). 
Despite the well-established importance of continuous care provision for ACHD patients, 
previous studies have demonstrated that 7 to 76% of patients experienced care gaps or were lost to 
cardiac follow-up during adulthood (9-16). These studies have shown that the provision of 
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continuous care to young people with CHD remains a largely unfulfilled need in Western countries. 
The implications can, however, be far-reaching as demonstrated by the threefold likelihood of 
needing urgent cardiac interventions in patients experiencing a care gap (9).  
Although guidelines on the provision of ACHD follow-up care were published about a decade 
ago, implementation of these recommendations in clinical practice has yet to be examined. 
Therefore, this cross-sectional study describes the implementation of ACC/AHA 2008 guidelines for 
ACHD care through the investigation of the type of professional, the setting and the frequency at 
which outpatient visits are performed in young adults with CHD. Furthermore, this paper explores 
the profile of patients who received care in line with the recommendations and compares this with 
the profile of patients who appeared untraceable in the healthcare system. 
Material and methods 
Setting  
This observational study was conducted at a large free-standing pediatric hospital (Boston 
Children’s Hospital) in the United States of America that has an outpatient cardiology volume of > 
23,000 visits per year. There is an ACHD care clinic onsite and a transitioning liaison helping patients 
navigate from pediatric cardiology to ACHD care. Subjects for study inclusion were identified by 
searching institutional and departmental databases. 
Study population 
Eligible patients were selected from the pediatric cardiology outpatient clinic list overviewing 
all visits performed between 2001-2005. Based on the following criteria, patients were selected for 
participation: a confirmed diagnosis of CHD, defined as “a gross structural abnormality of the heart 
and/or the intrathoracic great vessels that is actually or potentially of functional significance” (17); 
born in 1987 (aged 23y in 2010); at least one documented outpatient pediatric cardiology visit at the 
institution between 2001-2005 (before age 18y); and living in the region of New England (USA) at the 
time of data collection.  
Data collection 
A clinical research form was completed after reviewing patient’s medical files. Information on 
sex, highest level of education, primary CHD diagnosis, and type of health insurance was collected 
based on chart review at the last outpatient visit. The ethnicity of patients was determined based on 
self-report. Based on the ZIP code of the place of residence, the travel distance (miles) to the nearest 
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ACHD center was calculated. Furthermore, the number of cardiac interventions performed in the 
past was determined. Interventions of cardiac ablation and implantation of a pacemaker or a 
cardioverter defibrillator were included, whereas intracardiac electrophysiology studies were not 
taken into account. 
Furthermore, a four phase-approach was used to determine the setting and frequency of the 
outpatient visits. During phase one, the hospital’s cardiology database was checked to determine if 
patients were currently in follow-up at the institution. Subsequently, the Social Security Death Index 
was checked to exclude deceased patients. If data were missing or unavailable from chart review, 
and the mortality status remained undetermined, the last known cardiologist was contacted. Finally, 
if no additional information on follow-up could be provided by this cardiologist, the patient was 
contacted through mail or telephone using the patient’s last known contact details.  
This study was approved by the Boston Children's Hospital Center for Clinical Investigation 
and was performed in accordance with the 2002 Declaration of Helsinki. 
Definitions 
The CHD diagnosis was determined based on chart review. The primary heart lesion was rank 
ordered using a modified CONCOR (CONgenital COR Vitia) classification (18). The defect was 
anatomically defined as simple, moderate or complex using Task Force 1 (7). Patients were 
considered to be currently in follow-up if an outpatient visit could be documented using the 
aforementioned four-phase protocol. Furthermore, patients were categorized as not being in cardiac 
follow-up if a complete cessation of cardiac care was confirmed. If at stage four, the patient could 
not be contacted, then this patient was considered to be untraceable and no further information on 
the cardiac follow-up care was collected.  
 For the group of patients who were currently in follow-up, detailed information on the 
setting and frequency of scheduled visits was derived. The setting of care was subdivided into four 
groups: care provided by (a) a pediatric cardiologist exclusively, (b) an ACHD cardiologist exclusively, 
(c) a general community cardiologist in collaboration with a specialized CHD team (shared care), or 
(d) a general community cardiologist solely.  
 To assess the implementation of the ACC/AHA 2008 guidelines, the setting and frequency of 
visits was compared to the recommended setting of care and frequency of visits (19). Care was 
considered to be not in line with the current ACC/AHA 2008 recommendations, if the setting or 
frequency of cardiac follow-up visits was not in accordance to the minimally recommended level or 
frequency.  
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Statistical analysis 
Data were analyzed using SPSS 20.0 (SPSS, Inc., Chicago, Illinois). Nominal and categorical 
variables were presented using absolute numbers and proportions. Median values were reported for 
the non-normally distributed continuous variables. To explore the profile of patients receiving care at 
the recommended setting and frequency and patients found to be untraceable, two multivariable 
logistic regression models were analyzed (forced entry method). Assumptions of linearity, 
multicollinearity and independence of errors were checked and found to be met. Results were 
reported as odds ratios (ORs) and 95% confidence intervals (CIs). All statistical tests were 2-sided and 
a p-value of 0.05 was used as a cut-off point for statistical significance. 
Results 
Sample characteristics 
A total of 327 patients were eligible. However, one patient explicitly opted-out of further 
inquiries. Twenty patients moved out of New England, leaving 306 patients (94%) included in data 
analysis. Demographic and clinical characteristics are provided in Table 4.1. 
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Table 4.1: Demographic and clinical sample characteristics (n=306) 
Variables               n (%) 
 
Sex
 
   male 
   female 
 
 
180 (58.8) 
126 (41.2) 
Primary diagnosis of CHD
 
   Hypoplastic left-heart syndrome 
   Univentricular physiology 
   Tricuspid atresia 
   Tetralogy of Fallot 
   Pulmonary atresia without VSD 
   DORV 
   TGA 
   Congenitally-corrected TGA 
   Coarctation of the aorta 
   AVSD 
   ASD type I 
   Ebstein malformation 
   Pulmonary valve abnormality 
   Aortic valve abnormality 
   ASD type II 
   VSD 
   Mitral valve abnormality 
   Pulmonary vein abnormality 
   Other diagnoses 
 
2 (0.7) 
13 (4.2) 
2 (0.7) 
29 (9.5) 
3 (1) 
6 (2) 
28 (9.2) 
2 (0.7) 
24 (7.8) 
8 (2.6) 
1 (0.3) 
3 (1) 
26 (8.5) 
60 (19.6) 
43 (14.1) 
39 (12.7) 
3 (1.0) 
5 (1.6) 
9 (2.9) 
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Morphologic complexity of CHD (Warnes et al., 2001) 
   Simple 
   Moderate 
   Complex 
 
141 (46.1) 
98 (32) 
67 (21.9) 
Prior heart surgery 
   No, none 
   Yes, ≥1 surgery performed 
   Median number of surgeries 
   Range 
 
139 (45.4) 
167 (54.6) 
1 
0-7 
Prior cardiac catheter-based interventions 
   No, none 
   Yes, ≥ 1 catheterization performed 
   Median number of catheter-based interventions 
   Range 
 
173 (56.5) 
133 (43.5) 
0 
0-31 
Race/ethnicity
 
   Caucasian 
   Hispanic/Latino 
   African American 
   Asian 
   Other 
 
226 (73.9) 
15 (4.9) 
14 (4.6) 
7 (2.3) 
44 (14.4) 
Highest level of education  
   Grades K8-12 
   Graduated high school 
   Associate’s degree 
   Bachelor’s degree 
   Special education program 
   Other 
   Unknown ( e.g., patient was untraceable) 
 
9 (2.9) 
101 (33) 
18 (5.9) 
108 (35.3) 
28 (9.2) 
4 (1.3) 
38 (12.4) 
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Medical coverage
 
   Private insurance 
   State aid 
   Self-pay/no insurance 
   Unkown ( e.g., patient was untraceable) 
 
169 (55.2) 
53 (17.3) 
5 (1.6) 
79 (25.8) 
Travel distance to nearest ACHD center (miles) 
   Median 
               Range 
        
 29.9 
1-421 
ASD = atrial septal defect; AVSD = atrioventricular septal defect; CHD=congenital heart disease; DILV = double-
inlet left ventricle; DORV = double-outlet right ventricle; TGA = transposition of the great arteries; VSD = 
ventricular septal defect 
Setting of care for cardiac follow-up 
A total of 210 patients (68.6%) were in cardiac follow-up at the age of 23y. However, 20 
patients (6.5%) withdrew from follow-up. For 76 patients (24.9%) information on the setting or the 
frequency of follow-up could not be retrieved from chart review or from last known medial provider. 
In addition, direct contact with patient via last known phone or address was not possible. Since this 
latter group of patients could not be contacted, they were considered to be untraceable. Within the 
group of patients who were in follow-up, the majority (n=198, 64.7%) received cardiac care at 
tertiary care, while 12 patients (3.9%) were in follow-up with a community cardiologist who had no 
expertise in CHD care. Although 52 patients (17%) followed in tertiary care were seen at an ACHD 
program, the majority (n=146, 47.7%) received care exclusively provided by a pediatric cardiologist. 
Detailed information on the setting of follow-up can be found in Figure 4.1. 
 
Implementation of the guideline-recommended setting and frequency of cardiac follow-up  
Within the group of patients who were currently in follow-up, only 55 patients (26.2%) were 
being seen within a formalized ACHD setting of care as proposed by the ACC/AHA 2008 
recommendations (Figure 4.2). The majority of patients currently in follow-up (89.5%) were being 
seen at the minimally recommended frequency. Of those followed in formalized ACHD care, the 
minimally recommended frequency was implemented in 94.2%. For those in pediatric cardiology, this 
proportion was 89% (p=.412). Taken together, 52 patients (24.8%) of our sample were receiving 
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follow-up care at both a formalized ACHD care setting and at the frequency as proposed by the 
guidelines based on the anatomical classification of their primary defect (Figure 4.2).  
Figure 4.1 Flowchart of Setting of Care for Cardiac Follow-up (n=306) 
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Figure 4.2 Implementation of the Recommended Setting and Frequency of Follow-up (n=210) 
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Profile of patients receiving follow-up care at the proposed setting and frequency 
In this latter group of 52 patients, 19 patients had a simple lesion, 13 were diagnosed with a 
moderate defect and 20 had a complex defect. Using multivariable logistic regression analysis, the 
profile of patients who received care within the proposed setting and at the recommended 
frequency was explored. None of the demographic/clinical variables were, however, found to be 
significant predictors for receiving such care (Table 4.2).  
Profile of patients who are untraceable 
Patients who are untraceable require our attention, because they may be vulnerable for care 
gaps. In the group of patients who were untraceable, 65% had a simple defect, 29% were diagnosed 
with a moderate defect and 7% had complex CHD. Adults who underwent none or a lower number of 
surgeries in the past (OR=0.4; 95%CI: 0.2-0.7), had no insurance or relied on self-pay (OR=0.1; 95%CI: 
0.05-0.2), and were of a non-white ethnicity (OR=3.0; 95% CI: 1.5-6.1) had a significantly increased 
likelihood to become untraceable (Table 4.3). However, sex, anatomical CHD classification, travel 
distance to the nearest ACHD center and the number of prior interventions, were not found to be 
predictive of being untraceable.  
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Table 4.2 Multivariable logistic regression model predicting implementation of the recommended 
setting and frequency of follow-up visits in adults with CHD (n=210) 
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Table 4.3: Multivariable Logistic Regression Model Predicting Untraceability in Adults with CHD 
(n=306) 
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Discussion 
To the best of our knowledge, this was the first study appraising the implementation of the 
ACC/AHA 2008 guidelines for ACHD care, several years after their publication. For the purpose of this 
study, three components of follow-up care were examined: the type of physician providing follow-
up, the setting and the respective frequency of visits. We found that 65% of the 23-y old patients 
were in follow-up at a tertiary center, one-quarter of which was followed-up in the ACHD care 
program, whereas the remaining three-quarters remained in follow-up at pediatric cardiology. We 
observed that one in fifteen patients ceased follow-up completely; and one in four patients were 
untraceable. Regarding the setting and frequency of follow-up, the strictest interpretations of the 
recommendations (care within a formalized ACHD care program at particular timings) were 
implemented in one in four patients.  
The study methodology was based on previous work of Goossens and coworkers allowing an 
indirect comparison of the present findings with those obtained in Belgium (14). Although our 
proportion of ‘no cardiac follow-up’ was comparable to that of the Belgian study (14), for about one 
quarter of patients no information on cardiac follow-up was, however, derived. This proportion of 
untraceability is substantially greater than found in the Goossens study (14), where only 1.1% was 
untraceable. It was even higher than the 12% untraceability in the study of Norris and colleagues, 
conducted in Cincinnati (OH) (20). These differences in proportions may be due to differences in 
migration rates. Indeed, emigration from the state of Massachusetts (2.4% in 2012) is substantially 
higher than that from Ohio (1.7% in 2012) or Belgium (0.8% in 2010) (21;22). This indicates that 
population and system variables should be taken into consideration when assessing continuity of 
care.  
In the present study, we applied a four-step data collection strategy. Although the utilization 
of social media seems to be a trend-setting mean of communication that can be used in getting 
patients back on the radar for cardiac follow-up, IRB did not allow to contact patients through these 
websites for the purpose of this study (20;23). Although we cannot draw firm conclusions about the 
present cardiac care in untraceable patients, the prevalence of care gaps might be higher in these 
patients than in those who are contactable. Hence, patients with complex healthcare needs who 
disappear from the radar could experience discontinuous follow-up potentially leading to 
unrecognized complications, deterioration, or comorbidities and an impaired chance of receiving 
state-of-the-art care (24). Losing track of patients might be tackled by the development of 
nationwide databases, enabling professionals to keep track of patients within the overall healthcare 
system (25;26). Such systems might be of particular value during the transition phase and after 
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transferring patients to ACHD care, since this life event appeared to make patients vulnerable to care 
gaps (15). Our study is the first one identifying factors associated with untraceability. No or a lower 
number of surgeries in the past; health insurance issues; and a non-white ethnicity seemed to be risk 
factors for untraceability. 
Although it is encouraging to observe that more than two-thirds of the patients received care 
in a specialized setting, analysis demonstrated that the majority of patients were not formally 
transferred to an adult-specific care setting, as three in four patients remained in pediatric cardiology 
at the age of 23y. This observation is fully in line with the Norris study (20), but is in large contrast 
with the Belgian study where only one in ten young adults was seen by pediatric cardiologists, either 
at the pediatric cardiology department or at a satellite center (14). This low proportion of adults seen 
by pediatric cardiologists in Belgium is due to a formal policy, agreed upon between pediatric and 
ACHD cardiologists, to transfer patients to adult care at the age of 16y. Indeed, institutional factors 
contributing to ongoing pediatric care were found to be an unlimited age access to pediatric care and 
a limited capacity of the adult clinic (20). Other barriers affecting transfer to ACHD care were the 
patients’ unawareness of the need for follow-up, health insurance issues, not wanting further 
surgery, ambivalence towards the condition and not understanding the physician’s explanation 
emotional or cognitive delay, non-compliance of patients with the transfer plan, unstable social 
situation or instability of the health condition (15;16;27). Oppositely, the most frequently indicated 
reasons for prompting transfer to ACHD care were life events such as pregnancy, marriage and 
school graduation, and not necessarily health problems such as adult comorbidities or health risk 
behaviors (28). In addition, in both the current study and that of Norris (25), the presence of an on-
site ACHD care program within a pediatric medical facility had the potential ability to provide direct 
and indirect consultation to pediatric clinicians, influence pediatric-based care for adults with CHD, 
standardize care outcomes, and as such, may have lessened transfer of care to formalized ACHD care 
programs in young adults at an earlier age.  
 Overall, there was high implementation rate of the recommended frequency of follow up in 
both formalized ACHD care (94.2%) and pediatric cardiology (89%). However, only one quarter of 
patients were receiving care within a formalized ACHD care setting at the recommended frequency. 
Current recommendations advise a transfer to ACHD care when patients turn into adulthood 
(3;4;6;19;29;30). However, numerous influences to provision of ACHD care strictly within formalized 
care centers continue to exist in the U.S. as a model for national care delivery, including limited 
numbers of ACHD providers, emerging board certification for graduate medical education and 
development of competencies in ACHD care, patient and both medical and insurance provider 
knowledge of the need for (and allowance of the receipt of) specialty ACHD care, and both local and 
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regional established partnerships in effective care delivery. In addition, current ACHD guidelines are 
predominantly expert-based and lack vital empirical underpinning, which might explain the low 
implementation rates observed in our study. Future guidelines based on newly identified evidence 
that overall medical care provided in institutions that contain formalized specialty ACHD care does 
improve outcomes (11) and standardization of specialty ACHD care provision through board 
certification and program accreditation may provide the confidence that pediatric cardiologists 
require to routinely transfer adults to ACHD care within settings that contain a formalized ACHD care 
program.  
Study limitations 
This study was performed in one highly specialized pediatric hospital with both pediatric and 
ACHD services available for decades in a regional environment of more-widely accessible healthcare 
resources, limiting generalizability of results. Second, only patient-related characteristics were 
entered in the regression models predicting provision of care according to the recommendations and 
untraceability of patients.  
 
Conclusion 
We investigated the setting, type of clinician and frequency of outpatient visits received by 
young adults with CHD who were followed in pediatric cardiology during adolescence. Only one 
quarter of patients received care within formalized ACHD care at the frequency proposed by the 
guidelines. Retention to pediatric care was found to be high, indicating that transfer of care to an 
adult-oriented setting during young adulthood was not current standard practice. A considerable 
proportion of patients were untraceable in the healthcare system. Hence, this study demonstrated 
that additional efforts are needed to guarantee continuity of care across settings, time, and 
transitional life phases to patients with a chronic condition, such as CHD. 
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Abstract 
Context: Care gaps are observed in an important proportion of young people transitioning to 
adulthood. Development of interventions preventing such drop-out of the medical system, as 
adolescents leave pediatric care, requires an understanding of the determinants of care gaps.  
Objective: To systematically search the literature for determinants of care gaps in young 
people with chronic conditions transitioning to adulthood.  
Data sources: Medline, Cinahl, and Embase were queried for peer-reviewed publications. 
Study selection: Primary quantitative or mixed methods studies identifying determinants of 
care gaps in young people (10-25y) diagnosed with chronic conditions and written in English, French 
or Dutch were selected. Ten publications were included.  
Data extraction: For each publication, the determinants of care gaps and quantitative results 
were extracted. Based on thematic analysis, determinants were categorized into four groups. 
Quantitative results were standardized, converting raw data into Odds Ratio’s.  
Results: Overall, 11 risk factors and nine protective factors for care gaps were identified in 
literature. All identified factors were related to the patient’s characteristics. Demographics, disease-
related characteristics, healthcare services use, and patient’s health behaviors and beliefs were 
identified as significant determinants of care gaps in adolescents with chronic conditions.  
Limitations: The large variability in study methods, statistical techniques and study 
populations resulted in inconsistent study findings.  
Conclusions: This systematic review identified a set of patient-related determinants of care 
gaps. Unfortunately the internal and external validity of the study findings is limited, yielding the 
need for future prospective, multilevel studies addressing the remaining knowledge gaps
Chapter 5: Risk and protective factors impacting care gaps in young people with CCCs 
 
 
84 
 
Introduction  
As a result of improved medical therapies, diagnostic tools, and better survival rates for infants 
with life-threatening conditions, the prevalence of chronic health conditions in childhood increased 
substantially in Western countries 1;2. The estimated prevalence was found to range from 3.5% to 
35.3% 3. An emerging population of special interest is the group of young people with complex 
chronic conditions (CCCs) defined as “chronic physical, developmental, behavioral or emotional 
conditions lasting for at least 12 months, requiring specialized health services of a type or amount 
beyond that required by children in general”4-6. CCCs represent a specific subgroup within the 
population of children diagnosed with a chronic condition, accounting for approximately 20% of this latter 
group 7-11. The most frequent types of CCCs are of cardiovascular, congenital, neuromuscular, 
respiratory, or oncological nature12. In general, young people with CCCs account for a 
disproportionate use of healthcare resources due to their medical fragility. Indeed, these patients 
present with significantly higher hospitalization rates, readmissions, use of technology-dependent 
devices, prescribed medications, and inpatient mortality rates, yielding a financial and organizational 
burden for the current healthcare system 10-16. 
Since most young people with CCCs are at risk for developing long-term complications, life-
long specialized care is mandatory 13;17;18. During childhood, care is generally provided at pediatric 
services, but as patients transition to adulthood, a transfer of care towards adult-oriented services is 
recommended 18. This healthcare transition is an important but challenging life event 19 and a 
successful transfer to adult care is of paramount importance for young people with CCCs 20.  
Studies reported that gaps in this transitional process are observed in 7-21% of young people 
with acromegaly 21-23, 9-17% of HIV-infected adolescents 24, 11-24% of patients with diabetes mellitus 
type I 25, and 7-76% of young people with congenital heart disease 26. This drop-out of the medical 
system as adolescent patients leave pediatric care is associated with increased morbidity rates, long-
term complications, increased number of hospitalizations, the need for urgent (re-)interventions, and 
higher rates of health-risk behaviors 22;25-35. Therefore, measures to prevent such care gaps are of 
utmost importance. 
In order to develop tailored preventive interventions or health care system reforms, a 
comprehensive understanding of the determinants of care gaps is required. Indeed, it can be 
assumed that not only patient-related factors predict care gaps, but also factors at the level of care 
organization within hospital, and factors related to the healthcare system at large. Since to date, no 
comprehensive overview of determinants of care gaps is available, a systematic review was 
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performed. The aim of this present review was therefore to systematically search the literature for 
determinants of care gaps in young people with CCCs transitioning to adulthood. 
Methods 
A systematic literature review was performed. The review and reporting are in line with the 
instructions of the 2009 PRISMA statement 36.  
 Search strategy  
Three bibliographic databases, Medline, Cinahl, and Embase, were queried for peer-reviewed 
publications from inception to September 2014. A distinct search string was developed for each 
respective database (see Table 5.1) through subsequent brainstorm sessions, verified by a 
biomedical librarian, and supplemented with the snowball searching technique (i.e., screening of 
reference lists of relevant publications). 
Eligibility criteria 
Publications were selected if the following criteria were met: (i) primary studies including 
quantitative or mixed methods designs; (ii) studied sample comprised young people (aged 10-25y) 
diagnosed with (complex) chronic conditions4-6 transferring to adult care; (iii) one of the aims of the 
study was to identify determinants of care gaps; (iv) written in English, French, or Dutch; and (v) 
published in peer-reviewed journals. Qualitative studies, editorials, comments, and letters to the 
editor were excluded. No restrictions with respect to the time of publication were, however, 
implemented.  
A ‘care gap’ was defined as ‘any type of discontinuation of the care process where the time 
lapse between mandatory follow-up visits exceeded the recommended period of time’. Care gaps 
comprised concepts such as lapse(s) of care 30, loss/lost to follow-up 37;38, unsuccessful transfer or 
transition 39-41, and cessation of follow-up 26.  
Study selection 
A total of 1,718 records were identified in the respective databases. After removal of 130 
duplicates, the title and abstract of 1,588 records were screened using RefMan® software version 
12.0 (Thomas Reuters). This screening was performed by two authors (EG, LB) independently. Finally, 
8 full-text publications were selected for eligibility assessment by two authors (EG,LB) independently. 
At this stage, four publications were added using the snowball-technique. A total of 12 publications 
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were finally assessed for eligibility. Two publications were, however, excluded after a detailed review 
of the full-text; leaving ten publications to be included in this review (see Figure 5.1).  
Data extraction 
For each of the selected publications, a predetermined set of variables was extracted by one 
author (EG): first author; year of publication; setting; study design; method of data collection; sample 
characteristics; operational definition of the primary outcome; and statistical analyses. Furthermore, 
for each study, the determinants of care gaps and the quantitative results of the respective statistical 
tests were extracted. Results obtained through qualitative study designs or analysis techniques were, 
however, excluded. Based on a thematic analysis, we categorized determinants of care gaps into four 
groups: (i) demographic characteristics; (ii) disease-related characteristics; (iii) healthcare services 
use; and (iv) patient’s behavior. Quantitative study results were standardized, converting reported p-
values into Odds Ratio’s (ORs) and 95% confidence intervals (CI), using a web-based calculator 42. For 
some studies, however, insufficient data were reported enabling the calculation of these effect sizes.  
 Assessment of the methodological study rigor 
Since all selected studies had an observational non-randomized design, the methodological 
quality of every included article was critically appraised using an adapted version of the 
Methodological Index for Non-Randomized Studies (MINORS) instrument 43. The original MINORS 
instrument comprises 12 items, of which the first eight items are applicable for non-comparative 
studies. The four remaining items are to be evaluated in case of a comparative study design. After 
critically revising all MINORS-items, we deleted two items since they were not applicable for our 
included studies. Items 5 (‘unbiased (blind/double-blind) assessment of the study endpoint’) and 7 
(‘attrition of study participants less than 5%’) were found to be not applicable to the selected 
publications. Furthermore, although the original MINORS-instrument only assesses the 
appropriateness of applied statistical analysis techniques for comparative studies, we decided to 
evaluate this item for all studies. The respective MINORS-items were rated as ‘not reported’ (0), 
‘reported but inadequate’ (1), or ‘reported and adequate’ (2)43. The use of this adapted MINORS-
instrument, results in the calculation of a global score (maximum value of 14) for non-comparative 
studies and a global score for comparative studies (maximum value of 20) (Table 5.2). 
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Table 5.1: Overview of search strings 
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Figure 5.1: Flow diagram of the study selection process 
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Results 
 Study characteristics 
Within the ten selected publications, four type of CCCs were studied: sickle cell disease (SCD) 
39;44, congenital heart disease (CHD) 26;30;38;40;45;46, congenital adrenal hyperplasia (CAH) 37, and juvenile 
idiopathic arthritis (JIA) 41. Two of these studies explicitly stated that patients diagnosed with a 
neurodevelopmental condition were excluded 40;46. The majority of studies (80%) were performed in 
the USA 30;39;40;44;46 or Canada 38;41;45, while only two studies were conducted in Europe26;37. Sample 
sizes ranged from 18 to 922 young people (median 227). Although most studies did not report on the 
ethnic composition of their sample 30;37;38;40;41;45, the majority of studied samples were either 
exclusively African-American 39;44 or White, Caucasian 26;41. 
Seven studies used a retrospective descriptive design 26;30;37;39;41;44;45, two studies used a 
cross-sectional descriptive design 40;46, and one study used a limited mixed methods approach 
combining a matched case-control quantitative study with a qualitative interview study38. Most 
studies (70%) collected both data regarding care gaps as well as data on potential determinants 
based on a retrospective review of medical records or clinical databases 26;37-41;44. Some other studies 
used self-reported methods such as surveys, telephone interviews or structured face-to-face 
interviews to collect these data 26;30;38;40;44;46. One study analyzed a province-wide administrative 
database 45. Single center studies were most represented 26;30;37-39;41, although four studies used a 
multicentric study design 40;44-46 (Table 5.3). 
Quality assessment of research methodology 
The MINORS global quality score ranged from 15 to 16 out of 20 for comparative studies 38;39, 
and from 7 to 12 out of 14 for non-comparative studies 26;30;37;40;41;44-46. With the exception of one 
study 44, all eligible patients were included, follow-up periods were adequate, and a clear explanation 
was provided of the criteria used to evaluate the outcome of care gaps. Eight studies (80%) collected 
data on determinants retrospectively 26;37-39;41;44;45;47, and none of the studies performed a power 
analysis with a prospective calculation of the required sample size. The statistical analyses identifying 
determinants of care gaps were adequate in six (60%) studies 26;30;38;40;45;46 using multivariate logistic 
regression analyses accounting for potential confounders. Four studies, however, only performed 
two-group comparisons37;39; did not correct for multiple testing37;39;41;44; calculated correlation 
coefficients44, or performed only univariate analysis41 (Table 5.2). 
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 Table 5.2: Critical appraisal of methodological rigor using adapted MINORS-tool  
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Table 5.3: Overview of study characteristics 
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Table 5.4: Operational definitions of care gaps 
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 Definitions for care gaps 
A broad range of definitions of care concepts has been provided in the selected publications 
(Table 5.4). All studies provided an operational definition in their manuscript. However, the level of 
specification of the setting, time interval, and data source varied largely across studies. Some studies 
provided highly detailed information on these components, while for others; specifications could 
indirectly be derived from the study methodology or result section. Only one study did not provide 
any kind of information on the time interval considered for the determination of a care gap 44. 
Detailed information on the concepts, operational definitions, and specifications is provided as Table 
5.4.  
 Determinants of care gaps 
A total of 45 potential determinants of care gaps have been investigated. Either factors that 
could increase or decrease the likelihood of experiencing care gaps were identified. These factors can 
be considered as ‘risk factors’ or ‘protective factors’, respectively. Overall, 11 risk factors and nine 
protective factors were identified. An overview of determinants of care gaps identified is provided 
four tables (Tables 5.1-5.4).  
Demographics 
Living independently from parents 30, male sex 26;45, lower family income 38, and longer travel 
distance to closest adult specialized clinic 37;39 were identified as significant risk factors, although for 
the latter three factors non-significant results were reported as well. Older age at last pediatric visit 
was inconsistently found to be a risk factor 39 and a protective factor40. Ethnicity 39;44;46; type of 
healthcare insurance39;44; type of residence (urban/rural)45; age at diagnosis30; and educational 
level41;46 were not significantly related to care gaps (Table 5.5). 
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Table 5.5: Demographical determinants of care gaps 
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Disease-related characteristics 
 
Milder disease activity, severity or complexity was a significant risk factor for care gaps 
30;37;39;41;45;46. The study of Goossens and colleagues, however, did not find a significant impact of 
disease complexity on care gaps 26. For patients with CHD, not having undergone heart surgery in the 
past also increased the risk of having care gaps 26. Conversely, having at least one comorbid condition 
was found to be protective for the occurrence of care gaps 40. Determinants which were investigated 
but found to be non-significant were: residual hemodynamic problems at last echocardiography, 
medication use, and an implanted pacemaker or cardio defibrillator 38 (Table 5.6). 
 
Healthcare services use 
Regarding the use of healthcare services, a lower number of outpatient visits in pediatric care 
during the last three years pre-transfer 37;45; last visit organized outside a university hospital 45; 
hospitalizations in childhood 45; and a history of at least one missed appointment 38 were significant 
risk factors for care gaps. Furthermore, the multicentric study of Gurvitz et al. (2013) found a 
significant difference between locations of hospitals (i.e., Colorado, Oregon, Washington State) in the 
occurrence of care gaps. In contrast, having a written recommendation on the type of professional 
that should provide adult follow-up care38; and adherence to the first or second outpatient visit in 
adult clinic (i.e. good early attenders)37;44 were identified as protective factors (Table 5.7).  
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Table 5.6: Disease-related determinants of care gaps 
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Table 5.7: Determinants of care gaps related to healthcare services use 
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Patient’s behavior 
Greater independence in attending appointments 40; patient’s belief that follow-up should be 
continued in specialized adult care40; higher levels of self-efficacy 44; abstaining from substance use 
and full compliance with antibiotic prophylaxis regimens40 were identified as significant protectors 
for care gaps. Non-significant determinants were: self-reported family functioning40, health beliefs 40, 
SF-36 scores40, self-rated activity restictions40, general preferences of self-care40, patient-reported 
expected frequency of visits in adult clinic40, treatment adherence44, and patients’ knowledge of 
disease name46 (Table 5.8). 
Table 5.8: Determinants of care gaps related to patient’s behavior 
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Discussion  
Over the past decades, survival rates improved substantially for children diagnosed with a 
complex chronic condition (CCC) resulting in better prospects towards achieving adult life1;2. 
However, in order to guarantee that improved survival rates result in improved quality of life, 
enhanced health status, and prevention of complications, the provision of continuous care is 
mandatory. International guidelines stress the importance of providing uninterrupted, age- and 
developmentally appropriate health care to patients with CCCs throughout their life span 13;17;18. Safe-
guarding continuity of care appears, however, challenging in adolescents and young adults diagnosed 
with CCCs. Adolescence is the typical life phase in which authority is challenged and risk-taking 
behaviors, possessing additional risks for patients with CCCs, are more prominent 48;49. These 
developmental changes, in combination with the required transfer of healthcare setting, embody an 
important challenge for adolescents with CCCs. Previous studies demonstrated that an important 
proportion of young people with CCCs experience care gaps, or are even completely lost to follow-up 
21-26.  
Improving continuity of care for young people with CCCs, requires tailored interventions or 
strategies facilitating a smooth and continuous care process. An in-depth understanding of 
determinants of care gaps is, nevertheless, indispensable for the development of such interventions. 
Since a comprehensive overview of determinants of care gaps is currently missing, a systematic 
review of the existing literature was performed. This review identified ten relevant publications that 
were performed in young people diagnosed with a complex chronic condition. Four types of CCCs 
were represented: sickle cell disease39;44, congenital adrenal hyperplasia 37, congenital heart disease 
26;30;38;40;45;46, and juvenile idiopathic arthritis41. No other types of CCCs have been investigated. The 
issue of care gaps appeared to be most often studied in a population of young people with congenital 
heart disease26;30;38;40;45;46.  
A total of 11 risk factors and nine protective factors were identified. Based on a thematic 
analysis, these determinants could be categorized in four different group: (i) demographics, (ii) 
disease-related characteristics, (iii) healthcare services use, and (iv) patient’s behavior. 
Milder disease activity, severity, or complexity was the only risk factor for which all studies 
analyzing this disease-related characteristic, unanimously reported significant results 30;37;39;41;45;46. 
Furthermore, having no or less comorbid conditions 40 and not having undergone heart surgery in the 
past 26, both indirect indicators of milder disease, were significant determinants of care gaps. Hence, 
special attention should be paid to patients diagnosed with a milder type of CCC since these patients 
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seem to have an increased likelihood of experiencing care gaps. These patients might perceive their 
long-term risk for mortality and morbidity to be low as compared to patients with moderate-to-
complex conditions. Tailored interventions aiming to convince patients of the benefits of continued 
follow-up care could be implemented in practice as a preventive measure of care gaps.  
Demographical characteristics such as male sex26;45, family income38, age at last pediatric 
visit39, travel distance37;39, and living independently from parents30 were identified as significant 
determinants of care gaps. Unfortunately, non-significant results were also reported for some of 
these demographical risk factors leading to inconsistent research findings. These patient-related 
characteristics are less modifiable but could be used in practice when screening for patients at risk 
for care gaps. Finally, more hospitalizations45, less outpatient visits during childhood45, and a history 
of missed appointments38 increased the risk for care gaps while patients who demonstrated better 
self-management skills were less likely to experience care gaps 40;44 . 
Overall, this review revealed that a rather limited set of patient-related characteristics is 
known to alter the risk for care gaps in young people with CCCs transitioning to adult care. Most 
factors were related to demographics, characteristics of the disease, or the healthcare use of 
patients. Although most identified risk factors are modifiable to a limited extent, some protective 
factors such as guaranteeing that patients leave pediatric care with a written recommendation on 
the type of professional providing follow-up adult care, or checking if patients attend the first 
outpatient visits in adult care, might be components of interventions preventing care gaps. 
Although this review aimed to identify determinants of care gaps, no uniform definition for 
the concept of care gaps currently exists. This review revealed a large heterogeneity of operational 
definitions provided for the concept of discontinuation of care. Synonyms used for care gaps46 were: 
uninterrupted care44, lapse in care 30, lack of follow-up 45, no follow-up 26, lost to follow-up 37;38, and 
unsuccessful transition 39. All studies provided a relatively detailed operational definition, specifying 
which setting of care and respective time interval in-between visits were evaluated when 
determining the occurrence of care gaps. In order to enhance comparability of study results in the 
future, consensus should be reached on the operational definition of care gaps. Additional efforts 
should be made to provide such a uniform definition for this concept.  
Although all studies aimed to identify determinants of care gaps, a wide variety of statistical 
techniques, research designs, and data collection methods were used to address this research aim. 
Determinants were identified through a variety of techniques such as: two-group comparisons, 
calculation of correlation coefficients, or uni- and multivariable regression analysis.  From a 
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methodological point of view, there is an important difference in the robustness of results obtained 
through the performance of repeated group comparisons without correction for multiple testing 
versus multivariate regression analyses. Furthermore, critical appraisal of the methodological rigor of 
the included publications revealed that most studies analyzed determinants in a retrospective 
manner. Retrospective analyses, however, are characterized by the risk of missing information on 
specific factors not included in the previously established dataset.  
Despite the transparent, objective, and rigorous nature of this review, some methodological 
limitations should be kept in mind. First, although relevant literature was searched by using a 
rigorously developed search string, only 10 out of 1,718 (<0.5%) retrieved records appeared to be 
relevant. The inclusion of the search term ‘loss/lost to follow-up’ most likely resulted in a large 
number of unrelated publications. This search term is very often used in the abstract of papers, 
within the context of attrition of participants from a longitudinal study. This search term was, 
however, indispensable for our search string since it is often used as a synonym for a care gap. 
Furthermore, additional relevant references might have been overlooked when indexed in other 
databases or only retrievable in grey literature. Secondly, the development of forest plots or the 
performance of a meta-analysis would have been of high value when investigating determinants of 
care gaps. Unfortunately, these analysis techniques could not be applied due to a large variability in 
study designs, data collection methods, sample sizes, low number of studies investigating a specific 
factor and the lack of sufficient raw data. Thirdly, generalizability of study results is fairly low since 
only four types of CCCs were investigated; patients with neurodevelopmental impairments were 
explicitly excluded in most studies; and sample sizes were small to moderate.  
Although this systematic review identified factors associated with care gaps, additional 
research projects are needed to address the remaining knowledge gaps. Prospective, multicentric, 
international study designs analyzing both clinical and administrative datasets are highly needed to 
explore the relationship between care gaps and patient-, hospital-, and healthcare system-related 
factors. Furthermore, in order to enlarge the internal and external validity of research findings 
summarized in this review, additional studies should be performed in larger patient populations 
diagnosed with other types of CCCs.  
Conclusion  
This systematic literature review identified a set of determinants related to the characteristics 
of young people with CCCs found to increase or decrease the risk of experiencing a care gap. All 
identified determinants were related to the individual patient reflecting demographics, disease-
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related characteristics, the use of healthcare services, and patient’s behavior. Previous studies 
demonstrated that the transition to adulthood is a vulnerable period for young people with CCCs 
characterized by care gaps. Strategies to prevent such gaps in the care process are highly needed but 
additional prospective, multicentric, international research projects seem to be mandatory to 
enlarge our body of evidence. Furthermore, a uniform operational definition of a care gap is needed 
in order to increase the comparability of study findings.  
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Abstract 
Background: Adolescents with congenital heart disease (CHD) must take responsibility for their 
life and care. This requires that they have sufficient knowledge about their heart disease, treatment, 
and preventive measures. Thus, CHD-related education should be directed to adolescents. Research 
on adolescents’ understanding and knowledge of CHD is limited.  
Aims: What do adolescents with CHD know about their heart defect, treatment, and 
preventive measures necessary to avoid complications?  
Methods: We addressed this question in a descriptive cross-sectional study of 91 adolescents 
with CHD (53% males; median age, 17 years). In this study, we assessed the subjects’ knowledge of 
CHD using the Leuven Knowledge Questionnaire for Congenital Heart Disease.  
Results: The results showed that the patients had adequate knowledge (>80% correct 
answers) about the need for regular follow-up, required diet, past treatment, and dental practices. 
They had moderate knowledge (50-80% correct answers) about the frequency of follow-up, 
occupational choices, medication regimen, and sexual activities. However, the patients had poor 
knowledge (<50% correct answers) of the name of their heart defect; the reasons for follow-up; the 
effects of competitive sports; the symptoms that reflect deterioration of their heart disease; the 
definition, characteristics, and risk factors of endocarditis; the possibility of recurrent episodes of 
endocarditis during their lifetime; the impact of smoking and alcohol on their heart disease; the 
hereditary nature of their condition; the suitability of intrauterine devices as contraceptives; the 
appropriateness of oral contraceptives; and the risks of pregnancy.  
Conclusion: In conclusion, this study showed that the level of knowledge of adolescents with 
CHD has significant gaps.  
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Introduction 
To date, several studies investigating the level of knowledge of patients with congenital heart 
disease (CHD) have been undertaken. Five studies have been conducted in children [1-5], and 9 
studies have been performed in adults [6-14]. To our knowledge, only 4 studies have included 
adolescents among their subjects [3,4,5,15]. One study specifically targeted adolescent patients, 
focusing on their knowledge of bacterial endocarditis [15]. Other aspects of CHD, however, were not 
addressed. This means that information on the level of knowledge of adolescents with CHD is scant. 
Therefore, we designed a study to investigate what adolescents with CHD know about their heart 
defect, its treatment, and preventive measures necessary to avoid complications.  
Methods 
We recruited literate, Dutch-speaking adolescents with CHD to participate in our descriptive 
cross-sectional study. Adolescents were eligible for the study upon their initial visit to the Adult 
Congenital Heart Disease (ACHD) Program’s clinic after their transfer from pediatric cardiology. At 
the University Hospitals of Leuven, Belgium, it is standard practice for a pediatric CHD patient to be 
transferred to adult-focused care when he/she reaches the age of 16 years, unless the patient is 
medically unstable [16]. Patients were excluded from our study if they had learning disabilities. In a 
13-month period, 100 adolescents who met the inclusion criteria were asked to participate. One 
patient refused to participate due to lack of interest. Eight patients were excluded because of 
practical reasons. Hence, we recruited 91 adolescents with CHD; 53% were male and 47% female. 
Patients had a median age of 17 years. Table 6.1 summarizes the demographic and clinical 
characteristics of the study sample. 
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Table 6.1: Demographic and clinical characteristics of 91 adolescents with CHD 
Variable n (%) 
Sex   
  Male 48 (53) 
  Female 43 (47) 
Median age (years) 17 (Q1= 16; 
Q3=18) 
(Range: 15-
32 years) 
 
Marital status   
  Unmarried (living with parents)  87 (96) 
  Living together 2 (2) 
  Living alone 1 (1) 
  Married 1 (1) 
Highest educational level   
  Vocational high school 29 (31) 
  Technical high school 32 (34) 
  High school/College/University 30 (32) 
Responsible for the daily management of care   
  Parents 1 (1) 
  Patient 23 (25) 
  Patient and parents 67 (74) 
Treatment   
  Surgery 31 (34) 
  Medication 4 (4) 
  No treatment 30 (33) 
  Surgery and catheter intervention 7 (8) 
  Surgery, catheter intervention, and medication 2 (2) 
  Surgery and medication 6 (7) 
  Catheter intervention  8 (9) 
  Medication and catheter intervention  3 (3) 
History of endocarditis 0 (0) 
Number of pregnancies 0 (0) 
Contraception (for female patients only)   
  Pill 19 (43) 
  Other methods 1 (2) 
  No contraception 23 (55) 
Primary medical diagnosis   
  Ventricular septal defect   26 (29) 
  Coarctation of the aorta  14 (16) 
  Pulmonary valve stenosis 11 (12) 
  Transposition of the great arteries 5 (6) 
  Aortic valve stenosis 5 (6) 
  Tetralogy of Fallot 4 (5) 
  Atrial septal defect type secundum   3 (3) 
  Congenitally corrected transposition of the great 
arteries 
3 (3) 
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  Mitral valve regurgitation 3 (3) 
  Aortic valve regurgitation 3 (3) 
  Univentricular heart 2 (2) 
  Atrioventricular septal defect 2 (2) 
  Patent ductus arteriosus 2 (2) 
  Mixed aortic valve disease 1 (1) 
  Truncus arteriosus 1 (1) 
  Pulmonary atresia 1 (1) 
  Double aortic arch 1 (1) 
  Total anomalous pulmonary venous return 1 (1) 
  Marfan syndrome 1 (1) 
  Atrial septal defect type primum 1 (1) 
  Atrial septal defect type sinus venosus 1 (1) 
   
 
Demographic and clinical variables were gathered during patient interviews and by means of 
patient medical records. The patients’ CHD knowledge was assessed with the Leuven Knowledge 
Questionnaire for Congenital Heart Disease, which was developed by Moons and coworkers in 2001 
[10]. We adapted the questionnaire based on our experiences in the first study. The most current 
version of the questionnaire consisted of 27 items and covered 5 domains, which were identified as 
relevant aspects of patients’ knowledge about CHD: (1) knowledge on heart defect and treatment, 
(2) knowledge on prevention of complications, (3) knowledge on physical activities, (4) knowledge on 
sexuality and heredity, and (5) knowledge on contraception and pregnancy planning. The researchers 
evaluated each patient’s answers as ‘correct,’ ‘does not know,’ or ‘incorrect’ or ‘incomplete’ *10+. 
When the patients arrived for their scheduled outpatient visit at the ACHD Program’s clinic, a 
nurse from the advanced practice nursing team approached the patients and explained the aims and 
protocol of the study. After oral informed consent was obtained, the nurse asked the patient to fill 
out the knowledge questionnaire, as he/she sat in the waiting room. The nurse explicitly asked family 
members not to help the patient complete the questionnaire. Moreover, the patient was forbidden 
from consulting external sources. The advanced practice nurse checked the questionnaire for 
completeness and asked for additional information, if necessary. Upon completion, the patient and 
his/her parents entered the consultation room, where the advanced practice nurse used the 
completed questionnaire as a guide to provide appropriate patient education [17]. The Institutional 
Review Board (IRB) of the University Hospitals Leuven approved the study protocol.  
Chapter 6: Adolescents’ CHD-related knowledge after transfer to ACHD care 
 
 
113 
 
The data were analyzed with SPSS 16.00. Descriptive statistics of demographic and clinical 
variables were expressed in percentages, medians, and quartiles. The knowledge variables were 
dichotomized as correct or incorrect answers (the latter included incomplete, does not know, and 
incorrect responses).  
Results 
Less than half of the patients knew the name of their heart defect, while only 28% could 
describe their heart defect or locate the lesion on a diagram (Table 6.2). The majority of the patients 
knew the frequency of follow-up and the need for regular follow-up, but only 46% indicated that the 
main purpose of follow-up was to detect clinical deterioration. Most of the patients had adequate 
knowledge about their past treatment. Of the 15 individuals who took medications on a regular 
basis, 53% knew the name of the medication. Almost all of the patients knew which diet they had to 
follow. A small number of the patients could identify symptoms that reflect deterioration of the 
heart disease: dizziness, shortness of breath, palpitations, chest pain, fainting, increasing fatigue, and 
swollen feet and legs (Table 6.2).  
Only 21% of the adolescents could correctly define endocarditis, and only 1 adolescent 
recognized unexplained fever for > 5 days as the most characteristic sign of endocarditis (Table 6.3). 
The minority knew that endocarditis could recur, and 78% knew that they should not take antibiotics 
without consulting a doctor. Only a small number of patients knew the risk factors for endocarditis: 
contaminated needles, bacteria from skin infections, dental abscesses, poor nail and skin care, and 
body piercing and tattooing. The patients, however, had good knowledge of dental practices. The 
majority of patients incorrectly believed that smoking and alcohol consumption, respectively, were 
more harmful to them than to their healthy counterparts (Table 6.3).  
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Table 6.2: Frequency of patients’ knowledge about the disease and its treatment (n=91)
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Table 6.3: Frequency of patients’ knowledge about preventive measures (n=91) 
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In this study, 39% of the adolescents knew that engaging in high-level competitive sports, 
requiring daily training, is not allowed (Table 6.4). A large proportion of the patients were aware that 
they had to choose an occupation that is not too physically demanding.  
Table 6.4: Frequency of patient’s knowledge about physical activity (n=91) 
 
About 78% of the patients knew that they were allowed to have sex if they felt capable of 
doing so (Table 6.5). Only 20% of the adolescents knew about the hereditary nature of their 
condition. 
With regard to contraceptives, 14% and 35% of the female patients did not know whether 
intrauterine devices and oral contraceptives, respectively, were suitable or appropriate choices 
(Table 6.5). The majority of the female patients had insufficient knowledge of the risks of pregnancy. 
Table 6.5: Frequency of patient’s knowledge about reproductive issues (n=91) 
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Discussion 
As they grow older, adolescents with CHD presumably take responsibility for their own 
health and care. Transition programs should be implemented in order to prepare adolescents for this 
task [18-21]. A critical element of these transition programs is developmentally appropriate 
education for patients [18,22] that aim to improve the patients’ level of knowledge and to increase 
awareness of adopting adequate health behaviors, while taking the transition through puberty into 
account. With the exception of one study that assessed bacterial endocarditis knowledge [15], 
studies that have specifically investigated the level of knowledge of adolescents with CHD, to the 
best of our knowledge, do not exist. Hence, we studied the level of knowledge in a sample of 
adolescents upon their transfer from pediatric cardiology to adult-focused care.  
In general, our findings indicate that the level of knowledge of adolescents who recently 
transferred to adult care is poor. The findings of our study are to a certain extent comparable with 
those of prior investigations. In the studies of Veldtman [3] and Cetta [15], 30% to 69% of the 
patients were able to describe or provide the name of their heart defect. In the present study, 45% of 
the patients were within this range. On the other hand, there are also substantial differences 
between our study and previous ones. For instance, the level of knowledge about medication was 
considerably lower in our study (53%) than in that of Cetta [15]; and the knowledge of risk factors for 
endocarditis (8%-24%) was lower than that in Knirsch [5]. By contrast, our patients were more 
knowledgeable about other areas than patients of previous studies: definition of endocarditis (21% 
vs. 4%) [15]; preventive measures (75%-96% vs. 0%) [15]; and antibiotic prophylaxis (78% vs. 40%) 
[5,15]. Note, however, that the findings of the different studies are not comparable, because the age 
ranges, focus of the research, and measurements differed across the studies.  
Currently, it is the policy of our institution to transfer adolescents from pediatric cardiology 
to the ACHD program when they reach the age of 16 years [16]. This policy is successful, with to date 
84% of the patients have received specialist care after they have left pediatric cardiology [23]. A 
formal transition program, however, does not precede this transfer. The findings of the present study 
advocate such a transition program. Indeed, patient education is a critical element of transition 
programs [18,22], particularly because the responsibility of healthcare management shifts from the 
family to the patient [18]. To support adolescent patients to take responsibility for their healthcare, 
healthcare professionals should inform and instruct them before they transfer to adult-focused care. 
Although pediatric cardiologists and the patients’ families already discuss several topics covered in 
the education program, this strategy apparently does not ensure that patients retain the 
information. Indeed, there is a huge disparity between the information provided, the information 
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understood, and the information retained. In addition, the growth rate of each adolescent varies; 
thus, their mental maturity, sense of responsibility, and self-care can differ widely. It is therefore of 
paramount importance to realize that the onset of puberty can hinder patients from being open to 
information and instruction by healthcare professionals. For this reason, ACHD programs should also 
continuously invest in patient education, to ensure that information is retained. Therefore, the 
integration of nurse specialists in ACHD teams is advocated [24-26]. 
Structured patient education has proved to be effective in increasing the level of knowledge 
in patients with CHD. At our ACHD program, the effects of a structured education program were 
evaluated using a pre-post design, with an interval of 5 years [27]. An improvement of >10% was 
observed for knowledge about the name of the heart defect, side effects of medication, symptoms of 
deterioration, risk factors for endocarditis, appropriate use of antibiotics, appropriateness of 
contraceptive pills and intrauterine devices, definition of endocarditis, and characteristics of 
endocarditis [27]. In another study, we demonstrated that advanced practice nursing teams can have 
an impact on the pregestational counseling of CHD patients [28]. Before the implementation of 
advanced practice nursing, 44% of female patients received cardiac follow-up during pregnancy. This 
proportion increased to 71% after the advanced practice nursing team implemented systematic 
educational interventions that contribute to a better understanding of the rationale for cardiac 
appointments during pregnancy and a better adherence to follow-up recommendations [28]. 
Admittedly, we do not have empirical evidence supporting the effectiveness of such an education 
program in adolescents. Further research in this respect is imperative. Furthermore, it is important to 
determine which aspects of knowledge are indispensable. This can help ACHD professionals to set 
priorities in the content of patient education programs, because too much information overloads 
patients and hinders information retention.  
Some methodological limitations require that the results of this study be interpreted with 
caution. First, this study is a single center study conducted at an outpatient clinic. Therefore, we have 
to be careful in generalizing the study results. Second, the Leuven Knowledge Questionnaire for 
Congenital Heart Disease was developed in 2001 [10]. The scale was initially tested in 62 adults with 
CHD [10]. The content validity of the questionnaire was not examined in adolescents with CHD, 
neither was the ability of these adolescents to read and understand the questions in this instrument. 
Although we did not experience problems in this respect in the present study, further testing of the 
validity and reliability of the questionnaire in this specific population is needed. Third, the instrument 
is multidimensional, making the calculation of an overall knowledge score have little meaning. The 
absence of a total score may in some situations be an obstacle. It may be useful to find a way in 
which the level of knowledge of a patient can be aggregated into a single index value.   
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Abstract 
Background: To optimize long-term outcomes, patients with congenital heart disease (CHD) 
should adopt health-promoting behaviors. Studies on health behavior in afflicted patients are scarce 
and comparability of study results is limited. To enlarge the body of evidence, we have developed the 
Health Behavior Scale-Congenital Heart Disease (HBS-CHD).  
 
Aims: We examined the psychometric properties of the HBS-CHD by providing evidence for (a) 
the content validity; (b) validity based on the relationships with other variables; (c) reliability in terms 
of stability; and (d) responsiveness. 
 
Methods: Ten experts rated the relevance of the HBS-CHD items. The item content validity 
index (I-CVI) and averaged scale content validity index (S-CVI/Ave); the modified multi-rater Kappa 
and proportion of missing values for each question were calculated. Relationships with other 
variables were evaluated using six hypotheses that were tested in 429 adolescents with CHD. 
Stability of the instrument was assessed using Heise’s method; and responsiveness was tested by 
calculating the Guyatt’s Responsiveness Index (GRI). 
 
Results: Overall, 86.3% of the items had a good to excellent content validity; the S-CVI/Ave 
(0.81) and multi-rater Kappa (0.78) were adequate. The average proportion of missing values was 
low (1.2%). Because five out of six hypotheses were confirmed, evidence for the validity of the HBS-
CHD based on relationships with other variables was provided. The stability of the instrument could 
not be confirmed based on our data. The GRI showed good to excellent capacity of the HBS-CHD to 
detect clinical changes in the health behavior over time.  
 
Conclusion: We found that the HBS-CHD is a valid and responsive questionnaire to assess 
health behaviors in patients with CHD. 
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Introduction 
As adolescents born with a congenital heart defect (CHD) transition to adulthood, they are 
supposed to increasingly take responsibility over their health. During this developmental transition, 
adolescents become more independent and search for their own identity, develop a social network 
of peers, and increasingly adhere to their own values, beliefs, and customs (1). This developmental 
stage is generally characterized by experimenting behaviors such as smoking tobacco, use of illicit 
drugs, and alcohol (2,3).  
 
 Although to date about 90% of children born with CHD reach adulthood (4), they remain 
susceptible for developing arrhythmias, ventricular dysfunction, endocarditis, and premature 
mortality (5,6). In order to prevent these complications and to optimize long-term outcomes, 
patients should conduct health-promoting behaviors. These behaviors comprise moderate use of 
alcohol, avoidance of smoking cigarettes, no use of illicit drugs, excellent oral hygiene, adequate 
engagement in physical activities, and good dietary habits (7). 
 
 Current literature shows that studies investigating health behaviors in adolescents and 
emerging adults with CHD are scarce. Studies demonstrated that rates of substance use among these 
youngsters were lower compared to general population samples or healthy peers (1,6,8,9). 
Nonetheless, 28% of adolescents and 54% of young adults with CHD performed significant substance 
use during the past 30 days (9). Excellent oral hygiene, characterized by annual dental visits, flossing, 
and daily brushing of teeth, was identified in a small proportion of patients (9,10). The comparability 
of these study results, however, is limited because no standardized method to collect data on health 
behavior exists to date (9). Although to date some self-administered questionnaires are available for 
assessing health behaviors in patients with CHD (1,9-12), to the best of our knowledge none of them 
cover all items relevant for afflicted patients comprehensively. Furthermore, previously developed 
surveys differ substantially in wording, components of health behavior measured, and time frames 
used to assess health risk behavior (1,9-12).  
 
 In order to enlarge the body of evidence and to support clinical practice in assessing health 
risk behaviors of patients with CHD, we developed the Health Behavior Scale-CHD (HBS-CHD). This 
scale is a comprehensive tool for measuring and detecting potentially health-compromising 
behaviors in patients with CHD. Hence, the HBS-CHD contains items that are particularly relevant for 
afflicted patients, because these components may worsen patients’ outcomes. 
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 However, to use this tool in research or clinical practice, psychometric properties should be 
determined. The aim of this study was therefore to assess the psychometric properties of the HBS-
CHD. 
 
Methods 
Development of the HBS-CHD 
The HBS-CHD (Appendix Figure 7.3) was partially based on existing instruments comprising 
questions regarding health behavior in adolescents or adults (9,13-21). Twenty-five questions on 22 
components of health risk behavior in individuals with CHD were formulated. Four questions 
regarding consumption of alcohol were based on the Alcohol Use Disorders Identification Test 
(AUDIT) (13,19,20). Three questions on the use of tobacco during the past month were based on the 
Youth Risk Behavior Survey (YRBS) (15,16,18). Seven questions, developed for a population-based 
study in the Netherlands, asked respondents about the use of (illicit) drugs, sleeping pills, sedatives, 
and tranquillizers during the past month (21). Information on dental hygiene was obtained through 
four questions derived from the Self-reported Health Risk Behaviors questionnaire (9,22). Seven 
questions pertained to physical activity levels, which were inspired by the Baecke questionnaire for 
the Measurement of a Person’s Habitual Physical Activity (14,17). Levels of physical activity were 
operationalized using the classification schemes published by Godin et al. (23) and Durnin et al. (24). 
These questions were put in a specific lay-out to guide respondents through the HBS-CHD 
instrument.  
 
Psychometric properties 
To evaluate the psychometric properties of the HBS-CHD, we used the approach described and 
terminology used in the Standards for Educational and Psychological Testing (25). More specifically, 
we evaluated the evidence for content validity; validity evidence based on relationships with other 
variables; reliability evidence based on stability; and responsiveness evidence. These evaluations 
were undertaken concomitantly.  
 
Content validity of the HBS-CHD 
To evaluate the content validity, ten experts (three nurses, seven cardiologists) in pediatric 
cardiology and Adult Congenital Heart Disease were invited to rate the relevance of all 22 HBS-CHD 
items, using a 4-point rating scale (1=not relevant; 4=very relevant) (26). Free text space was 
provided to give additional comments. Calculation of both item content validity index (I-CVI) and 
averaged scale level content validity index (S-CVI/Ave) was performed. The excellence of the content 
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validity was assessed using generally accepted cut-off values (≥0.78 I-CVI for ≥6 experts; ≥0.80 S-
CVI/Ave) (26-29). To adjust for agreement by chance, the modified multi-rater Kappa (ĸ*) was 
calculated. Cut-off values for ĸ* were <0.40 for poor, ≥0.40 and <0.60 for fair, ≥0.60 and <0.75 for 
good, and ≥0.75 for excellent item relevance (30,31).  
 
 Furthermore, the proportion of missing values for each item of the HBS-CHD was 
determined. This is a parameter of how intelligible an item is (25). 
 
Validity evidence based on relationships with other variables  
Evidence based on relationships with other variables was evaluated by testing six hypotheses 
(1,8-12). Population-based health behaviors surveillance systems (18,32) and a study on health 
behaviors in individuals with CHD (9) showed that risky health behaviors are more prevalent in 
(emerging) adults than in adolescents. Even within the groups of adolescents, increasing trends of 
health risk behaviors were observed (32). This brought us to formulate the following three 
hypotheses: 
Hypothesis 1: The prevalence of substance use in adolescents and emerging adults with CHD 
is positively associated with increasing age (9,32). 
Hypothesis 2: The prevalence of preventive dental hygiene in adolescents and emerging 
adults with CHD is negatively associated with increasing age (9). 
Hypothesis 3: The prevalence of overall health-risk behaviors is positively associated with 
increasing age (18,32).  
 
Studies that compared health behaviors of patients with CHD and healthy controls showed 
better behaviors in patients with regard to the use of alcohol, illicit drugs, and tobacco, but worse 
behaviors in terms of dental practices (1,8-10,12). Therefore, we formulated two hypotheses on the 
difference between patients and healthy controls. 
Hypothesis 4:  The prevalence of substance use in adolescents and emerging adults with CHD 
is lower than that of controls from the general population (1,8-10,12). 
Hypothesis 5: The prevalence of preventive dental hygiene in adolescents and emerging 
adults with CHD is lower than that of controls from the general population 
(9,10). 
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Finally, we formulated a hypothesis regarding the relation between the Baecke’s sport score 
(14) and the HBS-CHD physical exercise score. Although there is no gold standard in the self-report of 
physical activities, the Baecke questionnaire is well validated (33,34). A good relationship between 
the Baecke sports score and the HBS-CHD physical exercise score, which calculation was based on the 
Baecke’s algorithm, would support the validity evidence.  
Hypothesis 6: There is a high correlation (≥0.70) between the physical exercise score of the 
HBS-CHD and the Baecke’s Sport Score (14).   
 
If the hypotheses are confirmed by empirical testing, the validity of the instrument under 
study is supported (25,35).  
 
Reliability evidence based on stability 
For the evaluation of the stability of the HBS-CHD, a traditional test-retest is not applicable 
because behaviors are not stable in itself. Therefore, an alternative approach that is able to 
distinguish the stability of the concept (i.e., health behavior) from the stability of the tool (i.e., HBS-
CHD) is used. We employed the technique as described by Heise (1969) (36,37), which requires four 
measurement points.  
 
Responsiveness evidence 
Responsiveness is “the ability of an instrument to record meaningful or clinically relevant 
changes in the patient’s clinical state (e.g., health behavior) over time” (38). We assessed the internal 
responsiveness of the HBS-CHD, defined as “ the ability of a measure to change over a predefined 
time frame” (39). Internal responsiveness can be evaluated with the use of a repeated measures 
design evaluating the changes in scale scores in a single sample of patients (39). More specifically, we 
calculated Guyatt’s Responsiveness Index (GRI) (40). 
 
Study population for the hypothesis-testing, assessment of reliability and responsiveness 
We examined the validity in relation with other variables, reliability and responsiveness of the 
HBS-CHD as part of a four-wave longitudinal project, spanning three years (at nine-month intervals): 
the i-DETACH project (Information technology Devices and Education program for Transitioning of 
Adolescents with Congenital Heart disease). Eligible patients were selected from the database of 
pediatric and congenital cardiology of the University Hospitals Leuven, Belgium. Patients were 
included if: they had a confirmed diagnosis of CHD, defined as structural abnormalities of the heart 
and/or great intrathoracic vessels that are actually or potentially of functional significance (41); aged 
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14-18 years at the start of the study on October 22, 2009; last cardiac outpatient visit at our tertiary 
care center performed ≤ 5 years ago; being able to read and write Dutch; and the availability of valid 
contact details. Patients were excluded if they had cognitive and/or physical limitations that inhibit 
the patient to fill out questionnaires; if the patient previously underwent heart transplantation; and 
if patients and/or their parents did not consent to participate.  
 
 Overall, 498 patients met these criteria. A total of 429 adolescents (86%) participated in the 
first wave of the study; 398 patients (80%) partook in the second wave; and 363 patients (73%) 
completed the questionnaires in the third wave. In all, 348 participated in wave 1, 2, and 3. Wave 4 is 
currently still in progress. In June 2012, a total of 231 respondents had participated in the four 
subsequent waves. 
 
 At Wave 1, control subjects, comprising peers from the general population, were recruited at 
four secondary schools in two regions of Belgium. Matching (1:1) was performed based on gender 
and age, resulting in 401 patients matched with a control subject (93.5%). 
 
Measurements and procedure 
Data were obtained using the HBS-CHD and a modified version of the Baecke questionnaire. 
The Baecke questionnaire is a self-report instrument assessing the habitual physical activity of adults 
(14), which has been extensively used during the past two decades in physical activity research 
(42;43). Although no gold standard for the self-report of physical activity levels exists, the Baecke 
questionnaire was found to be a standard of reference that was validated against the double labeled 
water technique and a tri-axial accelerometer (33,34). The Baecke questionnaire comprises three 
dimensions: (a) physical activity at work; (b) sports activity during leisure time; and (c) physical, non-
sports activity during leisure time. Since our study respondents are all school-attending adolescents, 
we used a modified version of the Baecke questionnaire that collects data on leisure time and sport 
physical activity indices. For the purpose of the present study, we only used the Baecke Sport Score. 
 
 Each wave, all eligible adolescents with CHD received a package by surface mail, which 
included a set of questionnaires, an information letter, an informed consent form (for parents and 
adolescents), and a pre-stamped and addressed return envelope. To obtain a high response rate, a 
modified Dillman’s approach was used (44). More detailed information on this approach can be 
found in a related article (45). The study was approved by the Institutional Review Board of the 
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University Hospitals Leuven and the investigation was conducted in keeping with the principles 
outlined in the Declaration of Helsinki (46).  
 
 Statistical analysis 
To test the six hypotheses, we first calculated summary scores. A ‘physical exercise score’ was 
calculated based on the usual time (in hours) spent per week in various types of physical exercise, 
including the walk or bike ride to school or work (there and back), multiplied by the average energy 
expenditure per unit of time (MJ/h), as derived from Baecke (14). This physical exercise score ranges 
from 0 to ∞, with higher scores indicating higher levels of physical exercise. Furthermore, the 
Baecke’s Sport Score was calculated by multiplying the intensity of the practiced sport, the amount 
of time weekly playing that sport and the proportion of the year in which the sport was practiced 
(14). 
 
 A ‘substance use score’, ranging from 0 to 3, was calculated based on the presence of (a) 
binge drinking at least monthly, (b) use of ≥1 of 7 predefined drugs once a month or less, and (c) 
smoking of cigarettes. A ‘dental hygiene risk score’, varying between 0 and 3, was calculated based 
on the reporting that (a) the patient did not visit the dentist annually, (b) did not daily brush, and (c) 
did not floss his teeth. Finally, an ‘overall health risk score’ was computed based on the individuals’ 
substance use score, dental hygiene risk score, and the absence of sport participation. This latter 
score ranges from 0 to 7. These latter three risk scores are recoded to a scale ranging from 0 (no risk) 
to 100 (maximum risk). In other words, a higher risk score represents a worse health behavior.  
Statistical analyses were performed using SPSS version 17.0 (SPSS Inc., Chicago, Illinois). 
Descriptive statistics of the three risk scores were expressed in terms of means and standard 
deviations for reasons of clarity and comparability. Differences in median risk scores between 
different age cohorts were tested using the non-parametric Jonckheere-Terpstra trend test. Intra-
individual changes in median subscale scores over a period of 18 months were evaluated using the 
Friedman’s test. Differences between patients and matched controls were tested using the McNemar 
test for nominal data and the Wilcoxon-signed rank test for ordinal data. To test the convergent 
validity of the HBS-CHD compared with the Baecke’s questionnaire, we investigated the relationship 
between the HBS-CHD physical exercise score and the Baecke’s Sport Score, both measured on a 
continuous scale, by calculating the Pearson’s product moment correlation coefficient.  
 
To test the stability of the HBS-CHD, we used the algorithms described by Heise (37) 
employing data of 4 measurement points. We calculated reliability and stability coefficients for the 
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three risk scores: substance use risk score; dental hygiene risk score; and overall health risk score. 
The reliability coefficient of the instrument was calculated based on the equation:  
rxx = (r12 x r23)/r13 
 where the rs are the test-retest correlations (37). To test the assumptions underlying this 
technique, the product of r14 and r23 must be very close to the product of r13 and r24 (37). 
 
To evaluate the internal responsiveness of the HBS-CHD, we calculated the Guyatt’s 
Responsiveness Index (GRI). This GRI is the ratio of the minimally clinically important difference (i.e., 
a priori determined delta) divided by the root square of two times the Mean Squared Error of the 
ANOVA for repeated measures (39,40). We determined that a clinically significant change in health 
behavior is represented by one additional behavioral risk factor, reflecting a delta-value of 1. Cut-off 
levels for the interpretation of the GRI are 0.20 for poor; 0.50 for moderate; 0.80 for good; and >1 for 
excellent responsiveness (40).  
 
Results  
Sample characteristics 
Adolescents with CHD in our sample had a median age of 16.3 years (Q1=15.3y; Q3=17.3y) 
(Table 7.1). The most common diagnosed heart defect was a Ventricular Septal Defect (18.2%), 
followed by aortic valve abnormality (16.1%) and secundum Atrial Septal Defect (13.1%). The 
majority of respondents had a moderately complex heart defect (47.6%), whereas mild and complex 
heart lesions were diagnosed in 40.6% and 11.9%, respectively. Additional details on sample 
characteristics can be found in Table 7.1. Participants did not differ on sex (χ2=0.163;p>0.05) and age 
(U=593.0;p>0.05) from non-participants. However, differences were found on complexity of CHD 
(F=9.255;p<0.05), with the group of non-responders having relatively more mild and fewer moderate 
congenital heart lesions. 
 
 Content validity  
Fourteen out of 22 (63.6%) HBS-CHD scale items were rated with an excellent content validity 
(I-CVI ≥0.78; ĸ*≥0.75), and five other items (22.7%) were evaluated with a good content validity 
(ĸ*≥0.60-<0.75). Two items (‘11. Use of hallucinogenic mushrooms during last 12 months?’ and ‘20. If 
yes, how long does it take by bike or on foot (there and back)?’) obtained an I-CVI of 0.60 and a ĸ* of 
0.50, representing a fair content validity (ĸ*≥0.40-<0.60). One item (‘18. How often do you floss your 
teeth?’) was evaluated as having a poor content validity (I-CVI=0.50; ĸ*=0.34). The S-CVI/Ave was 
0.81 and the overall instrument’s Kappa was 0.78, which reflects an adequate content validity 
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(26;29). If the three items with poor or fair content validity would be removed from the scale, the S-
CVI/Ave would increase to 0.85. However, because of clinical and theoretical considerations, these 
items were kept in the questionnaire to allow further analysis of the psychometric properties. The 
overall proportion of missing values over all scale items was low (1.2%). At item level, the proportion 
of missing values ranged from 0.0% to 5.3%. Questions regarding the frequency of flossing (5.3%) and 
brushing the teeth (3.9%) yielded the highest rate of missing values (Table 7.2).  
 
Validity based on relationships with other variables 
A comparison of the risk scores for substance use, dental hygiene and overall health risk, 
according to the age group, was performed (Table 7.3). In order to test the intra-individual evolution 
in risk scores over a period of 18 months, we compared these risk scores in adolescents with CHD 
(n=348) compared across wave 1, 2, and 3 (Table 7.4).  
 
 Data revealed that there is an increasing trend in substance use when adolescents with CHD 
are growing older (Z = 3.71; p<0.001) (Table 7.3). During an 18-month interval, a significant intra-
individual increase in substance use was found (χ2=38.138; p<0.001) (Table 7.4). Hence, the first 
hypothesis can be confirmed.  
 
The dental hygiene risk score increased in patients with CHD aged 16.9 years, but declined 
afterwards. Trend analysis showed no statistically significant evolution (Z= -1.32; p=0.19) (Table 7.3). 
Intra-individual comparisons confirmed that the dental hygiene risk score remained relatively stable 
over an 18-month period (χ2=0.258; p=0.879) (Table 7.4). These results did not confirm our second 
hypothesis.  
 
Analysis of the overall health risk scores demonstrated increased scores in patients until the 
age of 16.9 years, although this trend was not statistically significant (Z=1.37; p=0.17) (Table 7.3). 
Intra-individual analysis, however, showed a significant increase in the overall health risk of patients 
with CHD (χ2=14.983; p=0.001). Thus, our third hypothesis could be supported. 
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Table 7.1: Demographic and clinical characteristics of adolescents with congenital heart disease 
(n=429) 
Variables  
Sex n (%) 
Male 
Female 
 
229 (53.4) 
200 (46.6) 
Age (median; Q1-Q3) 16.3y;15.3-17.3y 
Primary diagnosis of CHD n (%) 
Hypoplastic left-heart syndrome 
Univentricular physiology 
Tetralogy of Fallot 
Double-outlet right ventricle 
Double-inlet left ventricle 
Truncus arteriosus 
Transposition of the great arteries (TGA) 
Congenitally-corrected TGA 
Coarctation of the aorta 
Atrioventricular septal defect 
Atrial septal defect,  type 1 
Ebstein malformation 
Pulmonary valve abnormality 
Aortic valve abnormality 
Aortic abnormality 
Left ventricle outflow tract obstruction 
Atrial septal defect, type 2 
Ventricular septal defect 
Mitral valve abnormality 
Pulmonary vein abnormality 
Other 
 
2 (0.5) 
4 (0.9) 
11 (2.6) 
12 (2.8) 
1 (0.2) 
1 (0.2) 
26 (6.1) 
5 (1.2) 
43 (10.0) 
6 (1.4) 
4 (0.9) 
2 (0.5) 
38 (8.9) 
69 (16.1) 
9 (2.1) 
5 (1.2) 
56 (13.1) 
78 (18.2) 
37 (8.6) 
9 (2.1) 
11 (2.6) 
Complexity of primary CHD diagnosis 
(60)
 n (%) 
Complex 
Moderate 
Simple 
 
51 (11.9) 
204 (47.6) 
174 (40.6) 
Cardiac surgery for CHD n (%) 
Yes, at least one cardiac surgical intervention 
No 
 
200 (53.4) 
229 (46.6) 
Current level of education n (%) 
High school/College/University  
Vocational high school 
Technical high school 
Education for adolescents with special needs 
 
194 (47.0) 
128 (31.0) 
84 (20.3) 
7 (1.7) 
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Table 7.2: Content validity: Analysis of item content validity index (I-CVI), modified multi-rater 
Kappa (ĸ*) and missing values 
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Comparison of the prevalence of binge drinking (i.e., ≥6 glasses of alcohol during one 
occasion) between adolescents with CHD and matched controls from general population, showed 
that significantly more controls performed binge drinking than patients with CHD (p<0.001). 
Furthermore, smoking of cigarettes and use of drugs during the past 12 months was significantly less 
prevalent in adolescents with CHD than peers (p<0.001). This corresponds with a significantly lower 
substance use score in patients than in matched controls (Z=-6.38; p<0.001). This corroborates the 
fourth hypothesis. 
 
With regard to dental hygiene, more adolescents with CHD have an annual visit with their 
dentist than matched peers, although fewer patients report daily brushing of teeth or flossing of 
teeth. For the difference in flossing, statistical significance was reached (p<0.001). Furthermore, the 
dental hygiene risk score was significantly higher in patients with CHD compared to controls (Z=-2.05; 
p=0.04). Thus, the fifth hypothesis can be confirmed. 
  
Finally, analysis showed the HBS-CHD physical exercise score to be significantly correlated 
with the Baecke’s Sport Score (Pearson’s r=0.75; p<0.001). This means that 56% of the variance (R²) 
in the HBS-CHD physical exercise score could be explained by the Baecke’s Sport Score (Figure 7.2). 
Therefore, our sixth hypothesis was confirmed. 
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Figure 7.2: Scatterplot of Health Behavior Scale – Congenital Heart Disease (HBS-CHD) physical 
exercise score versus Baecke’s Sport Score 
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Table 7.3: Substance use, dental hygiene and health risk scores in adolescents with CHD 
according to their age group (n=424) 
 
 
Table 7.4: Comparison of substance use, dental hygiene and health risk scores in adolescents 
with congenital heart disease (CHD), 18 month interval (n=348) 
 
 
Reliability based on stability 
Using Heise’s method (37), we found a reliability coefficient of 1.08 for the substance use risk 
score; 0.37 for the dental hygiene risk score; and 0.57 for the overall health risk score. The underlying 
assumptions for this technique were violated for data on the substance use risk score, resulting in a 
coefficient >1. For the other two risk scores, the assumptions were fulfilled. The reliability 
coefficients were moderate to low. Based on these findings, the stability of the HBS-CHD over 9 
month intervals could not be confirmed in the present study.  
 
 Responsiveness  
The GRI was found to be 1.58 for the substance use risk score; 1.38 for the dental hygiene risk 
score; and 0.95 for the overall health risk score. This means that the HBS-CHD has a good to excellent 
capacity in detecting clinical changes in health behavior of patients with CHD over time. 
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Discussion 
Although the importance of health-promoting and preventive behaviors in patients with CHD is 
well-established, a valid and comprehensive instrument to assess these behaviors is currently lacking. 
Therefore, we developed the comprehensive Health Behavior Scale-CHD scale (HBS-CHD), which 
relied in part on four existing questionnaires (9,13-15,17-20). The use of the HBS-CHD allows to 
calculating four summary risk scores: physical exercise score; substance use risk score; dental 
hygiene risk score; and total health risk score. In order to use this scale in research and clinical 
practice, we evaluated some psychometric properties of the instrument. 
 
 Our study revealed that 19 of the 22 items (86.3%) of this scale had a good to excellent 
content validity. The overall scale content validity was found to be adequate since S-CVI/Ave was 
0.81 (26,29). Two items received an I-CVI <0.60 and ≥0.40 which corresponds to a fair content 
validity. Four experts commented that the use of hallucinogenic mushrooms as a drug is rare in the 
Belgian population. Therefore, these experts rated this item as irrelevant. However, because we 
aimed at developing a comprehensive health behavior questionnaire that is also applicable in an 
international context, we wanted to keep this question in our scale. Indeed, the use of hallucinogenic 
mushrooms is more prevalent in other countries than in Belgium (47). The second question, of which 
the relevance was found to be fair, concerned the duration of the bike ride or walk from home to 
school or work. Five experts rated this question as being not relevant but, unfortunately, gave no 
additional comments or suggestions. However, to be able to determine whether patients perform 
physical activities in accordance with general guidelines (48), we prefer to keep this question in the 
HBS-CHD.  
 
 The relevance of one item was assessed to be poor: the frequency of flossing the teeth. The 
importance of excellent dental care in patients with CHD is well established. Several guidelines 
recommend annual visits to the dentist, daily brushing of teeth, and the administration of antibiotics 
prior to specific dental procedures as essential components to prevent infective endocarditis (IE) 
(49,50). The relationship between flossing teeth and IE is controversial (49-56). On one hand, it is 
known that flossing may increase the occurrence of transient bacteremia, and thus may amplify the 
risk for IE (57). On the other hand, flossing teeth is an essential element of good dental hygiene, 
which in its turn can avoid IE. In order to prevent the formation of caries, patients should brush their 
teeth daily and floss their teeth at least weekly (55,58). Since the benefits of good dental hygiene, 
which includes interdental flossing, outweigh the risk for IE due to bacteremia, we keep this item in 
the HBS-CHD. Although none of the panel experts suggested adding additional items to the HBS-CHD, 
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one could argue that our scale should also cover aspects of healthy eating and weight control as 
these are potential risk factors for the development of cardiovascular disease in cardiac patients.  
 
 Furthermore, analysis of the missing values showed that the average proportion of missing 
values was low. Only for the questions regarding the frequency of flossing and brushing the teeth, 
the proportion of missing values was somewhat higher. Hence, there is sufficient evidence to 
consider the content of the HBS-CHD as valid. 
 
 Validity evidence based on relationships with other variables was tested with six hypotheses. 
The first three hypotheses pertained to substance use, dental hygiene, and overall health risk 
behaviors, and their relationship with age. We analyzed differences in risk scores across four age 
groups, and investigated the intra-individual evolution in patients over an 18-month period. These 
results provided evidence for hypotheses 1 and 3. We did not find support to confirm hypothesis 2, 
regarding dental hygiene. Based on the comparison of the prevalence of binge drinking, smoking, use 
of drugs, and annual dental visits, the fourth and fifth hypotheses stating that substance use and 
preventive dental hygiene measures are less prevalent in adolescents with CHD compared to peers, 
was confirmed. Finally, our last hypothesis on the relationship between the HBS-CHD physical 
exercise score and the Baecke’s Sport Score provided evidence for the convergent validity of the 
HBS-CHD. Since five out of six proposed hypotheses were confirmed, the validity of the HBS-CHD 
based on relationships with other variables was generally supported.  
 
 Analysis of the reliability coefficients using the method of Heise (37) revealed that we could 
not confirm the stability of the HBS-CHD over a nine-month period of time. We assume that the nine-
month intervals that we used in our study design were not optimal in order to assess the stability of 
our scale. Hence, further research on the instrument’s stability is needed, in which shorter intervals 
between the measurements are required. On the other hand, the responsiveness of this scale could 
be supported.  
 
Methodological limitations 
 This study aimed to assess some psychometric properties of the HBS-CHD. We provided 
evidence to support the content validity and evidence on relationships with other variables of this 
scale. Other aspects of validity, such as validity on response processes; validity on internal structure; 
and predictive validity with respect to consequences, were not investigated. Assessing the validity 
based on response processes necessitates specific research designs. Indeed, participant’s response 
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processes could be evaluated using cognitive interviewing or observations during questionnaire 
completion (25). The validity on the internal structure is traditionally investigated using factor 
analysis (25,35). Several arguments were found against the use of exploratory factor analysis on the 
HBS-CHD scale. First, scale items are measured using several scale levels (e.g. nominal and ordinal 
data). Second, our scale comprises items aiming to screen patients for the use of alcohol, tobacco, 
etc. The use of these dichotomous items results in a large number of missing values for the sub-items 
when an item was not applicable to the patient. Factor analysis can only be performed on a dataset 
without missing values. Third, health behaviors are not necessarily interrelated (e.g. a patient who 
use alcohol does not necessarily use illicit drugs or smokes cigarettes), and a high frequency of 
alcohol consumption does not necessarily mean that the person drinks a high volume per occasion. 
Fourth, the analysis of a correlation matrix revealed that some items of our scale do not correlate 
with any other item; that a large number of items had a correlation coefficient <0.30; and that 
negative coefficients were observed. For all these reasons, the performance of exploratory factor 
analysis is not appropriate and not permitted on the HBS-CHD.  
 
Assessment of the validity on the intended or unintended consequences (25) has limited 
relevance for validity testing of the HBS-CHD, because its relevance lies more in educational and 
employment testing than in testing clinical phenomena. 
 
 For reliability, we evaluated the instrument’s stability. Other aspects of reliability, such as 
interrater reliability and internal consistency (25), were not tested. Since the HBS-CHD is a self-
administered questionnaire, interrater reliability is not relevant. The same is true for the internal 
consistency. The items of the HBS-CHD are not supposed to measure one common concept. In 
addition, a Cronbach’s alpha assumes that the items of the scale are correlated with each other at a 
level of 0.30 or above, because they are supposed to measure a common entity (59). In order to 
check this assumption, a correlation matrix was constructed to examine the direction and magnitude 
of correlations between the items of the instrument. We found that a number of items did not 
correlate to any other item, and that negative correlations were found. Hence, the calculation of 
Cronbach’s alpha is not appropriate and not permitted.  
 
Conclusion 
 The HBS-CHD was developed as a brief questionnaire to assess the health risk behaviors of 
adolescents, emerging adults and adults with CHD. The present study provided evidence for the 
content validity and on relationships with other variables, and on the responsiveness of this 
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instrument. We evaluated the HBS-CHD to be a valid and responsive instrument for its use in 
research and clinical practice, although further research on the instrument’s stability is required.  
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Appendix- Figure 7.3: Health Behavior Scale –Congenital Heart Disease - English (USA). 
Health behaviour 
This questionnaire is about your health behavior. Colour the correct answer black. 
Only 1 answer per question please. 
1. Do you consume alcohol from time to time? (by alcohol is meant: beer, wine, liquor, coolers,...) 
 
 
 No (Proceed to 
question 4) 
  Yes 
 
  If yes, how often? 
  o once a month or less 
  o 2 to 4 times a month 
  o 2 to 3 times a week 
  o 4 or more times a week 
 
  2. When consuming alcohol, how many glasses do you have 
on average?  
  o 1 to 2 
o 3 to 4 
o 5 to 6 
o 7 to 9 
o 10 or more 
 
  3. How often do you drink 6 glasses or more on one occasion? 
  o Never 
o Less than once a month 
o Monthly 
o Weekly 
o Daily or almost every day 
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4. Do you smoke cigarettes occasionally or regularly? 
 
 
 No  
(Proceed to question 7) 
  Yes 
 
  5. During the last 30 days, on how many days did you smoke 
cigarettes? 
  o 1 to 2 days 
o 3 to 5 days 
o 6 to 9 days 
o 10 to 19 days 
o 20 to 29 days 
o on all 30 days 
 
  6. During the last 30 days, on the days you smoked, how many 
cigarettes did you smoke a  day? 
  o 1 cigarette or less a day 
o 2 to 5 cigarettes a day 
o 6 to 10 cigarettes a day 
o 11 to 20 cigarettes a day 
o more than 20 cigarettes a day 
 
7. How often, in the last 12 months, did you take the following drugs? 
 Never once a month  
or less 
2 to 4 times 
a month 
2 times or 
more a week 
a. Cannabis (marihuana, hash) o  o  o  o  
b. XTC (ecstasy) o  o  o  o  
c. Cocaine o  o  o  o  
d. Hallucinogenic mushrooms o  o  o  o  
e. Speed o  o  o  o  
f. Sleeping pills, sedatives or 
tranquillizers 
o  o  o  o  
g. Other (illicit)drugs: o  o  o  o  
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8. Have you been to the dentist in the past year? 
 
 
 No  
 
  Yes 
(Proceed to questions 10 and 11) 
 
9. If not, when did you last go to the dentist? 
o I never go to the dentist 
o 1-2 years ago 
o 2-3 years ago 
o more than 3 years ago 
 
10. How often do you brush your teeth? 
o I don’t brush my teeth 
o I brush my teeth every now and then 
o once a day 
o twice a day 
o 3 times a day 
o more than 3 times a day  
 
11. How often do you floss your teeth? 
o I don’t floss my teeth 
o I floss my teeth every now and then 
o once a day 
o twice a day 
o 3 times a day 
o more than 3 times a day 
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12. Do you regularly walk or cycle to school or to your place of work? 
  
 
 
 
 
 
14. Do you regularly practice a sport? (this includes school sports but NOT the bike ride or walk to 
school or your work place 
 No  
(Proceed to question 14) 
  Yes 
13. If yes, how long take it take by bike or on foot (there 
and back)? 
o < 15 min 
o 15-30 min 
o 30-45 min 
o > 45 min 
 
 No (the questionnaire 
stops here; go to the 
next page) 
  
 Yes 
15. During a 7-day week, how many hours of the following physical activities do you do? 
a. Sport at school, during P.E. lessons or other sports periods  
                                hours/week 
b. Sports or activities that are very physically demanding, which increase your pulse (e.g. football, a 
long run, basketball, handball, korfball, squash, rowing, rugby, hockey, spinning, Thai boxing, 
kickboxing, cycle racing, rope-skipping, mountain biking, tennis,...) 
                                hours/week 
c. Sports or activities that are moderately physically demanding and where, afterwards, you don’t 
feel exhausted or worn out (e.g. jogging, volleyball, swimming up and down, ballet, dancing, 
judo, karate, athletics, badminton, baseball, fitness classes, horse riding, wall climbing,...) 
                                hours/week 
d. d. Sports or activities with minimal physical effort or gentle exertions (e.g. billiards, bowling, 
darts, golf, playing cards, yoga, fishing,...) 
                                hours/week 
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KNOWLEDGE LEVEL IN YOUNG PEOPLE WITH CONGENITAL HEART 
DISEASE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter was published as: Goossens E., Van Deyk K., Zupancic N., Budts W., Moons P. 
(2014). Effectiveness of structured patient education on the knowledge level of adolescents 
and adults with congenital heart disease. Eur J Cardiovasc Nurs; 13(1): 63-70 
  
 
 
Chapter 8 Impact of structured education on knowledge in young people with CHD 
 
 
151 
 
ABSTRACT 
Background: Patients with congenital heart disease (CHD) have poor understanding of their 
heart condition, treatment and prevention of complications. To improve their level of health-related 
knowledge, a structured education program was implemented at the adult congenital heart disease 
program. This study aimed (a) to evaluate the level of knowledge of patients who received structured 
CHD education as compared to patients who did not receive this education; (b) to explore if the 
provision of structured education is an independent determinant of knowledge; and (c) to evaluate if 
patients who received structured education reached the educational target (>80% correct answers).  
Methods and results: A total of 317 patients were included: 226 in the education group, and 
91 in the comparison group. Knowledge was assessed using the ‘Leuven Knowledge Questionnaire 
for Congenital Heart Disease’. The mean total knowledge score in the education group (57%) was 
significantly higher as compared to the comparison group (43%) (p<0.001). However, only 24 patients 
(11%) in the education group reached the educational target of the program. After adjusting for 
patient’s age, educational level and disease complexity, hierarchical multivariable linear regression 
analysis showed that the provision of structured CHD education was an independent determinant of 
higher levels of knowledge.  
Conclusion: A structured education program was associated with a higher level of knowledge. 
However, the educational target for sufficient knowledge was reached in a very limited number of 
patients. Hence, continuous efforts in educating patients and developing alternative education 
methods are needed. 
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Introduction 
A significant proportion of patients diagnosed with congenital heart disease (CHD) remain at 
risk for developing cardiac complications such as atrial arrhythmias, infective endocarditis and 
congestive heart failure (1,2). A good understanding of the heart condition, treatment and 
components of heart-healthy behavior is necessary to prevent these potential complications (3,4). 
Limited knowledge of patients might result in health-compromising behaviors or result in unseemly 
restrictions influencing the well-being of patients. A good understanding of the impact of the heart 
condition on daily living is fundamental especially for adolescents as they are prepared to become 
responsible for their healthcare and self-management in adult life (5). 
Studies that comprehensively assessed the level of knowledge of adults (3,6) and adolescents 
with CHD (5) are scarce. Previous studies predominantly evaluated selected aspects of knowledge in 
these patients such as the name and location of the heart defect (7-13), prevention of endocarditis 
(8,10-12,14), inheritance (15), risk of pregnancy (11), restrictions to physical activity (16), use of 
contraceptives (17) and medication for anti-coagulation (18). These studies demonstrated that 
adolescents and adults with CHD have poor to moderate understanding of their heart condition (3,5-
13), aspects of self-care activities preventing endocarditis (3,5,6,8-12,14,18), inheritance of CHD and 
reproductive issues(3,6,15,17), and safe levels of physical activity (3,5,9,16,18). The comparability of 
these cross-sectional studies is however limited since the level of knowledge was assessed using 
different methods: by interview (7,14); drawing techniques (13); or structured questionnaires 
(3,5,6,8-10,12,15,16,18-21). However, several studies that used questionnaires, had limited or no 
data that supported their validity or reliability of the questionnaires (8-10,12,15,16,18).  
To enhance the level of knowledge in patients, repetitive and structured educational 
interventions are recommended (11,12,19,22). Since provision of patient education is a time-
consuming activity, requiring the investment of sufficient time, space and trained personnel, studies 
evaluating the effectiveness of patient education are highly needed (12,23). However, the evidence 
supporting the effectiveness of structured education programs is currently lacking.  A preliminary 
pre-post study showed a promising 10% increase of knowledge levels in 31 adults with CHD after the 
implementation of a structured education program (19). Since no study comparatively investigated 
the effectiveness of educational efforts, this study aimed (a) to compare the level of knowledge 
between patients with CHD who received structured education and a comparison group of patients 
who did not receive prior structured education; (b) to explore if the provision of structured education 
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was an independent determinant of higher levels of knowledge; and (c) to evaluate if patients who 
received education reached the educational target of the education program.  
Methods 
Study population 
In this descriptive, cross-sectional study, patients with CHD were recruited at the outpatient 
clinic for adults with CHD. Patients were eligible if they had a structural heart defect, were literate, 
Dutch speaking, and gave verbal informed consent. Patients were excluded if they had learning 
disabilities, if they were not in regular follow-up at the pediatric cardiology or ACHD program of the 
hospital. Patients who were newly diagnosed as adults with an atrial septal defect or foramen ovale 
after a cryptogenic stroke were excluded since the congenital cardiac condition was diagnosed 
secondary to the stroke. 
Participants were recruited on preselected dates during a 13-month period from January 
2006 to February 2007. Overall, 493 patients were planned for an outpatient visit on these selected 
dates, 353 (72%) of which met the inclusion criteria and were therefore asked to partake in the 
study. Six patients refused to participate due to a lack of interest or time constraints. Thirty patients 
were excluded because of practical reasons, e.g. did not bring their glasses; physician was waiting; 
etc. Thus, 317 (90%) of the eligible patients participated. Participants were divided into two groups: 
(a) patients who previously had an outpatient visit at the ACHD clinic and therefore received at least 
once structured patient education, and (b) patients who transferred directly from pediatric 
cardiology or other adult services and had their very first ACHD visit. These latter patients comprised 
the comparison group since they did not receive structured education before. The education group 
consisted of 226 patients with a median age of 27.5 years; 54% were male. The comparison group 
consisted of 91 patients with a median age of 17 years; 53% were male. Demographic and clinical 
characteristics of both groups are detailed in Table 8.1.
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Table 8.1: Demographic and clinical characteristics of 317 patients with congenital heart disease  
Variable Education group 
(n=226) 
Comparison group 
(n=91) 
Sex   
       Male 123 (54%) 48 (53%) 
       Female 103 (46%) 43 (47%) 
Median age (in years) 27.5 (Q1=23; Q3=34) 
(Range: 16-60) 
17 (Q1= 16; Q3=18) 
(Range: 15-32) 
Complexity of CHD   
       Simple 40 (18%) 32 (35%) 
       Moderate 152 (67%) 48 (53%) 
       Complex 34 (15%) 11 (12%) 
Marital status   
       Unmarried (living with parents)  98 (43%) 87 (96%) 
       Married or living together 18 (8.0%) 3 (3%) 
       Living alone 110 (49%) 1 (1%) 
Highest educational level   
       Vocational high school 60 (28%) 29 (31%) 
      Technical high school 35 (16%) 32 (34%) 
      High school/College/University 123 (56%) 30 (32%) 
Primary medical diagnosis   
       Tetralogy of Fallot 47 (21%) 4 (4%) 
       Aortic valve disease 44 (19%) 11 (12%) 
       Coarctation of the aorta  29 (13%) 12 (13%) 
       Ventricular septal defect  24 (11%) 26 (29%) 
       Transposition of the great arteries 14 (6%) 5 (5%) 
      Pulmonary valve disease 11 (5%) 11 (12%) 
      Other  
 
 
57 (25%) 22 (24%) 
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Responsible for the daily management of care   
     Parents - 1 (1%) 
     Patient 210 (93%) 23 (25%) 
    Patient and parents 16 (7%) 67 (74%) 
History of infective endocarditis 9 (4%) 0 (0%) 
History of pregnancies (for women only) 36 (35%) 0 (0%) 
Contraception (for women only)   
      Birth control pill 66 (66%) 19 (43%) 
      Other methods 10 (10%) 1 (2%) 
      No contraception 24 (24%) 24 (55%) 
CHD = Congenital Heart Disease  
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Setting and Intervention 
The division of Congenital Cardiology, established in 1960, is part of the University Hospitals 
of Leuven in Belgium and contains two programs: pediatric cardiology and the ACHD program. To 
date, more than 35,000 individuals have been examined and/or treated in this center. In 1995, a 
dedicated ACHD program with a different provider team was established. At this hospital, young 
people with CHD are transferred from pediatric cardiology to the ACHD program when they reach 
the age of 16, unless they are medically unstable. This transfer is not preceded by structured 
provision of information or instruction as part of a formal transition program.  
According to the complexity of the heart defect, patients are planned to have an outpatient 
visit on a regular basis (24-26). For patients diagnosed with a simple heart lesion, outpatient visits to 
check the patient’s cardiac condition, are planned every 3-5 years either in a non-specialized setting 
or at a shared care facility (24,25). In patients with a moderately severe condition, check-ups are 
recommended every 1-2 years preferably done at specialist centers (24). Patients who have a 
complex heart lesion are advised to have a follow-up visit at an ACHD program every 6-12 months 
(24). 
A typical outpatient visit of an adult patient to the ACHD program starts with the registration 
of an electrocardiogram (ECG) by a nurse. Then patients will meet one of the nurses of the ACHD 
advanced practice nursing (APN) team to discuss their subjective condition, experienced symptoms, 
lifestyle issues and questions they have. Furthermore, structured patient education is provided 
verbally during this session. This education program was based on the framework of educational 
assessment in CHD (27) and provides information about the heart defect, the current treatment, the 
need for regular follow-up, characteristics and prevention of endocarditis, physical and vocational 
lifestyle issues, inheritability of the heart defect, potential risk of pregnancy, contraception, sexuality 
and traditional cardiovascular lifestyle issues. Education is provided to patients on an individual basis 
during an outpatient visit and takes 15-30 min. Topics are discussed repeatedly during subsequent 
outpatient visits to facilitate retention of the provided information. During the education session, a 
computerized intake form/checklist is used by the nursing team to guarantee that information is 
provided in a structured and systematic way. Finally, the last part of the outpatient visit entails a visit 
to the congenital cardiologist who performs the medical check-up using clinical examination, 
echocardiography, or other diagnostic tools.  
To date, two advanced practice nurses and three specialized nurses are on the staff in the 
ACHD program, corresponding with 1.73 full-time equivalents. With the current staffing, education 
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can systematically be provided during each outpatient visit, which resulted in 2,528 patients who 
received education in the year 2012. 
Variables and measurement 
Demographic data were gathered during a patient interview. Clinical variables (primary 
diagnosis, disease complexity as defined by Task Force 1 of the 32nd Bethesda conference (28), 
history of endocarditis, history of pregnancy, prescribed contraception) were collected from patients’ 
medical records. Assessment of the level of knowledge of all participants, irrespective of the group to 
which they were assigned, was performed using the Leuven Knowledge Questionnaire for Congenital 
Heart Disease (LKQCHD) (3,29). This instrument was developed and refined by Moons and coworkers 
as a comprehensive questionnaire assessing knowledge in patients with CHD. A revised version of the 
LKQCHD was developed in 2009 comprising 34 questions for female and 31 questions for male 
patients (29). The LKQCHD covers five domains: (a) knowledge of the heart defect and treatment, (b) 
knowledge of the prevention of complications, (c) knowledge of physical activities, (d) knowledge of 
sexuality and heredity, and (e) knowledge of contraception and pregnancy planning, and has been 
described in detail elsewhere (3). Expert review, pilot testing, and confirmation of theoretically 
derived hypotheses provided evidence for the content and construct validity of the LKQCHD (3,29).  
Procedure 
A nurse from the ACHD nursing team explained the purpose and procedure of the study to all 
patients prior to their scheduled outpatient visit at the ACHD clinic. After receiving verbal consent, 
the nurse gave the patients instructions on how to fill out the LKQCHD while they were sitting in the 
waiting room. To ensure that the patients filled out the questionnaire independently, the nurse 
asked relatives not to help. External sources (e.g., internet) could not be consulted. After completion 
of the LKQCHD, the nurse checked whether all items were filled out and asked for clarification if 
necessary. The researcher evaluated the patients’ answers as ‘correct,’ ‘does not know,’ ‘incorrect,’ 
or ‘incomplete.’ The study was approved by the Institutional Review Board of the University Hospitals 
Leuven, Belgium.  
Statistical analysis 
Statistical analyses were performed using SPSS, version 17.0 (SPSS Inc., Chicago, Illinois, 
USA). Data derived from the LKQCHD were analyzed at two levels: item level and patient level. At the 
item level, knowledge variables were dichotomized as ‘correct’ or ‘incorrect’ (i.e. includes 
incomplete, does not know, and incorrect responses), and the proportion of patients that gave a 
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correct answer was calculated. At the patient level, a total knowledge score was calculated by 
computing the percentage of correct answers per patient. The educational target for individual 
patients in this education program was set at an overall knowledge score of ≥80% based on a cut-off 
used in previous studies (3,5). Descriptive statistics for nominal variables were expressed in absolute 
numbers and percentages. Continuous data were presented as means and standard deviations if 
data were normally distributed. To test differences in overall knowledge score between the 
education and comparison group, an unpaired t-test was used. The effect size was determined by 
calculating the Cohen’s d. Effect sizes were categorized as a small (0.2–0.5); moderate (0.5–0.8); or 
large difference (>0.8) (30). 
To explore if the level of knowledge was independently determined by the structured 
education provided, a hierarchical multivariable linear regression analysis (enter method) was 
performed, adjusting for confounding factors, potential differences between the groups, and 
interaction effects. Based on empirical evidence, three potential confounders were included in this 
analysis: age (3,7,9,10,12), level of education (3,9,12,15), and complexity of disease (3). The 
assumptions of normality and linearity of residuals, and absence of multicollinearity were met. 
Furthermore, to test the robustness of this model a matched (1:1) control analysis was performed, in 
which the difference in knowledge levels was directly tested between pairs of patients, matched on 
the confounders emerging from the multivariable model. All tests were two-sided, and the level of 
significance was set at p < 0.05. 
Results 
Comparison of the level of knowledge  
Patients who previously received education displayed adequate knowledge in 8 of 34 (24%) 
questions (>80% respondents answered correctly); moderate knowledge in 11 of 34 (32%) questions 
(50-80% respondents answered correctly); and poor knowledge in 15 of 34 (44%) questions (<50% 
respondents answered correctly).  
Patients who did not receive prior education (comparison group) displayed adequate 
knowledge in 5 of 34 (15%) questions; moderate knowledge in 7 of 34 (20%) questions; and poor 
knowledge in 22 of 34 (65%) questions. The proportion of patients providing a correct answers for all 
items of the LKQCHD was consistently higher in the education group, with the exception of items 5 
and 17 (Table 8.2).  
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Patients in the education group had a significantly higher mean total knowledge score (57%), 
as compared to the comparison group (43%)(t=8.737; p<0.001). The difference between the scores of 
the two groups was not only statistically different, but also clinically meaningful as shown by the 
calculation of the Cohen’s d (d = 1.24).  
Exploration of independent determinants of knowledge 
In order to correct for confounding factors and for differences between the groups, a 
hierarchical multivariable linear regression analysis was conducted. This analysis revealed that, after 
adjusting for age, educational level, and disease complexity (block 1), structured patient education 
(block 2) was significantly associated with the total knowledge score (Table 8.3). This model 
demonstrated that a higher educational background and a higher disease complexity were significant 
correlates of a higher level of knowledge. This means that structured patient education was a 
significant factor in explaining improved levels of patient knowledge, over and above the impact of 
educational background and disease complexity. The knowledge score was not related to patients’ 
age, suggesting that knowledge in this population is not time-dependent. Moreover, no interaction 
effect between age and structured education was observed. The final regression model explained 
28% of the variance for the level of knowledge (Table 8.3).  
The matched control analysis, comparing the level of knowledge of 85 pairs of patients 
matched on educational background and disease complexity showed that the knowledge score of the 
education group was significantly higher as compared to the matched controls (t=-4.474; p<0.001). 
This displays the robustness of the model and provides additional support for the effectiveness of 
structured patient education.  
Proportion of patients reaching the educational target  
Although the level of knowledge was significantly higher in the education group, the 
educational target of the program, defined as a total knowledge score of ≥80, was only achieved in 
24 (11%) patients of the education group.  
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Table 8.2: Proportion of correct answers in patients who previously received education 
(education group) and those without prior education (comparison group)    
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Questions in this table replicate the Leuven Knowledge Questionnaire for Congenital Heart Disease (LKQCHD) 
questionnaire 
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Table 8.3: Hierarchical multivariable linear regression analysis on the effect of education 
on total knowledge score in 317 patients with congenital heart disease, adjusted for age, 
education background, and disease complexity. 
 
Discussion 
This study showed that patients who partook in a structured education program were 
significantly more knowledgeable about their heart defect, its treatment, and various preventive 
measures than patients who did not receive structured education. Furthermore, this difference in 
knowledge levels of both groups was found to be large and clinically relevant.  
Hierarchical multivariable regression analysis showed that the provision of structured patient 
education was a significant and independent predictor of higher levels of knowledge in patients. 
Additionally, higher levels of educational background and a more complex heart defect were 
identified as significant predictors of increased levels of knowledge in this study. Higher levels of 
knowledge might be expected in patients with more complex CHD, since these patients are 
recommended to have an outpatient visit at least once a year. Therefore, these patients will receive 
structured education more frequently and as a result information might be better retained. 
Furthermore, this study confirmed previous study results that indicated a positive correlation 
between knowledge of CHD and higher educational levels(3,9,12,15,29). This finding stresses the 
importance of providing more attention to patients with lower educational levels because they might 
need more time or repetition in order to understand the information and lifestyle instructions. As in 
line with previous studies in adolescents (3,10,12) and adults (7) with CHD, the level of knowledge 
was found to be independent of age. Since there were significant differences in the size of the two 
groups and in the characteristics of patients belonging to either the education or comparison group, 
a matched case control analysis was performed. This analysis created 85 pairs of patients matched 
on their educational background and CHD complexity. Since age was not identified as a significant 
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determinant of knowledge, patients were not matched with a control on their respective age. In sum, 
this study was the first to show that structured patient education by an advanced practice ACHD 
nursing team is effective in improving patient’s knowledge about their heart condition, treatment, 
lifestyle issues and health-promoting behaviors.  
Nonetheless, this study revealed that patients with CHD who received structured patient 
education still have a relatively low level of knowledge on multiple aspects of their condition since 
only 1 in 10 patients achieved the predefined educational target. Analysis of the responses of 
patients in the education group showed that most patients still had a poor understanding of the 
definition, symptoms, and risk factors of endocarditis; the signs of deterioration of the heart 
condition; inheritance of the defect; the risk of pregnancy; the anatomy of the lesion; and the 
suitability of intrauterine devices as contraceptives. Hence, the educational efforts currently 
implemented in the ACHD program of the hospital were not capable of achieving the anticipated 
educational target. This result might be disappointing, given the investment of supplementary 
resources which are needed to systematically and repetitively provide education to these patients. 
However, previous studies showed that retention of health-related information is generally low in 
patients (31-33). Therefore, complementary or alternative forms of patient education should be 
explored. To date, education was provided verbally in this ACHD program. Alternative forms of 
education could be provided by means of written information (booklets), video education, or 
interactive computer programs such as digital game-based learning (34-36). This latter type of 
education seems to be a promising method to educate young people with a chronic condition. 
Rönning and colleagues performed an initial evaluation of the implementation of an Education and 
Psychosocial Support (EPS) model (21). This model comprised three components: medical 
consultation by an ACHD cardiologist, computer-based education, and psychosocial support provided 
by a multidisciplinary team. A 3-month follow-up of 55 adults who received this type of education 
showed an increase in self-perceived levels of knowledge. Unfortunately, this pre-post study did not 
objectively assess the impact of this model on the level of knowledge through the use of a 
questionnaire (21).  
Chapter 8 Impact of structured education on knowledge in young people with CHD 
 
 
164 
 
Methodological issues 
One must consider some methodological limitations inherent to this study when interpreting 
these findings. First, since this cross-sectional study was conducted in a single outpatient clinic of a 
university hospital in Belgium, study results have limited generalizability. However, this single-center 
approach was critical to yield a relatively large sample size, low attrition rate, and no missing data. An 
RCT-design is generally used to test the effectiveness of an intervention in patients. Since structured 
education is a standard element of the current care provision, it would be unethical to withhold part 
of the patients of this intervention. Therefore, this study used a non-randomized comparison design 
using a convenience comparison group reflecting the day-to-day practice. Furthermore, knowledge 
about CHD was measured using the LKQCHD, an instrument for which previous studies provided 
evidence to support the content validity and validity based on relations with other variables (3,29). 
However, additional aspects of reliability and validity of this instrument remain subject to scrutiny 
(29). Third, the LKQCHD questionnaire gives the same weighting to all items although it might be 
argued that some items, e.g. prevention of endocarditis, would be of more importance to a subset of 
patients than to others. For the purpose of this study, a total knowledge score was calculated by 
simply computing the percentage of correct answers. Future studies should evaluate whether 
calculation of a summary score based on weighing factors assigned to items with a higher relevance 
would be meaningful and relevant. Fourth, although all nurses of the APN team were trained to 
provide structured education in a standardized way, variation in the education provided by these 
nurses could not be excluded. This variation might result in bias, but is a reflection of the real-life 
clinical practice.  
Conclusion 
This study was the first to support the effectiveness of structured patient education provided 
by an advanced practice nursing team in improving the level of knowledge of adolescents and adults 
with CHD using a comparative study design. Unfortunately, the educational target of this program 
was only reached by a limited number of educated patients. Therefore, clinicians and researchers 
should continue their efforts in teaching patients and in developing alternative education methods.
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Abstract 
Objective: Providing structured patient education is hypothesized to be a critical element of a 
transition program helping young people  with congenital heart disease (CHD) developing the skills, 
insights, and behaviors needed to transition to adulthood. Evidence supporting the benefit of 
education on patient knowledge and health-related behaviors is very limited. This study investigated 
whether a single educational session increased the level of knowledge and changed the prevalence 
of health risk behaviors in young people with CHD. 
Study design: We conducted a longitudinal study of patients transferred to adult CHD care 
who received one educational session (n=201) at a tertiary care center. Their knowledge level and 
prevalence of health risk behaviors were assessed using the Leuven Knowledge Questionnaire CHD 
and the Health Behavior Scale CHD, respectively. A general linear model (GLM) for longitudinal 
measurements analyzed the natural progression of patients’ knowledge over a 27-month period and 
the effect of one educational session on outcomes. 
Results: Participating in an educational session resulted in a small-to-moderate, but significant, 
increase in total knowledge level and better understanding of deterioration symptoms, and rationale 
and frequency of follow-up. However, it did not improve patients’ health behaviors.  
Conclusions: This prospective study is the first to demonstrate the effectiveness of structured 
education for improving the overall knowledge of young people with CHD. However, this type of 
education did not improve the patients’ tendency to engage in better health behaviors. Urgently 
needed are studies assessing the effect of repetitive exposure to educational sessions dealing with 
CHD.  
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Introduction 
Adolescence is a critical and vulnerable period for young people with chronic conditions, such 
as congenital heart disease (CHD). During this developmental phase, young patients transition to 
adult life and are expected to develop an increased sense of responsibility by managing their 
lifestyle, health, and healthcare (1, 2). However, like other teenagers, they are tempted to engage in 
high-risk health behaviors, such as experimentation with cigarettes, illicit drugs, and binge drinking 
(3-5). Implementing transition programs is one suggested way to help young people with chronic 
conditions better navigate the transition into adulthood, teaching them to master a set of new skills, 
knowledge, and developmental tasks. As young patients grow older, changing healthcare needs 
demand a change in care setting, that is, from a pediatric- to an adult-focused program. Hence, a 
timely transfer of care is advocated. Transition programs also can prepare patients for this handing 
over of care (2, 6-9).  
Many authors have proposed definitions for the concepts of transfer and transition (1). 
Transition can be defined as “the process by which young people with chronic childhood illnesses are 
prepared to take charge of their lives and their health in adulthood” (10). Transfer can be defined as 
“an event, or series of events, through which young people with chronic physical and medical 
conditions move their care from a pediatric to an adult healthcare environment” (10). Even though 
the objectives of a transition program for patients with CHD are well documented (2, 11), a clear 
operational definition for such a program is lacking. Experts have outlined key features and 
components of CHD transition programs (2, 8, 11, 12). Unfortunately, the critical elements of a 
formal transition program are not yet clearly defined. Literature promoting the development and 
implementation of transition programs is extensive (2, 6-9). However, no prospective study has been 
published on the benefit of such a program in young people with CHD. 
Structured patient education has been proposed as a standard element of a transition 
program (2, 8, 9, 12-14). Developmentally appropriate education about the patients’ medical 
condition and other disease-related issues is hypothesized to be critical in fostering self-management 
in young people with CHD (2). The objective of structured education is not merely to improve 
patients’ understanding of their disease, but also to encourage patients to adopt a healthy lifestyle, 
leading to a reduction in morbidity and increase in life expectancy (15-17). 
Although patient education is a recommended core component of transition programs, 
empirical evidence demonstrating its effectiveness in increasing disease-related knowledge in young 
people with CHD remains scarce (18-20). Furthermore, evidence describing the impact of such 
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education of young people with CHD on the prevalence of engaging in positive health behaviors is 
currently absent. Finally, no longitudinal studies have been done or initiated to evaluate the 
prospective effects of education. Therefore, this longitudinal study had two objectives. First, we 
sought to describe how disease-related knowledge and engagement of high-risk health behaviors 
develop in young people with CHD transitioning into adulthood. Second, we sought to determine 
whether a single structured educational session would increase the level of disease-related 
knowledge and decrease the prevalence of high-risk health behaviors among these young patients. 
Methods 
Setting and educational session 
This longitudinal study was conducted at a large tertiary care center, housing both a pediatric 
and an adult congenital heart disease (ACHD) care program. In this center, patients are transferred 
from pediatric cardiology to ACHD care at the age of 16 years, provided they are medically stable. A 
multidisciplinary team specialized in adult care provides ACHD care. This team is distinct from the 
pediatric cardiology team. During a patient’s last pediatric visit, the patient is given information on 
the rationale and timing of transfer to ACHD care. With the consent of all parties, a designated adult 
provider is generally chosen. This recommendation is documented in the patient’s file, and then a 
pediatric cardiologist writes a referral letter. Currently, a formal educational transition program does 
not precede this transfer of care within our hospital.  
 For adults, the frequency of outpatient visits is based primarily on the anatomical 
classification of the heart defect. The standard frequency of outpatient visits is every 6-12 months for 
those patients diagnosed with complex heart lesions, every 1-2 years for moderately complex 
defects, and every 3-5 years for simple lesions (11;13;21). A routine ACHD outpatient visit standardly 
comprises a consultation with a member of the ACHD advanced practice nursing (APN) team, 
followed by a medical check-up performed by an ACHD cardiologist. During the APN visit, patients 
have the opportunity to discuss their health status, symptoms experienced, and pending questions or 
concerns. Furthermore, every patient receives verbal structured education on disease-related and 
behavioral issues, including CHD diagnosis; current treatment; rationale for regular follow-up; 
infective endocarditis symptoms and strategies for preventing it; healthy lifestyle; vocational and 
educational choices; sexuality; inheritability of the defect; risks associated with the use of 
contraceptives; and pregnancy. Education and counseling sessions are about 15-30 min. In order to 
document which items were discussed, repeated, or already known by the patient, the APN team 
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uses a computerized checklist. Detailed information on the comprehensive list of issues addressed 
during the education is provided in Table 9.1. 
Table 9.1: Overview of content and working sequence of structured education session  
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Study population 
This longitudinal study was conducted as part of the i-DETACH project (Information Technology 
Devices and Education Program for Transitioning of Adolescents with Congenital Heart Disease). 
Patients were selected from the database of pediatric and congenital cardiology of the hospital. They 
were eligible for inclusion if they had a confirmed diagnosis of CHD, were 14-18 years old at the start 
of the study, had their last outpatient visit at our hospital ≤5 years ago, were able to read and write 
Dutch, and if their valid contact details were available in the hospital administration. CHD was 
defined as “structural abnormalities of the heart and/or great intrathoracic vessels that are actually 
or potentially of functional significance” (21). Patients were excluded if they had cognitive and/or 
physical limitations, preventing them from filling out questionnaires; had undergone heart 
transplantation; or if they and/or their parents did not consent to participate in the study. Overall, 
498 patients met the inclusion criteria.  
 
Over a period spanning three years, four measurements (T1-T4) were taken, one every nine 
months. A set of questionnaires was sent by surface mail to the patients’ home address. Patients 
were asked to fill-out the questionnaires and to return them in a pre-stamped envelope. They 
received a movie ticket upon completion of the questionnaires. The study was approved by the 
Institutional Review Board of the University Hospitals Leuven and was performed in line with the 
principles outlined in the Declaration of Helsinki (22). A total of 429 (Response Rate [RR]=86%), 398 
(RR=86%), 366 (RR=82%), and 337 (RR=77%) adolescents participated at T1, T2, T3, and T4, 
respectively.  
 
For the present study, data on a selected group of patients were analyzed. Because our aim was to 
evaluate the impact of a single structured educational session on the knowledge and health risk 
behaviors of young CHD patients, we analyzed only data from patients who were in current follow-up 
within our center. Patients who already transferred to the ACHD program prior to the start of the 
study were excluded from data analysis, because they had already received this type of education. 
Hence, our final sample comprised 210 patients. Response rates varied between measurement 
points since a limited number of patients decided to cease participation during the longitudinal data 
collection (see Figure 9.1). Self-reported questionnaires were completed by patients at home and 
some patients appeared to have missing values for particular items. Complete data for the respective 
items were available for at least 193 to 196 patients at T1; 183 to 185 patients at T2; 169 to 171 
Chapter 9: Effectiveness of transitional care on intermediate outcomes 
174 
 
patients at T3; and 149 to 150 patients at T4. These respective ranges varied between measurement 
points since response rates  
 
Apart from a few exceptions, patients who transferred to ACHD care during the study period 
had one outpatient visit, and thus were exposed to one educational session. A total of 37, 36, and 33 
patients received the educational session after T1, T2, and T3, respectively. One hundred and four 
patients (49.5%) did not transfer during the study period and therefore were not exposed to patient 
education (non-education group). Figure 9.1 presents a detailed flowchart diagram of the sample 
selection.  
Variables and measurements 
Demographic data (i.e., age, sex, and educational level) were collected using a self-report 
survey. Clinical characteristics were collected by means of chart review and included primary CHD 
diagnosis, anatomical complexity of the heart defect based on guidance from Task Force 1 of the 32nd 
Bethesda Conference (13), and history of surgery or catheter-based interventions. The precise date 
when patients were transferred to ACHD care was determined based on chart reviews. The patient’s 
first ACHD outpatient visit coincides with the first time the patient received structured patient 
education. The patients were not exposed to this type of education in pediatric cardiology. 
The level of disease-related knowledge was measured longitudinally using the Leuven 
Knowledge Questionnaire for Congenital Heart Disease (LKQ-CHD), which comprises 34 items 
relevant for female patients and 31 items relevant for male patients (23, 24). For each patient, a total 
knowledge score was calculated by computing the number of correct answers divided by the number 
of eligible answers, multiplied by 100. The total knowledge score ranged from 0-100. In addition, 
eight thematic subscale scores were calculated, representing the level of patient knowledge 
regarding (1) CHD diagnosis, (2) treatment, (3) follow-up, (4) cardiovascular risk, (5) symptoms, (6) 
endocarditis, (7) physical activity, and (8) reproduction. These subscale scores also ranged from 0-
100 and were calculated as the percentage of correct answers on the respective items comprising 
these eight subscales. The total knowledge score and the eight thematic scores were calculated for a 
patient only if at least two-thirds of the survey items were filled out. A patient was said to have 
adequate understanding if he/she had >80% correct answers, moderate understanding with 50-80% 
correct answers, and poor understanding with <50% correct answers (24). The LKQ-CHD is a valid 
instrument for assessing the level of knowledge in patients with CHD and is based on an excellent 
content validity and relationships with other variables (23). 
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Health risk behaviors were assessed longitudinally using the 22-item Health Behavior Scale-
Congenital Heart Disease (HBS-CHD) (25). This is a self-report instrument that addresses four 
important components of health behaviors in patients with CHD: (1) the use of alcohol, (2) the use of 
tobacco and illicit drugs, (3) oral hygiene, and (4) engagement in physical activities. Three health 
behavior risk scores can be calculated. A substance use risk score (range: 0–3) is based on whether 
(a) binge drinking occurred at least once a month, (b) ≥ one of seven predefined drugs were used 
once a month or less, and (c) cigarettes were smoked. A dental hygiene risk score (range: 0–3) is 
based on whether (a) the patient failed to visit a dentist annually, (b) did not brush his/her teeth 
daily, and (c) did not floss his/her teeth. Finally, an overall health risk score (range: 0-7) is based on 
the individual’s substance use risk score, dental hygiene risk score, and the absence of sports 
participation. These three risk scores are transformed into a scale ranging from 0 (no risk) to 100 
(maximum risk) in order to facilitate interpretation and to allow for comparisons. The HBS-CHD was 
found to be a valid and responsive tool for assessing various components of health risk behavior of 
young people with CHD (25).  
Figure 9.1 Flow diagram of subject selection, group comparison, and response rates 
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 Statistical analysis 
Differences in demographic and clinical characteristics of patients included in the education 
group or non-education group were tested using a Chi2-test for nominal-level data, a Mann-Whitney 
U test for ordinal-level data, and an unpaired t-test for continuous-level data.  
 
A general linear model (GLM) for longitudinal measurements was used to analyze both the 
natural progression of patients’ knowledge over a 27-month period and the effect of education on 
LKQ-CHD and HBS-CHD scores. More specifically, a direct likelihood approach was adopted using an 
unstructured 4x4 covariance matrix for the four longitudinal measurements (26), while considering 
the measurement point as a categorical predictor (27). The exposure to the educational session was 
considered to be a binary, non-reversible, time-dependent predictor. That is, the variable is ‘0’ 
before transfer and ‘1’ after transfer to ACHD care with exposure to structured education. The exact 
timing of the educational session was determined based on the date at which patients had their first 
ACHD outpatient visit. For statistical purposes, it was determined whether the educational session 
was provided to patients after T1, T2 or T3, respectively. At T1, the baseline levels of knowledge and 
prevalence of health risk behaviors were determined in 196 patients. 
 
Some basic characteristics of the patients in the present analyses have been previously 
reported (19, 23, 28). Since significant differences in levels of knowledge according to patients’ age; 
sex; educational level (i.e., high school/college/university, technical high school, vocational high 
school); and anatomical classification of the heart defect (i.e., mild, moderate, complex) were found 
(19, 23, 28), these characteristics were added to the model as potential confounding variables here. 
By including an interaction term between education and when education was provided, the effect of 
structured education was allowed to differ between T2, T3, and T4. Patients of the same age, sex, 
education level, and level of CHD anatomical classification were assumed to follow the same 
knowledge progression as long as they were not exposed to the educational session. This latter 
assumption allowed for a direct estimation of the effect of the single educational session at the 
various measurement times and was justified, based on clinical and statistical considerations.  
 
P-values <0.05 were considered to be significant. No corrections for multiple testing were 
considered.  
 
Sensitivity analysis was also performed using Friedman’s repeated measures ANOVA test to 
assess the robustness of the results obtained through the GLM analysis for the natural progression of 
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knowledge level and risk behaviors over 27 months. This supplementary sensitivity analysis was 
performed on the complete data of patients in the non-education group who participated in the four 
subsequent measurements (n=65). SPSS version 20.0 (SPSS Inc., Chicago, Illinois, USA) and SAS© 
software, version 9.2 of the SAS© System for Windows (SAS Institute Inc., Cary, NC, USA) were used. 
 
Results 
Sample characteristics at baseline (n=210) 
Patients had a mean±SD age of 16±1.1 years (range: 14.1-18.2 years). The most commonly 
diagnosed heart defect was ventricular septal defect (25.7%), followed by aortic valve abnormality 
(19.5%) and pulmonary valve abnormality (15.7%). Almost half of the sample was diagnosed with a 
mild defect (49.1%). Moderately and highly complex heart defects were diagnosed in 41.4% and 9.5% 
of the sample, respectively. More details about demographic and clinical characteristics at baseline 
(T1) are presented in Table 9.2.  
Patients in the education group (n=106) did not differ from patients in the non-education 
group (n=104) in terms of sex (Χ2=.017; p=0.897); level of CHD anatomical classification (U=5.708; 
p=0.621); prevalence of cardiac surgery (Χ2=.001; p=0.970); or educational level (U=4.884; p=0.437). 
Patients of the education group were significantly older than those in the non-education group 
(16.2±1 years versus 15.7±1 years; t=-3.47; p=0.001). However, a difference in mean age of 7 months 
would likely not be clinically relevant (Table 9.2).  
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Table 9.2: Demographic and Clinical Sample Characteristics at Baseline of Sample (n=210) 
 
Baseline assessment of disease-related health-risk behaviors and knowledge level  
 Before transferring from pediatric to ACHD care (i.e., at T1) the prevalence of health risk 
behaviors and the level of knowledge were measured in the overall sample (T1, n=196). From this 
baseline assessment, we were able to calculate the health behavior risk scores and the overall and 
thematic knowledge scores of all participants, both the education group and non-education (control) 
group.  
The prevalence of health-compromising behaviors in the overall sample of patients with CHD 
(n=196) was low, since the mean±SD overall health risk score was 17.5±14.5 (me= 14; IQR= 15), on a 
scale from 0 to 100. The mean±SD substance use risk score was even lower (5.4±16.7; me= 0; IQR= 0). 
The highest risk score was related to dental hygiene, with a mean±SD risk score of 29.1±24.4 (me= 33; 
IQR= 33). 
The overall level of knowledge at baseline was poor, with a total knowledge score of 43±14 
for the overall group of patients with CHD (n=210). None of the patients achieved an adequate 
understanding (>80% correct) on the eight thematic subscales. At baseline, we observed moderate 
levels of knowledge (50-80% correct) for the subscales CHD treatment (56.2±29.2), rationale and 
frequency of follow-up (55.6±29.4), and physical activity (67.9±26.2). Poor understanding (<50% 
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correct) was found for CHD diagnosis (37.2±39.8), endocarditis prevention (40.2 ±22.7), issues 
related to sexual reproduction (15.7±29.4), cardiovascular risk factors (47.8±20.3), and symptoms of 
illness deterioration (11.7±32.3). 
Impact of structured patient education on health risk behaviors and knowledge level 
Exactly when patients were exposed to the structured educational session varied. Therefore, 
we evaluated the effect of education as a function of when it was provided (i.e., after T1, T2, or T3). 
Because the effect of the educational session might depend on when it was provided during the 
study, an interaction effect between the timing of education and the actual exposure was tested. 
This interaction effect, however, was not significant. Hence, the effect of education could be 
averaged over the respective times of exposure.  
 
Figure 9.2 summarizes the longitudinal evolution of knowledge scores over a period of 
almost 3 years. Furthermore, this figure illustrates the significant effects of education in four 
different groups of patients according to the timing at which education was provided. Total 
knowledge scores increased after exposure to education, regardless of when the session took place 
(i.e., after T1, T2, or T3 versus non-education group). Providing education produced an average 
increase in knowledge level of 3.48 (95%CI: 0.63-6.32), and was statistically significant (p=0.017), 
adjusted for potential confounding factors. The effect size, however, was small (ES=0.23; 95%CI: 
0.04-0.42). The effect of education did not depend on when it was provided. That is, the interaction 
between the timing of the educational session and the actual exposure to the education session was 
not significant (p=0.726). 
 
Analysis of the eight thematic subscale scores revealed a significant but small effect of 
education on the subscale that assessed patients’ understanding of “symptoms of deterioration” 
(0.14, 95%CI: 0.05-0.24, p=0.0006; ES=0.39, 95%CI: 0.17-0.60) (Figure 9.2). Furthermore, a moderate 
but significant effect of education was found for the subscale “rationale and frequency of follow-up” 
(0.11, 95%CI: 0.05-0.17, p=0.0026; ES=0.43, 95%CI: 0.15-0.70) (Figure 9.2). Education did not affect 
the scores of the remaining thematic subscales. 
 Regarding health risk behaviors, the educational session did not have a significant effect on 
overall health risk behavior, substance use, and dental hygiene risk scores.  
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Figure 9.2: Effect of a single education session on knowledge scores (LKQ-CHD) plotted as function of when a session was given 
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Progression of health risk behaviors and knowledge in patients not exposed to education  
The GLM analysis revealed that over time the mean overall knowledge score (p<0.0001), 
overall health risk score (p<0.0001), and substance use risk score (p<0.0001) increased significantly in 
patients who did not receive an educational session. The dental hygiene risk score, however, 
decreased significantly over time (p<0.0001) in the non-education group. 
These findings were consistent with those from the sensitivity analyses performed on data 
from a subgroup of 65 patients with CHD who participated in each of the four subsequent 
measurements and who were not exposed to education during the study. This confirmed that, over 
time, the prevalence of health risk behaviors in the non-education group increased significantly. 
Indeed, the mean±SD overall health risk scores (T1 15.4±13.9 to T4 30.8±12.7; Χ
2=60.51; p<0.001) and 
the mean±SD substance use risk scores (T1 4.6±15.5 to T4 15.8±17.7; Χ
2=35.51; p<0.001) increased 
from T1 to T4 in the non-education group of patients. The dental hygiene risk score, however, did not 
differ significantly over the study (T1 25.4±25.7 versus T4 26.5±25.4; Χ
2=1.987; p=0.575). The mean 
total knowledge score increased from 45.6±13.7 at T1 to 47.9±17.1 at T4, but this difference was not 
significant (F=.709; p=0.548) (see Table 9.3).  
Table 9.3. Results of Sensitivity Analysis: Disease-related Knowledge and Health Risk Behaviors in 
Patients Who Did Not Participate in Education Session (n=65) 
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Discussion 
Within the field of CHD care, there is limited evidence on the benefit of educational 
interventions designed to improve patients’ understanding and knowledge of their condition. 
Previous studies assessed the effect of education using a matched case-control (19), a pre-post 
design in a relatively small sample of adults with CHD (18) or a small interventional study without 
randomization (20). Studies assessing the effect of education on the health risk behaviors of patients 
with CHD are clearly lacking. To our knowledge, the present study is the first to investigate the 
prospective effect of education on both knowledge and health risk behaviors in young people with 
CHD.  
In line with previous reports, our study showed that young people with CHD generally 
possess poor knowledge of their condition prior to education (15, 20, 29-32). Our results also confirm 
poor-to-moderate levels of understanding of the diagnosis, alarming symptoms, cardiovascular risk 
factors, reproductive issues, and possible preventive measures against infective endocarditis, as 
previously reported in a comparable but smaller sample of young people who were not exposed to 
an educational program (19). Before exposure to the educational session, the prevalence of health-
compromising behaviors in our sample was low. This relatively infrequent occurrence of risky 
behaviors was expected, because published data show low rates of risky health behaviors in 
comparable samples of young people with CHD (33, 34), and because our respondents were fairly 
young.  
This longitudinal study confirms that one educational session significantly improved overall 
disease-related knowledge, had a small positive effect on the recognition of symptoms of 
deterioration, and resulted in a small improvement in knowledge of the rationale and frequency of 
follow-up visits. During the first ACHD outpatient clinic, the primary aim of the APN team is to 
introduce young CHD patients to the ACHD team, help them establish a professional relationship 
with the team, and increase their confidence in the new healthcare team. The education provided at 
this first meeting predominantly focuses on comprehensively explaining the need for regular cardiac 
follow-up and how to recognize symptoms requiring medical attention. It is precisely on these 
subjects that we found a significant effect. Although the educational session appeared to be 
successful in improving the disease-related knowledge of young patients, the overall effect was small 
(with a mean increase of 3.5 after exposure to education). This finding emphasizes the need to 
implement a staged approach when providing education to patients. Gradually building up the 
content of educational sessions, in combination with a systematic reiteration of important items, is 
hypothesized to increase retention of information in patients (35-37). Therefore, future longitudinal 
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studies should assess the potential benefit of consecutive, repeated exposure to educational sessions 
on the knowledge level of patients in the long term.  
 
Although the primary aim of this educational session is to improve patients’ understanding of 
their disease and treatment, the ultimate goal is to optimize their self-management and behaviors, 
thereby improving outcomes in the long run. Unfortunately in the present study, a single educational 
session failed to significantly affect the prevalence of health-compromising behaviors. However, this 
finding should be evaluated in the context of the pattern of risk behaviors in young CHD patients 
generally. Longitudinal analysis of the non-education group revealed a significant increase in the 
overall health risk and substance use scores as they grew older. Hence, young CHD patients tend to 
acquire more risk behaviors regardless of the type of education, coaching, or guidance they might be 
exposed to while transitioning to adulthood. One should also bear in mind that the baseline 
prevalence of risk behaviors in this sample was fairly low, leaving limited room for any possible 
improvement related to the education. Another possibility is that data were collected for only 3 
years, and this might be too brief of a period to detect significant behavioral changes.  
 
Within our hospital, transfer of care to an ACHD program is executed when adolescents with 
CHD reach the age of 16 years. This transfer is currently not preceded by a formal transition program. 
However, when reviewing the consensus statements on transition programs, we find that a number 
of important transition components are in fact currently implemented in our daily practice outside of 
a formally designed education program. A survey exploring the practices of CHD centers related to 
transfer and transition showed that for about three-quarters of the centers, the median age of 
patients at the time of transfer to ACHD care was 18 years. A structured preparation—which 
participants referred to as a transition program—was only provided in one-third of these transferring 
centers. The most frequently reported transition-related key elements delivered at the time of 
transfer was explaining why and how patients would be transferred and providing education about 
the cardiac condition, treatment plan, and health behaviors (38). At the majority of the centers, 
these transition-related information sessions took place in both pediatric cardiology and ACHD 
programs. Only a very limited number of centers had a separate transition clinic in which all these 
services were provided. In our hospital, pediatric and adult cardiac care is provided in the same 
building. Patients are prepared for the transfer of care at pediatric cardiology. During their last 
pediatric visit, the pediatric team discusses the rationale for the transfer, choice of adult provider, 
and queries the patient about any apprehensions they might have. However, because of logistic 
considerations and the limited availability of financial and human resources, education, counseling, 
and guidance relating to adult responsibilities and developmental tasks take place within the ACHD 
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program after the transfer to ACHD care. When reviewing the interventions performed within our 
hospital, theoretically, one may conclude that these activities fit within the design parameters of a 
formal transition program aimed at preparing young people for adulthood.  
Methodological considerations  
Although a longitudinal observational study design was used, data were collected in a sample 
of young people receiving care and education within a single tertiary care center, limiting 
generalizability of our study results. On the other hand, this sample could be considered highly 
representative of the population of young adults with CHD, because the distribution of CHD 
anatomical classification levels was in line with those reported in epidemiologic studies (39, 40). 
Since our ACHD clinic is located in a tertiary care center, which is easily accessible in Belgium, the 
entire spectrum of CHD is represented at our clinic, including a fairly high proportion of mild CHD. 
Patients who underwent heart transplantation or patients who had cognitive limitations, however, 
were excluded from our study. We sent a set of questionnaires to patients four times over a period 
of three years, and a remarkably high response rate (range: 77%-86%) was achieved, arguing against 
selection affecting our results. Although data were analyzed for a selection of 210 patients derived 
from the overall i-DETACH sample (n=429) (25), comparative analyses of the characteristics of these 
two sample demonstrated a high level of comparability, indicating that selection bias was unlikely. 
Another possible limitation of the study was that the nine-month intervals between measurement 
points might have been too brief to detect significant improvements in the respective outcomes, 
especially in terms of altering health risk behaviors. Furthermore, we can state that during their first 
outpatient visit at the ACHD clinic, patients were exposed to structured and comprehensive 
education for the first time. Although we cannot claim that no disease-related information is 
provided at pediatric cardiology, information is given rather ad hoc than in a systematic and 
structured way. 
Conclusion 
This study was the first to demonstrate the prospective effectiveness of structured education 
in improving the overall understanding of young people with CHD transitioning to adulthood. 
However, this limited education did not significantly improve patients’ health risk behaviors. 
Additional longer-term studies are needed to assess the effect of repetitive exposure to education on 
improving knowledge and risk behaviors in young adults with CHD.  
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To optimize the life expectancy and quality of life of patients diagnosed with complex chronic 
conditions, life-long continuity of care is indispensable (1). Congenital heart disease (CHD) is 
exemplary of such a complex chronic condition. Over the past decades, tremendous investments 
have been made in the care for patients with CHD through the optimization of CHD detection, 
performance of early surgery, and long-term management. These efforts were very successful, as 
they resulted in a substantial increase of the life expectancy. Nowadays, 90% of children born with 
CHD reach adulthood (2). Despite these improvements, patients with CHD unfortunately have a life-
time risk for deterioration of their health condition due to emerging complications. It is estimated 
that >50% of adults with CHD are at medium-to-high risk for complications such as heart failure, 
endocarditis, pulmonary hypertension, arrhythmias, and sudden cardiac death (3). Life-long 
specialized care therefore becomes of paramount importance to safeguard longevity and prevent 
life-threatening complications (3-5).  
International task forces defined the requirements for continuous follow-up care in terms of 
the frequency of visits and the recommended healthcare setting, based on the complexity of the 
heart defect and the patient’s age (3-5). Indeed, since CHD became a life-cycle disease, patients need 
to move from pediatric cardiology, over adolescent clinics, to adult-focused settings, and even 
geriatric care (6). To address the specific care needs of patients at each life stage, age-appropriate 
care programs are required. During childhood, patients should receive care at specialized pediatric 
cardiology programs. However, when reaching adulthood, care should be transferred to adult 
congenital heart disease (ACHD) programs, non-specialist general cardiology care settings, or in 
shared care programs, according to the heart lesion and healthcare needs of the patient (3-5). This 
handing-off of care should, however, not occur as an isolated practical event. Since adolescents are 
experiencing a lot of changes, both from a biological, social, intellectual, and developmental 
perspective, additional support and counseling should be provided to patients in order to prepare 
them for the transition to adulthood and the transfer of care. The provision of transitional care, as 
part of a comprehensive care program, has been proposed as the ultimate strategy to achieve 
uninterrupted, age- and developmentally appropriate follow-up care throughout the life cycle of 
patients (7).  
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This PhD dissertation focused on these two important and highly relevant themes: the 
importance of life-long care and the provision of transitional care in young people with CHD. Since it 
remained unclear what the relevance and the magnitude of the problem of gaps in the life-long care 
process of patients were, this PhD aimed to have a better understanding of this issue by developing 
an international research agenda for ACHD nursing care (Chapter 2); investigating transfer 
destinations of young people with CHD in a Belgian setting (Chapter 3); evaluating the level of 
implementation of ACHD follow-up guidelines in a US setting (Chapter 4); and identifying 
determinants of care gaps in the overall population of young people diagnosed with a complex 
chronic condition (Chapter 5). Furthermore, although the importance of developing, implementing, 
and testing of transitional care interventions in young patients with CHD is well-established, 
significant gaps remain in our body of knowledge. All consensus documents or recommendations 
regarding transitional care, stress the importance of an educational curriculum for patients as part of 
a transition program. Patient education plays a predominant role in transitional care because of its 
hypothesized value in improving patients’ knowledge of their condition and establishment of heart-
healthy behaviors (7). Evidence demonstrating the effectiveness of such educational interventions in 
altering these intermediate outcomes was, however, lacking. This PhD therefore had the second 
objective to investigate intermediate outcomes of transitional care in young patients with CHD, 
focusing on disease-related knowledge and health behaviors (Chapters 6-9).  
In conclusion, this PhD dissertation is structured around the two general themes of life-long 
care and transitional care which are addressed in several research questions (Figure 10.1).
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Figure 10.1: Overview of research objectives addressed in this PhD dissertation 
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LIFE-LONG CARE FOR PATIENTS WITH CHD 
As a result of the markedly improved prognosis of patients born with a congenital heart lesion, 
CHD became a life-cycle disease. About 90% of patients nowadays have the prospect of achieving 
adult age (2) and even the population of geriatric patients with CHD is emerging (6). These advances 
in CHD management, however, bring along new challenges for the current healthcare system. In 
order to address the age-specific healthcare needs of patients with CHD, age- and developmentally 
care programs are mandatory at every stage of life. Since patients with CHD are affected at birth, 
their care process generally starts at pediatric cardiology. As patients grow older, a shift of care from 
pediatric cardiology, over adolescent care to adult, and even geriatric care is required. 
Understandably, such complex transfers of care across settings make patients vulnerable for 
discontinuation of their care process. Such discontinuations leading to exceeding the recommended 
guideline-based period of time between mandatory follow-up visits are called ‘care gaps’(8). 
Previous studies indicated that such care gaps occur regularly in several types of complex 
chronic conditions (9-13). Furthermore, the period during which patients developmentally transition 
to adulthood seemed to be characterized by an increased vulnerability for this care problem. 
Empirical evidence demonstrated that gaps in the transitional care process are observed in about a 
quarter of young people with acromegaly (9;10;14), Human Immunodeficiency Virus (HIV) -infection 
(15),  or diabetes mellitus type I (16).  When focusing on young people with CHD, the problem of care 
gaps, however, appears to be most prominent in this population (17-22).  Studies reported that 21 to 
76% of adolescents with CHD experienced care gaps, or are even completely lost to follow-up (17-
22). 
Empirical evidence demonstrated that care gaps are present in a noteworthy proportion of 
young patients with a complex chronic condition, such as acromegaly (9), diabetes mellitus type I 
(16), and juvenile idiopathic arthritis (23). The occurrence of care gaps seemed, somewhat 
surprisingly, to be the highest in patients with CHD. Systematic literature reviews on transfer and 
transition in chronic conditions, however, revealed that this issue is currently predominantly studied 
in patients with CHD (24-27). Due to a lack of studies investigating the problem of care gaps in other 
populations of young people with a chronic condition, it remains currently unknown whether this 
problem is truly more prominent in patients with CHD as compared to other conditions, or seems to 
be of significance due to the fact that it is currently more frequently studied in patients with CHD 
(i.e., the numbers tell the tale). Furthermore, based on the results derived from the systematic 
review of literature describing risk factors for care gaps in patients with complex chronic conditions, 
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an important number of identified risk factors are frequently present in patients with CHD. For 
example, a significant proportion of patients has a mild heart lesion, do not need to undergo surgical 
interventions, encounters healthcare insurance problems, or need to travel a large distance in order 
to reach the nearest specialized adult clinic. These respective patient characteristics were found to 
increase the likelihood of experiencing care gaps. Additional studies are, however, needed in order to 
support this hypothesis. 
 This growing interest in studies investigating transfer and transition was also reflected in the 
list of research priorities established as part of this PhD (Chapter 2). Based on the opinion of about 40 
nurse specialists and researchers within the field of ACHD nursing, we learned that studies 
investigating transfer and transition are one of the top 5 priorities for future research (28). Although 
this mixed methods study was the first to develop a research agenda for ACHD from an international 
perspective, this study had a rather limited scope since the expert panel consisted only of nurse 
specialists and researchers. Ideally multiple perspectives, including the opinion of CHD clinicians, 
patients, families, and policy-makers should be investigated in order to develop a comprehensive 
research agenda which could direct future research initiatives. After the publication of our list of 
research priorities for ACHD nursing, two additional publications reported on the development of a 
science agenda for CHD (29;30). Based on the report from the Centers for Disease Control and 
Prevention (CDC) Experts Meeting (2013) we can conclude that priority should indeed be given to 
studies focusing on the continuation of care from adolescence to adulthood in patients with CHD. 
This CDC initiative developed a research agenda based on the perspectives of medical doctors, 
surgeons, epidemiologists, public health officers, patient advocates, and patients themselves (29).  
The list of clinical research priorities that was developed by the Alliance for Adult Research in 
Congenital Cardiology (AARCC), however, did not include any research priorities related to transfer, 
transition, or the challenges of providing life-long care (30). This study, nonetheless, aimed to 
exclusively identify clinical research objectives related to treatment, surgery, and medical 
management of CHD.  
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Levels of care 
Since data were lacking on the level of care continuity of young people with CHD within the 
Belgian healthcare system, we investigated the destinations of transfer of patients known to be 
cared for at pediatric cardiology at the University Hospitals Leuven (Chapter 3) (18). This study 
revealed that only a small proportion of patients ceased cardiac follow-up (6.2%) or appeared to be 
untraceable within the healthcare system (1.1%). The majority of patients (80%), however, remained 
at the specialized cardiac care level. Only a minority (2.2%) of young people with CHD apparently did 
not transfer to adult care and thus remained within the pediatric program. When comparing the 
results obtained in this single center Belgian study with published literature, it was clearly noticed 
that the proportion of patients experiencing a care gap was significantly lower as compared to the 
21-76% reported previously (17;21;22;31-33). Since comparability between studies is, however, 
rather limited due to important differences in study methodology, we replicated this initial study in a 
sample of young adults with CHD known to be cared for at the Children’s Hospital Boston, USA 
(Chapter 4). Using the same research methodology, the implementation of recommendations 
regarding the level of ACHD care was evaluated in this sample. As part of this study, the setting of 
care, frequency of outpatient visits, and healthcare professional providing follow-up care were 
evaluated. Despite the uniform study methodology, important differences were found. While the 
proportion of patients who ceased cardiac follow-up was almost comparable (6.2% versus 6.5%), 
other important differences appeared.  
First, though in both samples the majority of young adults received care within a specialized 
cardiology setting, the proportion of patients not having made the transfer to ACHD care was 
surprisingly larger in the Boston sample (48%) as compared to the Leuven sample (2%). Within the 
University Hospitals Leuven, an internal policy is implemented resulting in the transfer of patients to 
ACHD care around the age of 16 years. Furthermore, from a practical point of view, patients do not 
necessarily have to change their care to another hospital since pediatric cardiology and the ACHD 
care program are located under the same roof. In order to facilitate the transfer of care, clinical 
information of patients is shared between both care programs through the use of an electronic 
database. It can be hypothesized that these organizational components (i.e., transfer policy, location 
of programs, and shared electronic database) might support the transfer of care to ACHD, although 
empirical evidence supporting this hypothesis is currently lacking.  
Second, this contrast in the proportion of patients remaining in pediatric cardiology might be 
related to significant differences in the availability of ACHD specialists across areas and regions 
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hampering transfer of care to ACHD care. Belgium is a fairly small country with a large population 
density, in which the travel distance for patients to arrive at the closest ACHD center did not emerge 
as a determinant of cessation of cardiac care (18). Although, to date two additional studies 
performed in adolescents with CHD reported that the travel distance to the closest ACHD center was 
not a determinant of care gaps, this variable was a significant risk factor in patients with sickle cell 
disease (11) and congenital adrenal hyperplasia (23).  
Currently, a limited number of studies explored barriers to transferring young patients 
towards ACHD care (8;33-35). Besides institutional factors such as unlimited age access to adult care 
or a limited capacity of ACHD centers (34), mainly patient-related barriers were reported. Examples 
of these latter barriers are: non-compliance with the transfer plan, emotional or cognitive delay, 
health insurance issues or unawareness of need for ACHD care (8;33;35). Although one could argue 
that the recommendation, stating that a transfer of care towards adult-focused care is mandatory, is 
based on expert opinion, preliminary evidence demonstrated the benefit of transferring patients to 
ACHD care (36). Mylotte and colleagues was the first to demonstrate a significant association 
between decreased mortality rates and increased referral rates towards ACHD care following the 
publication of national consensus guidelines on ACHD care in Canada.  
Untraceability 
Although the proportion of patients self-reporting cessation of cardiac follow-up was 
comparable between the Leuven (6.2%) and Boston (6.5%) samples, a large contrast was, however, 
observed with regard to the number of patients who were untraceable in the healthcare system 
(1.1% versus 24.9%, respectively). To our opinion, losing sight of patients due to their untraceability 
within the healthcare system is very closely related to becoming entirely lost to follow-up. To date, 
with the exclusion of this PhD study, only two additional studies explicitly investigated the problem 
of untraceability of young patients with CHD (18;34). In these latter studies, untraceability was an 
issue in a small (1.1%) (18), moderate (12%) (34), and large proportion of young patients with CHD 
(24.9%). The difference in prevalence rates of untraceability between these samples indicates that 
multiple factors including characteristics of geography, population, and healthcare systems might 
play a prominent role in this issue. Our study was, however, the first to explore potential 
determinants of untraceability (Chapter 4). Patients who underwent none or a lower number of 
heart surgeries in the past; had health insurance issues; or were of a non-white ethnicity had an 
increased risk for becoming untraceable. Furthermore, it could be hypothesized that differences in 
migration of patients between countries or states might play a role.  Indeed, US-citizens are known 
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to move more often in-between states or countries as compared to Belgian citizens. This difference 
can be demonstrated when emigration rates from that state of Massachusetts (2.4% in 2012) (38) is 
compared to Belgium (0.8% in 2010) (39). Hence, studies that provide empirical evidence describing 
the magnitude of this problem and identifying potential drivers of untraceability are highly needed. 
The development and implementation of (inter)national databases which keep track of patients with 
CHD throughout their life and within the overall healthcare system, might be one strategy to tackle 
the problem of untraceability (8;29;40).  
Specialized follow-up care 
Though it might be encouraging to observe that about three quarters of young patients with 
CHD remain in specialized follow-up care, one might question if all these patients actually need to be 
cared for at this highly specialized level. Indeed, based on the hierarchical algorithm for ACHD care 
provision, only a selected group of patients diagnosed with a highly complex heart defect is 
recommended to receive care exclusively provided by ACHD specialists (3-5;41;42). Patients with 
moderately complex CHD characterized by an uncomplicated disease course could, however, also be 
cared for within shared care facility. Shared care is the level of follow-up in which care is provided by 
community providers and ACHD specialist collaboratively. Such shared care could, however, be 
predominantly organized in regional hospitals, dispersing care across the larger healthcare system. 
Based on the insights gained in this PhD, unfortunately, we have to conclude that shared care is only 
provided in a limited number of cases. Future efforts should be made to establish shared care 
networks in a formal way, facilitating the transfer of selected patients to this level of care. Hence, in 
order to safeguard the accessibility and affordability of the current healthcare system, strategies 
should be developed. Since the group of adults with CHD will likely grow exponentially during the 
upcoming decades, existing ACHD care centers might become saturated and problems like waiting 
lists might become inevitable. One of the proposed strategies, which might safeguard the current 
easy accessibility of tertiary care, is the implementation of the principles of subsidiarity. Subsidiarity 
can be defined as the provision of care at the least complex level that is clinically appropriate to the 
patient’s condition (43). In general, lower levels of care are associated with lower healthcare costs 
and with less fragmented, but more continuous and coordinated care (44). Over the past decades, 
the provision of care for a number of chronic conditions such as diabetes mellitus and chronic renal 
insufficiency was therefore successfully shifted from secondary (i.e., specialized) toward primary 
levels (45-47). Since an important proportion of patients with CHD are medically stable during 
specific life stages and can function relatively well without continuous surveillance in tertiary care 
centers, this principle of subsidiarity might be of value.  
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Currently the delivery of care across different levels of care is grounded on expert-based 
recommendations. Unfortunately, the evidence base underpinning these consensus documents is 
poor with less than 1% of recommendations grounded on level A-evidence (3). This hierarchical 
algorithm for follow-up care determines the most appropriate level of care according to patient-
related characteristics such as: medical stability, CHD complexity level, and potential risk for long-
term complications. One could, however, argue that a list of additional criteria such as predicted 
clinical outcomes and the costs of care are more appropriate, valid, and relevant as a basis to choose 
the level of care. Unfortunately, empirical data underpinning such a strategy for redirection of care 
to lower levels is non-existing at the moment. Hence, there is a need for the development and 
investigation of an empirically-based algorithm for the assignment of patients with CHD to different 
levels of care, in accordance with the principles of subsidiarity. Such an algorithm can guide clinicians 
and policymakers to refer patients to the most optimal level of care by obtaining the best clinical 
outcomes at the fairest price. Such efforts are of paramount importance to make CHD care 
sustainable and affordable within the context of the numerous challenges that our current 
healthcare system will most likely face in the future.  
Determinants of care gaps 
Tailored interventions preventing care gaps should focus on identified risk factors. Based on a 
systematic literature review performed as part of this PhD, we learned that nowadays a limited set of 
patient-related characteristics is known to influence the risk of experiencing care gaps (Chapter 5). 
Four categories of patient-related characteristics were identified in young people afflicted with 
complex chronic conditions: demographics, disease-related characteristics, healthcare services use, 
and patient’s health behaviors and beliefs. Although most identified risk factors are only modifiable 
to a limited extent, some protective factors such as guaranteeing that patients leave pediatric care 
with a written recommendation on the type of professional providing follow-up adult care, or 
checking if patients attend the first outpatient visits in adult care, might be components of 
interventions preventing care gaps. Although this systematic review provided a set of 19 
determinants of care gaps, all factors were identified on the patient level. Comparison of the results 
of studies currently performed in patients with CHD, however, revealed substantial differences 
between countries or healthcare systems with regard to the proportion of patients experiencing care 
gaps. Such differences cannot be explained solely on the basis of the known patient-related 
determinants of care gaps. This observation formed the basis for the development of a hypothesis 
stating that determinants of care gaps most likely have a multi-factorial and multi-level nature. In 
addition to patient-related factors, aspects of care providers, the organization of care within the 
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institution, and the characteristics of the healthcare system are believed to have an important 
impact on continuity of care (18;20). Healthcare system and organizational factors, such as the 
introduction of co-payment and obligatory transfer policies, have yet to be systematically evaluated. 
In order to scrutinize this hypothesis, an international, multicentric, multi-level study investigating 
healthcare system, organizational and patient-related characteristics associated with care gaps in 
patients with CHD is imperative.  
Based on the results obtained as part of this PhD, it became clear that the occurrence of gaps 
in the care process is an important problem during the adolescence and young adulthood, although 
the prevalence differs across healthcare systems (Chapters 3 & 4). To date, it is, however, unknown 
to what extent care gaps occur during other life stages. Furthermore, the clinical impact of such care 
gaps is poorly understood. In patients with CHD, such care gaps might potentially aggravate disease 
burden, as the complex nature of the heart defect and its inherent high risk for comorbidity onset 
warrants close and sustained follow-up. Preliminary results indicated that care gaps in patients with 
CHD are associated with an increased risk for developing comorbidities and a need for urgent 
interventions (17;32), although evidence demonstrating the effect of care gaps in patients with CHD 
is currently scarce.  
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TRANSITIONAL CARE 
During the developmental transition towards adulthood, young people with CHD are 
supposed to attain a set of skills, insights, attitudes, and behaviors deemed mandatory in order to 
function autonomously within adult life and the adult healthcare system. In order to achieve this set 
of developmental tasks, adolescents should be supported and challenged to accomplish skills related 
to decision-making, self-advocacy, and self-efficacy (48). The provision of transitional care is 
suggested as the most relevant strategy to accomplish these goals (7). Based on the available 
consensus statements regarding transitional care for young people with CHD, an educational 
curriculum is considered to be an indispensable component of a transitional care program. The 
evidence base supporting this recommendation and demonstrating the beneficial effects of providing 
education is, however, very poor. Patient education is hypothesized to increase patients’ knowledge 
of their condition, treatment regimen, preventive measures, and lifestyle matters (7). Furthermore, it 
is assumed that education will enable patients to gradually assume all responsibilities related to adult 
life, health, and healthcare. Ultimately, education is provided with the initial objective to increase 
patients’ knowledge, but secondarily aims to result in the establishment of heart-healthy behaviors. 
This PhD was the first to address significant gaps in the knowledge base regarding the effectiveness 
of educational interventions in young people with CHD as part of transitional care provision. 
Based on observations made in adults with CHD, demonstrating a poor level of disease-
related knowledge (49-52), it could be hypothesized that adolescents and young adults most likely 
have significant shortcomings in their knowledge level. This PhD was the very first to investigate the 
level of knowledge in adolescents at several moments in their transitional care process (i.e., pre- and 
post- transfer to ACHD care) (53;54). As anticipated, significant gaps in the level of knowledge were 
identified in this population (Chapter 6). Although patients demonstrated adequate to moderate 
levels of knowledge on a limited set of CHD-related topics, poor knowledge was observed for most 
prominent topics such as the specifications of the defect, risk and recognition of life-threatening 
complications, and healthy lifestyle matters (54;55).  
These findings demonstrated there is significant room for improvement and a potential 
pathway for educational interventions to improve the level of disease-related knowledge. Several 
studies performed as part of this PhD, enlarged the evidence base regarding the effectiveness of 
educational interventions on two intermediate outcomes, disease-related knowledge and health risk 
behaviors (Chapters 8 & 9).  
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Disease-related knowledge 
Using several samples, research designs, and statistical analysis techniques, this PhD 
demonstrated that the provision of structured CHD education was an independent determinant of 
higher levels of knowledge in young people with CHD, irrespective of the age, educational level or 
complexity of the heart defect (Chapter 8). Furthermore, longitudinal analyses confirmed that one 
educational session significantly improved overall disease-related knowledge, had a small positive 
effect on the recognition of symptoms of deterioration, and resulted in a small improvement in the 
level of patients’ knowledge regarding the rationale and frequency of follow-up visits. Despite the 
fact that the provision of one educational session proved to significantly improve the level of 
knowledge, this effect was rather small (Chapter 9).  
Furthermore, although the provision of education proved to be an independent determinant 
of higher levels of knowledge, patients with more complex levels of CHD were found to have 
significantly higher levels of knowledge. Since patients with highly complex heart defects are more 
frequently exposed to education during the yearly outpatient visits, one could hypothesize that 
repeated exposure to education might result in a more prominent improvement of knowledge. 
Unfortunately, this hypothesis remains currently unstudied since no study in patients with CHD 
assessed the effect of an intervention comprising multiple consecutive education sessions on the 
knowledge level of individual patients. Future studies should investigate the potential dose-effect 
relationship between the number of education sessions and the total knowledge score of patients.  
As stated before, the magnitude of the effect gained through the provision of one 
educational session was rather disappointing. Despite the fact that significant resources (e.g., time, 
personnel) were invested, a small mean increase of 3.5 (scale 0-100) was obtained after exposure to 
the educational intervention. Other alternative interventions, methods, and strategies aiming to 
improve the disease-related knowledge of patients could, however, have a larger effect. Examples of 
such interventions are the provision of written information, organization of group education 
sessions, use of computerized education programs (56), or application of motivational interviewing 
techniques. On the other hand, since evidence is lacking on the potential benefit of repeated 
exposure to education, it currently remains unknown whether a large effect can be obtained by 
repeating this educational sessions over a period of time in individual patients. 
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Health behaviors 
With regard to altering the health behaviors of adolescents with CHD, providing one single 
session of education did not appear to be an effective strategy since our longitudinal study could not 
demonstrate a significant improvement of the health behaviors of patients. Within our sample of 
more than 400 adolescents, risky health behaviors were relatively rare. Previous studies, conversely, 
reported that adolescents are more likely to experiment with alcohol, illicit drugs, and risky sexual 
behaviors (57-60). In order to enlarge the generalizability of our study findings, additional studies are 
required. Both studies describing the health behaviors of young people with CHD in a comprehensive 
way, as well as studies scrutinizing the effect of interventions such as patient education or the 
motivational interviewing technique on the lifestyle of patients are mandatory.  
As part of this PhD, the Health Behavior Scale – Congenital Heart Disease (HBS-CHD) was 
developed as a comprehensive instrument for the assessment of self-reported health behaviors of 
patients with CHD (Chapter 7). In order to investigate the psychometric properties of this instrument, 
the HBS-CHD was completed four times over a period of three years in a sample of about than 400 
young people with CHD and 400 peers from the general population. Based on the results of this 
study, the HBS-CHD was found to be valid and responsive questionnaire to assess health risk 
behaviors in young people with CHD. Future studies are, however, needed in order to test the 
stability of the instrument and to provide evidence support its psychometric properties in other age 
groups such as adults with CHD. 
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IMPLICATIONS FOR PRACTICE 
This PhD substantially enlarged the evidence base indicating that transition towards adulthood 
is a vulnerable period for young patients with CHD.  Problems such as the occurrence of care gaps, 
cessation of cardiac follow-up, or patients becoming untraceable in the healthcare system were 
identified in diverse samples of young people across several healthcare systems. Furthermore, young 
people’s vulnerability was also demonstrated by the gaps in their disease-related knowledge and the 
slight increase of health risk behaviors around the age of transfer to ACHD care. These findings 
indicated there is a clear need for interventions, strategies and transitional care programs tackling 
these problems encountered in daily practice. 
Life-long care for patients with CHD 
Based on the results of this PhD, preliminary data are provided which could help healthcare 
professionals to identify patients who have an increased risk for either receiving care that is not 
totally in line with the current set of recommendations; at risk for stopping cardiac follow-up care; or 
at risk for becoming untraceable in the healthcare system. Based on this set of determinants, 
healthcare workers could screen for risk populations.  
 Although the evidence base identifying robust, valid, and relevant determinants of care gaps 
is relatively poor, healthcare professionals could implement components protective for care gaps 
such as providing written recommendations on the requirements for adult follow-up in patients’ 
medical file; or tracking the attendance rates of patients at their first outpatient visits in the adult 
clinic. 
Furthermore, a registry for patients with CHD throughout their entire life spectrum might be 
of value both from a clinical as well as a scientific point of view. Keeping track of patients from birth 
until death, enables healthcare providers to comprehensively follow the progress of the heart 
condition throughout life. Furthermore, such a registry could at an early stage identify patients who 
have missed appointments, are non-compliant to the proposed follow-up plan, experience care gaps 
or became untraceable in the healthcare system.  
The establishment of care networks in which care for patients with CDH is shared between 
specialist and non-specialist cardiologists should be explored. Redirection of patients to lower levels 
of care is deemed mandatory to safeguard the easy accessibility of tertiary care in the upcoming 
decades. This PhD concluded that shared care facilities are currently only used in a limited number of 
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patients. To advantages of redirecting patient care to shared care facilities in terms of preserving 
easy accessibility of tertiary care for patients with complex CHD, clinical outcomes, and associated 
healthcare expenditures should, however, be scrutinized.  
Transitional care 
Based on the current recommendations regarding transitional care, education and counseling 
are hypothesized to be highly important components of a transition program for adolescents with 
CHD. Data clearly demonstrated significant gaps in the knowledge of patient regarding their 
condition, treatment, preventive measures, and implications of the condition in adult life. The 
provision of structured, tailored education during a face-to-face consultation with adolescents results 
in a significant although small improvement of the disease-related knowledge. No improvement of 
health behaviors can, however, be expected after providing one educational session.  Innovative 
supplementary interventions aiming to increase patients’ level of disease-related knowledge must be 
developed and tested in practice.  
The prevalence of health-compromising behaviors appeared to be fairly low in our sample of 
adolescents with CHD. These data, however, clearly demonstrated a significant increase of 
experimenting behaviors around the age at which patients generally transfer to ACHD care (i.e., 16 
years). This finding indicated a need for actively detecting risky behaviors in patients. This can be 
done in a valid way by using the HBS-CHD. Altering the health behaviors of young people through the 
provision of education seemed, however, challenging and rather ineffective.  
Chapter 10: General discussion 
 
 
207 
 
AVENUES FOR FUTURE RESEARCH 
Although this PhD delivered an important contribution to the body of knowledge regarding 
transitional care for young people with CHD, significant gaps remain in our understanding of this 
important issue. Several avenues for future research are proposed. 
Life-long care for patients with CHD 
Firstly, a large variability in prevalence rates of care gaps across previous studies could be 
observed. It is unknown whether these differences originate from different study methodologies 
(e.g., used definitions, inclusion criteria, and recruitment settings) or reflect true differences between 
patients, hospitals, and/or healthcare systems. Hence, an international study, across different 
healthcare systems, exploring the predictive value of multi-level determinants of care gaps is 
required. In order to prevent such gaps in the care process of patients, tailored interventions need to 
be developed, implemented, and tested in practice. The preliminary set of determinants of care gaps 
identified through our systematic literature review in young people with complex chronic conditions, 
could provide evidence-based components to be included in such interventions. The number of 
studies exploring potential determinants of care gaps is, however, limited at the moment. Additional 
studies could add to our current understanding of this issue. 
 Second, previous studies focused on the prevalence and determinants of care gaps during 
the developmental transition of young people with CHD towards adulthood. However, since CHD 
became a life-cycle disease, patients will have to transfer care across several settings at multiple life 
stages. Therefore, studies scrutinizing care gaps along the entire life cycle of patients with CHD, from 
birth to death, are highly needed. Moreover, although life-long care is recommended by experts to 
prevent serious complications (3;5), evidence demonstrating the impact of care gaps on clinical 
outcomes is very limited (17;32). One study on about 150 adults with moderate-to-complex CHD 
living in the Unites States revealed that 60% of patients with a care gap were diagnosed with a 
secondary cardiac abnormality. Care gaps were furthermore associated with a threefold greater need 
for urgent cardiac interventions (17). A large scale assessment of the impact of care gaps in terms of 
mortality, morbidity, and healthcare services use is, however, missing. 
Besides the fairly well described problem of care gaps occurring during the transition of 
patients towards adulthood, this PhD identified important differences in the number of patients 
appearing untraceable across different healthcare systems. Since the true magnitude of this problem 
is poorly understood, additional studies determining the number of untraceable patients and 
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identifying determinants are needed. In order to guide such research initiatives, additional initiatives 
should be undertaken in order to provide a clear conceptual and operational basis for the concept of 
untraceability. There is currently a lack of consensus regarding the difference between patients who 
ceased cardiac follow-up, are classified as being lost to follow-up, or are identified to be untraceable.  
Finally this PhD reported that a significant number of young adults with CHD are cared for in 
highly specialized ACHD centers. Since the number of adult patients is expected to grow 
exponentially in the upcoming decades, strategies must be developed to safeguard the easy 
accessibility of tertiary care to patients with highly complex CHD in the first place. Future studies 
should explore the potential benefits of implementing the principle of subsidiarity in clinical practice. 
Outcomes of assigning patients to less specialized levels of care, in terms of mortality, morbidity, 
healthcare services use, and healthcare expenditures should be investigated thoroughly. 
Furthermore, there is a need for the development and investigation of an empirically-based 
algorithm for the assignment of adults with CHD towards the most appropriate and cost-effective 
levels of care.  
Transitional care 
In order to strengthen the generalizability of our findings demonstrating significant 
shortcomings in the levels of disease-related knowledge of adolescents with CHD, complementary 
studies are needed. As reported in our mixed methods study establishing an international research 
agenda for ACHD nursing, there was a vast consensus that the highest priority in future studies 
should be given to studies describing the level of knowledge and assessing the benefit of providing 
patient education. Identified research priorities related to knowledge and education of patients with 
CHD comprised the description of the disease-related knowledge of patients; the development of an 
educational plan for life; and having special attention for patients dealing with learning difficulties or 
neuro-cognitive impairments.  
 Although a significant but small effect of patient education was demonstrated in this PhD, 
several questions remain unanswered. Future studies comparing the effectiveness and effect size of 
several educational interventions such as a series of consecutive educational sessions, the provision 
of written information pamphlets, the use of computerized education programs or the 
implementation of the motivational interviewing technique need to be performed. 
Finally, there is a need for studies evaluating the psychometric properties of the HBS-CHD in 
adult populations derived in different centers, countries, continents, and even cultures. Such studies 
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should evaluate the validity, relevance and responsiveness of this instrument worldwide in different 
samples of patients with CHD. 
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Lay summary 
Congenital heart disease (CHD) is the most common birth defect in newborns, affecting about 9 per 
1,000 babies worldwide. It comprises a wide spectrum of anatomical defects of the heart and/or 
great intrathoracic vessels that have a variable long-term impact on patients’ health status, 
functionalities, and overall well-being. While CHD was one of the most common causes of infant 
mortality around the 1960s, about 90% of children with CHD nowadays have the prospect of reaching 
adult age. Over the past decades, tremendous investments have been made in the care for patients 
with CHD through the optimization of CHD detection, surgery, and long-term management. However, 
despite this ameliorated life-expectancy, patients with CHD have a life-time risk for developing life-
threatening complications such as heart failure, arrhythmias, pulmonary hypertension, endocarditis, 
and sudden cardiac death. In order to prevent such serious complications, the provision of life-long 
follow-up care performed by specialized healthcare professionals at predefined time intervals is 
recommended by experts.  
 Since the life expectancy of patients with CHD increased substantially, CHD became a life 
cycle disease. Patients have the prospect to reach several phases of life such as adolescence, 
adulthood, and parenthood. However, in order to address the specific healthcare needs of patients 
at each of these life stages, age-appropriate care programs are required. During childhood, patients 
should receive care at specialized pediatric cardiology programs. When reaching adulthood, patients 
are advised to transfer their follow-up care to adult-focused facilities. Based on the type of heart 
defects, patients will be recommended to transfer to either adult congenital heart disease (ACHD) 
programs, non-specialist general cardiology care settings, or shared care programs. Such transfers of 
care across different healthcare settings require patients to re-adapt themselves to a new context, 
healthcare team, responsibilities, and requirements. For some patients such handing-off of care 
could be stressful and be associated with detrimental outcomes. Understandably, these complex 
transfers of care across settings make patients vulnerable for a discontinuation of their care process. 
Such discontinuations characterized by exceeding the recommended guideline-based time interval 
between recommended follow-up visits are called ‘care gaps’. 
 In order to prepare, guide, and support patients for these transfers of care, comprehensive 
care programs facilitating this transition towards a new life phase, healthcare context, and set of 
responsibilities is recommended by international experts. Such care programs provide 
comprehensive care to patients addressing both medical and psychosocial needs of patients. 
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 As part of this PhD project on transitional care in young people with CHD, a total of eight 
studies were performed covering two important and highly relevant themes: the importance of life-
long care in patients with CHD, and the provision of transitional care in young people with CHD. 
 Although it is very important for patient to have regular check-ups of their cardiovascular and 
overall health status, this PhD demonstrated that care gaps are highly prominent in young people 
with CHD transferring to adult care. However, when comparing results of different studies from an 
international perspective, there appeared to be a significant difference in the magnitude of this 
problem across healthcare systems. Furthermore, important differences were found between the 
number of young people remaining in pediatric cardiology, discontinuing cardiac follow-up care, or 
becoming completely untraceable within the healthcare system. Based on a review of the existing 
scientific literature regarding the problem of care gaps in the overall population of young people 
diagnosed with a chronic condition, several risk and protective factors were identified. Four 
categories of determinants were identified: demographics, disease-related characteristics, healthcare 
services use, and patient’s health behavior. Additional studies are, however, needed to identify other 
determinants and ultimately develop effective strategies that can prevent patients from experiencing 
care gaps during life.  
As young people with CHD develop towards becoming adults, they are supposed to attain a set 
of skills, insights, attitudes, and health behaviors required in adult life and healthcare. The provision 
of transitional care as a comprehensive package of interdisciplinary guidance, support, and care is 
recommended by experts. Patient education on a broad range of CHD-related aspects is 
recommended as an important component of this transitional care. This PhD clearly demonstrated 
significant gaps in the knowledge of patient regarding their condition, treatment, preventive 
measures, and implications of the condition in adult life. This PhD demonstrated that the provision of 
one structured, tailored education session results in a significant but small improvement of the 
disease-related knowledge. No improvement of health behaviors was, however, demonstrated in this 
study. Innovative supplementary interventions aiming to increase patients’ level of disease-related 
knowledge must be developed and tested in the future.  
Adolescents typically engage in a more risky lifestyle as part of adolescent experimental 
behaviors with the use of tobacco, alcohol, and illicit drugs. Since a heart-healthy lifestyle is very 
important for patients with CHD, educational interventions informing patients about these risks and 
explain which lifestyle is deemed mandatory. The prevalence of health-compromising behaviors 
appeared to be fairly low in our sample of more than 400 adolescents with CHD. These data, 
however, demonstrated a significant increase of experimenting behaviors around the age at which 
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patients generally transfer to ACHD care (i.e., 16 years). This finding indicated a need for actively 
detecting risky behaviors in patients. This can be done in a valid way by using the HBS-CHD. Altering 
the health behaviors of young people through the provision of education seemed, however, 
challenging and rather ineffective. This PhD, however, could not demonstrate a beneficial effect of 
education on the correction of health risk behaviors of young people with CHD. Future studies are 
needed in order to investigate if there is a potential effect when patients are exposed to multiple 
subsequent educational sessions over a longer time span. 
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Samenvatting 
Een aangeboren hartaandoening (AHA) is de meest voorkomende aangeboren afwijking vastgesteld 
bij pasgeborenen. Deze aandoening treft wereldwijd ongeveer 9 per 1000 pasgeborenen. AHA omvat 
een brede verzameling van anatomische afwijkingen van het hart en/of de grote intrathoracale 
bloedvaten dewelke een variabele impact hebben op de gezondheidsstatus, de functioneringsgraad 
en het algemeen welzijn van patiënten. Ondanks de vaststelling dat AHA de meest voorkomende 
oorzaak van kindersterfte was in de jaren ’60, bereikt heden ongeveer 90% van de kinderen geboren 
met AHA de volwassen leeftijd. Doorheen de laatste decaden werden er significante investeringen 
gedaan in de zorg voor patiënten met AHA. Deze inspanningen leidde tot een verbeterde detectie 
van AHA, betere chirurgische behandelingstechnieken en een verbeterde lange termijnsvisie op het 
ziektemanagement. Ondanks deze verbeterde vooruitzichten in termen van levensverwachting, 
hebben patiënten met AHA echter een levenslang risico op de ontwikelling van levensbedreigende 
complicaties zoals hartfalen, hartritmestoornissen, pulmonale hypertensie, endocarditis en plotse 
cardiale dood. Om dergelijke complicaties te voorkomen wordt een levenslange follow-up, 
uitgevoerd door gespecialiseerde gezondheidswerkers op regelmatige tijdstippen, aanbevolen door 
experten. 
 Doordat de levensverwachting van patiënten met AHA sterk verbeterde is deze aandoening 
een chronische aandoening geworden die doorheen het ganse leven van de patiënt aanwezig blijft. 
Patiënten hebben heden het vooruitzicht om diverse levensfasen te bereiken zoals adolescentie, 
volwassenheid en ouderschap. Echter om de specifieke zorgnoden van deze patiënten met AHA 
doorheen de verschillende opeenvolgende levensfasen te kunnen beantwoorden, moeten er 
leeftijdsgebonden zorgprogramma’s ontwikkeld worden. Tijdens de kindertijd worden kinderen met 
AHA opgevolgd op gespecialiseerde afdelingen voor kindercardiologie. Echter wanneer zij de 
volwassen leeftijd bereiken, worden adolescenten geadviseerd om hun cardiale follow-up te 
transfereren naar zorgprogramma’s voor volwassenen met AHA. Op basis van de gediagnosticeerde 
aangeboren hartafwijking krijgen patiënten het advies om hun zorg te transfereren naar een 
gespecialiseerd zorgprogramma voor volwassenen met AHA, een niet-gespecialiseerde algemene 
cardioloog, of naar een programma waar zorg gedeeltelijk wordt uitgevoerd door gespecialiseerde en 
gedeeltelijk door niet-gespecialiseerde cardiologen (shared care). Dergelijke transfers van zorg over 
verschillende settings heen impliceert dat patiënten zich steeds moeten aanpassen aan een nieuwe 
context, een nieuwe zorgteam, en gerelateerde verwachtingen. Voor sommige patiënten is deze 
transfer stresserend en resulteert het in nadelige uitkomsten. Dergelijke transfers van zorg maken 
patiënten namelijk kwetsbaar voor discontinuering van het zorgprocess. Een dergelijke onderbreking 
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van het zorgprocess gekenmerkt door het overschrijden van de aanbevolen termijn tussen follow-up 
controles wordt ook wel omschreven als ‘care gaps’. 
 Om patiënten voor te bereiden, te begeleiden en te ondersteunen tijdens dergelijke transfers 
van zorg is het aanbevolen om een allomvattend zorgprogramma aan te bieden. Een dergelijk 
transitieprogramma heeft tot doel om de overgang naar een nieuwe levensfase, gezondheidszorg-
context en set van verantwoordelijkheden te faciliteren. Dergelijke transitieprogramma’s bieden een 
breed zorgpakket aan patiënten waarbij zowel medische als psychosociale zorgnoden worden 
beantwoord. 
 Als onderdeel van dit doctoraatsonderzoek naar transitionele zorg voor jongeren met AHA 
werden er in totaal acht studies uitgevoerd naar twee belangrijke en klinisch relevante onderwerpen: 
het belang van levenslange opvolging van patiënten met AHA en het aanbieden van transitionele 
zorg aan jongeren met AHA. 
 Ondanks het feit dat het voor patiënten met AHA enorm belangrijk is om op regelmatige 
basis een controle te laten uitvoeren van de cardiovasculaire en algemene gezondheid, toonde dit 
doctoraat aan dat onderbrekingen van het zorgprocess (care gaps) prominent optreden bij jongeren 
met AHA tijdens de transfer naar zorgprogramma’s voor volwassenen met AHA. Echter wanneer we 
de resultaten van verschillende studies omtrent deze problematiek met elkaar vergelijken, zien we 
grote verschillen in de grootte van dit probleem tussen verschillende gezondheidszorgsystemen. 
Daarenboven werden er ook belangrijke verschillen geobserveerd in het aantal jong-volwassenen die 
op de kindercardiologische afdeling blijven, cardiale follow-up onderbreken, of zelfs ondetecteerbaar 
werden in het gehele gezondheidszorgsysteem. Op basis van een literatuurstudie betreffende het 
probleem van zorgonderbrekingen in de algemene populatie van jongeren met een chronische 
aandoening werden er zowel risico- als protectieve factoren geïdentificeerd. Vier categorieën van 
determinanten werden geïdentificeerd: demografische kenmerken, kenmerken gerelateerd aan de 
aandoening, gezondheidszorggebruik, en het gezondheidsgedrag van patiënten. Bijkomende studies 
zijn echter noodzakelijk om bijkomstige determinanten van discontinuering van zorg te identificeren 
en uiteindelijk ook effectieve strategieën te ontwikkelen die een dergelijke discontinuering kan 
voorkomen. 
 Wanneer jongeren met AHA ontwikkelen naar opgroeiende volwassenen, worden zij 
verondersteld om een set van vaardigheden, inzichten en attitudes eigen te maken die vereist zijn in 
het volwassen leven en zorgsysteem. Het aanbieden van transitionele zorg als een allomvattend 
pakket van interdisciplinaire ondersteuning, begeleiding en zorg wordt sterk aanbevolen door 
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internationale experten. Patiënteneducatie betreffende diverse AHA-gerelateerde aspecten wordt 
aanbevolen als een belangrijke component van transitionele zorg. Dit doctoraatsonderzoek toonde 
aan dat er significante tekorten zijn in de kennis van patiënten omtrent hun aandoening, 
behandeling, preventieve gedragingen en implicaties van de aandoening op het verdere volwassen 
leven. Dit doctoraat toonde aan dat één gestructureerde, geïndividualiseerde educatiesessie 
resulteert in een significante, doch kleine verbetering van het kennisniveau. Een significante 
verbetering van het gezondheidsgedrag kon echter niet worden aangetoond in dit doctoraat. 
Innovatieve supplementaire interventies die tot doel hebben om het niveau van kennis te verhogen 
bij patiënten met AHA moeten in de toekomst verder ontwikkeld en getest worden.  
 Adolescenten vertonen typisch risicovoller gezondheidsgedrag als onderdeel van hun 
ontwikkeling als adolescent. Adolescentie is namelijk gekenmerkt door experimenteel gebruik van 
tabak, alcohol en (illegale) drugs. Het aanmeten van een hartbeschermende levensstijl is echter van 
enorm groot belang voor patiënten met AHA. Het geven van educatie aan patiënten over de risico’s 
van een risicovolle levensstijl en het omschrijven van het gewenste preventieve gedrag wordt 
belangrijk geacht door experten en clinici. Dit doctoraat toonde een significante toename van 
risicovol gezondheidsgedrag aan bij adolescenten net op de leeftijd waar zij doorgaans de transfer 
naar volwassen zorg maken, namelijk rond de leeftijd van 16j. Deze bevinding duidt aan dat het 
zinvol is om op een actieve wijze risicovol gedrag te detecteren bij patiënten met AHA. Een dergelijke 
detectie kan op valide wijze worden uitgevoerd aan de hand van de ‘Gezondheidsgedragschaal voor 
Aangeboren Hartaandoeningen’. Het wijzigen van risicovol gezondheidsgedrag bij jongeren door 
middel van educatie lijkt echter een uitdagende en eerder ineffectieve strategie te zijn. Dit doctoraat 
kon namelijk geen positief effect aantonen in het verbeteren van gezondheidsgedrag bij jongeren 
met AHA door educatie. Toekomstige studies zijn noodzakelijk om te onderzoeken of een groter 
effect kan bereikt worden indien patiënten worden blootgesteld aan meerdere opeenvolgende 
educatiesessies over een langere tijdsperiode 
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